<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d818709dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>among </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STRYKER
CORPORATION, </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STRYKER B.V. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WRIGHT MEDICAL GROUP
N.V. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated as of November&nbsp;4, 2019 </B></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Page</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Article I</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certain Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Article II</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">THE OFFER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The Offer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Company Action</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Treatment of Equity Awards; Company ESPP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Extraordinary General Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Further Actions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Post-Offer Reorganization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Section 16 Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Certain Adjustments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Withholding</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Article III</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Organization and Corporate Power</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Authorization; Valid and Binding Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Capitalization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Breach</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">SEC Reports; Disclosure Controls and Procedures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Undisclosed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Absence of Certain Developments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Compliance with Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Title to Tangible Properties; Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Contracts and Commitments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Employee Benefit Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Environmental Compliance and Conditions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Employment and Labor Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">FDA and Regulatory Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Brokerage</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Disclosure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Anti-Takeover Measures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Opinion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Other Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Article IV</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPRESENTATIONS AND WARRANTIES</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF
PARENT AND BUYER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Organization and Corporate Power</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Authorization; Valid and Binding Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Breach</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Offer Documents; <FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Brokerage</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Operations of Buyer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Ownership of Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Funds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Investigation by Parent and Buyer; Disclaimer of Reliance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Other Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Other Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Article V</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Covenants of the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Access to Information; Confidentiality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Acquisition Proposals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Employment and Employee Benefits Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Directors&#146; and Officers&#146; Indemnification and Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Further Action; Efforts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Public Announcements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Approval of Compensation Actions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Treatment of Certain Indebtedness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Post-Closing Reorganizations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Conduct of Buyer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Control of the Company&#146;s Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Operations of Buyer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Shareholder Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Delisting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Social and Economic Council Merger Regulation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Anti-Takeover Measures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notification of Certain Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Parent&#146;s Financing Activities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Ownership of Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Article VI</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TERMINATION, AMENDMENT AND WAIVER</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination by Mutual Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination by Either Parent or the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination by the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination by Parent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Effect of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Amendment and Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Article VII</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">GENERAL PROVISIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-Survival</FONT> of Representations, Warranties, Covenants and Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Assignment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Entire Agreement; Third-Party Beneficiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Headings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Performance Guaranty</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Jurisdiction; Waiver of Jury Trial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Service of Process</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Specific Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><U>Annexes</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex&nbsp;I</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Conditions to the Offer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex&nbsp;II(A)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Deed of Amendment for Price Determination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex&nbsp;II(B)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Amended Articles of Association of the Company after Conversion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex&nbsp;II(C)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Amended Articles of Association of the Company after Delisting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex&nbsp;II(D)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Financial Year Deed of Amendment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex&nbsp;III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Antitrust Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><U>Exhibits</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Asset Sale Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Merger Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Wave Luxembourg Articles of Association</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Wave Bermuda Memorandum of Association</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;E</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Wave Bermuda <FONT STYLE="white-space:nowrap">Bye-Laws</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;F</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Merger Sub Memorandum of Association</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;G</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Merger Sub <FONT STYLE="white-space:nowrap">Bye-Laws</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PURCHASE AGREEMENT, dated as of November&nbsp;4, 2019 (this &#147;<U>Agreement</U>&#148;), among Stryker Corporation, a Michigan corporation
(&#147;<U>Parent</U>&#148;), Stryker B.V., a private company with limited liability (<I>besloten vennootschap met beperkte aansprakelijkheid</I>) organized under the Laws of the Netherlands and a direct or indirect wholly owned Subsidiary of Parent
(&#147;<U>Buyer</U>&#148;), and Wright Medical Group N.V., a public limited liability company (<I>naamloze vennootschap</I>) organized under the Laws of the Netherlands (the &#147;<U>Company</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Parent and Buyer desire that Buyer acquire the Company on the terms and subject to the conditions set forth in this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the board of directors (<I>bestuur</I>) of the Company (the &#147;<U>Company Board</U>&#148;) has (i)&nbsp;determined that, on the
terms and subject to the conditions set forth in this Agreement, this Agreement and the Signing Transactions are in the best interests of the Company and its shareholders, employees and other relevant stakeholders, (ii)&nbsp;approved the terms and
conditions of this Agreement and the Signing Transactions, the execution and delivery of this Agreement, and the performance of the Company&#146;s obligations under this Agreement and the consummation of the Signing Transactions, and
(iii)&nbsp;resolved, on the terms and subject to the conditions set forth in this Agreement, to support the Offer, to recommend (A)&nbsp;acceptance of the Offer by the shareholders of the Company and (B)&nbsp;approval and adoption of the resolutions
set forth in <U>Section</U><U></U><U>&nbsp;2.4(a)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the boards of directors of Parent and Buyer have determined that, on the
terms and subject to the conditions set forth in this Agreement, this Agreement and the Transactions are in the best interests of Parent and Buyer, respectively, and have approved the execution and delivery of this Agreement and performance of
Parent&#146;s and Buyer&#146;s obligations under this Agreement and the consummation of the Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, on the terms and
subject to the conditions set forth in this Agreement, Buyer shall commence a tender offer (as it may be amended from time to time as permitted by this Agreement, the &#147;<U>Offer</U>&#148;) to purchase any (subject to the Minimum Tender
Condition) and all of the outstanding ordinary shares, par value &#128;0.03 per share, of the Company (collectively, the &#147;<U>Shares</U>&#148;) in exchange for $30.75 per Share, in cash, without interest (such amount or any higher amount per
Share paid pursuant to the Offer in accordance with this Agreement, the &#147;<U>Offer Consideration</U>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Parent,
Buyer and the Company desire to make certain representations, warranties, covenants and agreements in connection with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and agreements contained in this Agreement,
the receipt and sufficiency of which are hereby acknowledged and accepted, and intending to be legally bound hereby, Parent, Buyer and the Company hereby agree as follows: </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DEFINITIONS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>Certain Definitions</U>. For purposes of this Agreement the term: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2020 Call Spread</U>&#148; means (i)&nbsp;the Bond Hedge Confirmations and related Side Letters, dated February&nbsp;9, 2015 and
February&nbsp;10, 2015, as amended by the Partial Termination Confirmations, dated June&nbsp;13, 2016, among the Company, WMGI and the 2020 Dealers and as further amended by the Call Spread Unwind Agreements, dated as of June&nbsp;21, 2018,
January&nbsp;30, 2019 and January&nbsp;31, 2019 among the Company, WMGI and the 2020 Dealers and (ii)&nbsp;the 2020 Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2020 Dealers</U>&#148; means Deutsche Bank AG, London Branch; JPMorgan Chase Bank, National Association; and Wells Fargo Bank,
National Association. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2020 Indenture</U>&#148; means the Indenture, dated February&nbsp;13, 2015, between WMGI and the Trustee,
as supplemented by the Supplemental Indenture, dated November&nbsp;24, 2015, among WMGI, the Company and the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2020
Notes</U>&#148; means WMGI&#146;s 2.00% Cash Convertible Senior Notes due 2020, issued pursuant to the 2020 Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2020
Warrants</U>&#148; means the Warrant Confirmations and related Side Letters, dated February&nbsp;9, 2015 and February&nbsp;10, 2015, between WMGI and the 2020 Dealers, (i)&nbsp;as amended by the Amendments to the Warrant Confirmations and related
Side Letters, dated as of November&nbsp;24, 2015, between the Company and the 2020 Dealers, (ii)&nbsp;as amended by the Partial Termination Confirmations, dated June&nbsp;13, 2016, among the Company, WMGI and the 2020 Dealers and (iii)&nbsp;as
further amended by the Call Spread Unwind Agreements, dated as of June&nbsp;21, 2018, January&nbsp;30, 2019 and January&nbsp;31, 2019 among the Company, WMGI and the 2020 Dealers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2021 Call Spread</U>&#148; means (i)&nbsp;the Bond Hedge Confirmations and related Side Letters, dated May&nbsp;12, 2016, between the
Company and the 2021 Dealers and (ii)&nbsp;the 2021 Warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2021 Dealers</U>&#148; means JPMorgan Chase Bank, National
Association and Bank of America, N.A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2021 Indenture</U>&#148; means the Indenture, dated May&nbsp;20, 2016, between the Company
and the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2021 Notes</U>&#148; means the Company&#146;s 2.25% Cash Convertible Senior Note due 2021, issued pursuant to
the 2021 Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2021 Warrants</U>&#148; means the Warrant Confirmations, dated May&nbsp;12, 2016, between the Company and
the 2021 Dealers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2023 Call Spread</U>&#148; means (i)&nbsp;the Bond Hedge Confirmations and related
Side Letters, dated June&nbsp;20, 2018, January&nbsp;30, 2019, and January&nbsp;31, 2019 between WMGI, the Company and the 2023 Dealers and (ii)&nbsp;the 2023 Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2023 Dealers</U>&#148; means JPMorgan Chase Bank, National Association, Bank of America, N.A. and Deutsche Bank AG, London Branch.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2023 Indenture</U>&#148; means the Indenture, dated June&nbsp;28, 2018, among WMGI, the Company and the Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2023 Notes</U>&#148; means WMGI&#146;s 1.625% Cash Exchangeable Senior Note due 2023, issued pursuant to the 2023 Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>2023 Warrants</U>&#148; means the Warrant Confirmations, dated June&nbsp;20, 2018, January&nbsp;30, 2019, and January&nbsp;31, 2019
between the Company and the 2023 Dealers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acceptance Time</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.1(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acquisition Proposal</U>&#148; means any offer or proposal (whether or not in writing)
made or renewed by a Person or group (other than Parent or Buyer ) at any time after the date of this Agreement relating to, or that would reasonably be likely to lead to, any Person or group acquiring, directly or indirectly, beneficial ownership
of fifteen percent (15%) or more of any class of equity or voting securities of the Company (or of any resulting parent company of the Company) or assets representing fifteen percent (15%) or more of the consolidated revenues, net income or total
assets of the Company and its Subsidiaries, pursuant to a merger, consolidation, joint-venture, recapitalization, dissolution, liquidation or other business combination, sale of share capital, sale, license or other transfer or disposition of
assets, tender offer or exchange offer, or similar transaction, including any single or multi-step transaction or series of related transactions, in each case, other than the Offer, Asset Sale, Compulsory Acquisition, Liquidation, Second Step
Distribution and the Mergers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Action</U>&#148; means any pending or threatened claim, controversy, charge, cause of action,
complaint, demand, subpoena, prosecution, audit, examination, mediation, notice, action, suit, litigation, arbitration, inquiry, investigation or other legal administrative, arbitral or similar proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; of any particular Person means any other Person controlling, controlled by or under common control with such
particular Person. For the purposes of this definition, &#147;controlling,&#148; &#147;controlled&#148; and &#147;control&#148; mean the possession, directly or indirectly, of the power to direct the management and policies of a Person whether
through the ownership of voting securities or partnership or other interests, contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Agreement</U>&#148; has the
meaning set forth in the Preamble. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>AKS</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.20(m)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Alternative Acquisition Agreement</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.3(d)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Antitrust Laws</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5.6(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Anti-Corruption Laws</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3.20(g)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Anti-Takeover Measure</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3.23</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Asset Sale</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.4(a)(ii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Asset Sale Agreement</U>&#148; means the agreement between Buyer or one of its
Affiliates and the Company substantially in the form set forth in Exhibit A attached hereto, with such changes as may be agreed by Buyer or its Affiliate party thereto and the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Asset Sale Documentation</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.7(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Asset Sale Resolutions</U>&#148; means the resolutions described in <U>Section</U><U></U><U>&nbsp;2.4(a)(ii)</U> and
<U>Section</U><U></U><U>&nbsp;2.4(a)(iii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Beneficial Owner</U>&#148; with respect to any Shares has the meaning ascribed to
such term under Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act (and the terms &#147;beneficially owns&#148; and &#147;owns beneficially&#148; have a corresponding meaning). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Beneficial Ownership Regulation</U>&#148; means 31 C.F.R. &#167; 1010.230. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means a day, other than Saturday, Sunday or other day on which commercial banks in Amsterdam, The Netherlands
or New York, New York, United States are authorized or required by applicable Law to close. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer</U>&#148; has the meaning set
forth in the Preamble. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Directors</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.5(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Material Adverse Effect</U>&#148; means any change, effect, event, inaccuracy, occurrence, or other matter that has a material
adverse effect on the ability of Parent or Buyer to perform its obligations under this Agreement or to consummate the Transactions or on the consummation of, whether by prevention or material delay, any of the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Plan</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.4(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Shares</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.7(a)(vi)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Change of Board Recommendation</U>&#148; means (a)&nbsp;the withdrawal or modification or qualification of the Company Board
Recommendation or any public proposal to withdraw, modify or qualify the Company Board Recommendation, (b)&nbsp;the approval, authorization or recommendation by the Company Board or any committee thereof of any Acquisition Proposal or any public
proposal by the Company Board or any committee thereof to approve, authorize or recommend any Acquisition Proposal, (c)&nbsp;the failure to include the Company Board Recommendation in the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> or in
the Proxy Statement when disseminated to the holders of Shares, (d)&nbsp;the failure by the Company, within ten (10)&nbsp;Business Days of the public </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
announcement of the commencement of a tender or exchange offer for Shares that constitutes an Acquisition Proposal (whether or not a Superior Proposal) by a Person other than Parent or any of its
Subsidiaries, to file a Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> pursuant to Rule <FONT STYLE="white-space:nowrap">14e-2</FONT> and Rule <FONT STYLE="white-space:nowrap">14d-9</FONT> promulgated under the Exchange Act recommending that
the holders of the Shares reject such Acquisition Proposal and not tender any Shares into such tender or exchange offer, or (e)&nbsp;the failure by the Company Board to publicly reaffirm the Company Board Recommendation within ten (10)&nbsp;Business
Days after receiving a written request from Parent to provide such public reaffirmation following public disclosure of an Acquisition Proposal (or, if earlier (but still, after a written request delivered by Parent to the Company at least
forty-eight (48)&nbsp;hours prior to the then-scheduled Expiration Time, or the EGM or any Subsequent EGM, as applicable), prior to the then-scheduled Expiration Time, or the EGM or any Subsequent EGM, as applicable); <U>provided</U>, that, Parent
may deliver only one (1)&nbsp;such request with respect to any Acquisition Proposal subject to this clause (e) (it being understood that any change to the financial terms or any other material terms of any such Acquisition Proposal, shall constitute
a new Acquisition Proposal for this purpose). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.1(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.1(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.10</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company</U>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company 401(k) Plan</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.4(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Balance Sheet Date</U>&#148; means December&nbsp;30, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Board</U>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Board Recommendation</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Disclosure Documents</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.22</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Disclosure Letter</U>&#148; has the meaning set forth in <U>Article</U><U></U><U>&nbsp;III</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Equity Awards</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Equity Plans</U>&#148; means the Wright Medical Group N.V. 2017 Equity and Incentive Plan, the Wright Medical Group N.V.
Amended and Restated 2010 Incentive Plan, the Tornier N.V. Amended and Restated 2010 Incentive Plan, the Tornier N.V. Amended and Restated Stock Option Plan, the Wright Medical Group, Inc. Second Amended and Restated 2009 Equity Incentive Plan and
the Inducement Stock Option Grant Agreement dated as of September&nbsp;17, 2011 between Wright Medical Group, Inc. and Robert J. Palmisano. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company ESPP</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.3(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company ESPP Purchase Rights</U>&#148; means rights to acquire the Shares under the
Company ESPP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP</U>&#148; means all Intellectual
Property that is exclusively licensed to the Company or any of its Subsidiaries, whether registered or unregistered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company
Leased Real Property</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.11(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Material Adverse
Effect</U>&#148; means any change, effect, event, inaccuracy, occurrence or other matter that, individually or in the aggregate, (1)&nbsp;prevents or materially delays the Company from consummating the Transactions or performing its obligations
under this Agreement or (2)&nbsp;has a material adverse effect on the business, condition (financial or otherwise), assets, operations, or results of operations of the Company and its Subsidiaries, taken as a whole; <U>provided</U>, <U>however</U>,
that in the case of clause (2), any changes, effects, events, inaccuracies, occurrences, or other matters resulting from any of the following will be disregarded in determining whether a Company Material Adverse Effect has occurred: (a)&nbsp;matters
generally affecting the U.S. or foreign economies, financial or securities markets, or matters generally affecting the political, legislative, or regulatory conditions in the industry in which the Company and its Subsidiaries operate, except to the
extent such matters have a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the impact on other companies in the industry in which the Company and its Subsidiaries operate; (b)&nbsp;the announcement
or pendency of this Agreement or the Transactions; (c)&nbsp;any change in the market price or trading volume of the Shares; <U>provided</U>, that, this exception will not preclude a determination that a matter underlying such change has resulted in
a Company Material Adverse Effect; (d)&nbsp;acts of war or terrorism (or the escalation of the foregoing) or natural disasters, national emergencies, or other similar <I>force majeure </I>events, except to the extent such matters have a
disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the impact on other companies in the industry in which the Company and its Subsidiaries operate; (e)&nbsp;changes in GAAP, Laws, regulations, or
accounting principles, or interpretations thereof, except to the extent such changes have a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the impact on other companies in the industry in which the
Company and its Subsidiaries operate; (f)&nbsp;any action taken by the Company expressly required to be taken by the terms of this Agreement (it being understood and agreed that actions taken by the Company or its Subsidiaries pursuant to its
obligations under <U>Section</U><U></U><U>&nbsp;5.1</U> to conduct its business shall not be excluded in determining whether a Company Material Adverse Effect has occurred); (g)&nbsp;any action taken by the Company at the express written request of
Parent or Buyer after the date of this Agreement; or (h)&nbsp;any failure by the Company to meet any internal or analyst projections or forecasts or estimates of revenues, earnings, or other financial metrics for any period; <U>provided</U>, that,
this exception will not preclude a determination that a matter underlying such failure has resulted in a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Material Contract</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.13(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Option Grant Date</U>&#148; means a grant of Company Stock Options duly authorized no later than the date on which the grant
of such Company Stock Option was by its terms to be effective. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Organizational Documents</U>&#148; means the articles of association
(<I>statuten</I>), or equivalent organizational documents, of the Company as amended and in effect on the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Owned Real Property</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.11(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Permits</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.20(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Plan</U>&#148; means any Plan that the Company or any of its Subsidiaries sponsors, maintains, contributes to, is obligated
to sponsor, maintain or contribute to, in each case, for the benefit of any current or former employee, officer, independent contractor or director of the Company or any of its Subsidiaries and with respect to which the Company or any of its
Subsidiaries could have any Liability; <U>provided</U>, <U>however</U>, that Company Plan will not include any Plan (including any <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan) that is maintained for the benefit of current or former
employees, officers, independent contractors or directors of the Company or any of its Subsidiaries who are primarily located in a jurisdiction other than the U.S. if the benefits provided thereunder are required to be provided by statute and do not
exceed the level of benefits required to be so provided. For clarity, &#147;Company Plans&#148; includes &#147;Company Equity Plans.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company PSU</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Real Property</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.11(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Registered Intellectual Property</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.14(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company RSU</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company SEC Documents</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.7(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Stock Option</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Compensation Action</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.8</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Compulsory Acquisition</U>&#148; means the compulsory acquisition of Shares from each Minority Shareholder in accordance with
Section&nbsp;2:92a or, if applicable, Section&nbsp;2:201a of the DCC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Confidentiality Agreement</U>&#148; has the meaning set
forth in <U>Section</U><U></U><U>&nbsp;5.2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consent</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3.6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Contract</U>&#148; means any written, oral or other agreement, contract, subcontract,
lease, <FONT STYLE="white-space:nowrap">sub-lease,</FONT> occupancy agreement, binding understanding, obligation, promise, instrument, indenture, mortgage, note, option, warranty, purchase order, license, commitment or undertaking of any nature,
which, in each case, is legally binding upon a party or on any of its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Convertible Notes</U>&#148; means,
collectively, each of the 2020 Notes, the 2021 Notes and the 2023 Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Copyrights</U>&#148; means all works of authorship (whether or not copyrightable)
and all copyrights (whether or not registered), including all registrations thereof and applications therefor, and all renewals, extensions, restorations and reversions of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Credit Agreement</U>&#148; means the Amended and Restated Credit, Security and Guaranty Agreement, dated as of May&nbsp;7, 2018 among
the Company, WMGI, certain other direct and indirect subsidiaries listed on the signature pages thereto, MidCap Funding Trust IV Trust and the financial institutions or other entities parties thereto, as amended and in effect on the date of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Current Employees</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.4(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>DCC</U>&#148; means the Dutch Civil Code (<I>Burgerlijk Wetboek</I>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Demerger</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.4(a)(viii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Demerger Resolutions</U>&#148; means the resolutions described in <U>Section</U><U></U><U>&nbsp;2.4(a)(viii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Determination Notice</U>&#148; means any notice delivered by the Company to Parent pursuant to
<U>Section</U><U></U><U>&nbsp;5.3(e)(i)(C)</U> or <U>Section</U><U></U><U>&nbsp;5.3(e)(ii)(B)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dutch Merger
Publication</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.4(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>EGM</U>&#148; has the meaning set
forth in <U>Section</U><U></U><U>&nbsp;2.4(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>EGM Materials</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.4(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Enforceability Exceptions</U>&#148; means (i)&nbsp;any applicable bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and similar applicable Laws of general applicability, now or hereafter in effect, affecting or relating to creditors&#146; rights and remedies generally and (ii)&nbsp;the remedies of
specific performance and injunctive and other forms of equitable relief that may be subject to equitable defense, whether considered in a proceeding at Law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Laws</U>&#148; means all Laws concerning Hazardous Substances, pollution or protection of the environment or human
health (in regards to exposure to Hazardous Substances), as such of the foregoing are promulgated and in effect on or prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.17(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA Affiliate</U>&#148; means any trade or business (whether or not incorporated) which is, or has at any relevant time been, under
common control, or treated as a single employer, with the Company, Parent or any of their respective Subsidiaries, as applicable, under Sections 414(b), (c), (m) or (o)&nbsp;of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Expiration Time</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>FCPA</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.20(g)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>FDA</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3.20(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>FDCA</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3.20(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Federal Health Care Program</U>&#148; has the meaning set forth in 42 U.S.C. <FONT
STYLE="white-space:nowrap">1320a-7b(f).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Finance Leases</U>&#148; means all obligations for finance leases (determined in
accordance with GAAP). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Financing Parties</U>&#148; means, in its capacity as such, any agent, arranger, lender, underwriter
(including in a debt or equity offering (whether public or private)), purchaser, noteholder or other debt financing source providing a commitment to provide or arrange all or part of any public or private debt financing or any public or private
equity offering (including any offering of derivative securities or other securities exchangeable for, or convertible into, equity securities) pursuant to any commitment letter, engagement letter or any definitive financing documents in connection
with this Agreement and the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>First-Step Merger</U>&#148; means the merger of the
Company with and into Wave Luxembourg as contemplated by the Merger Documentation, with, subject to the terms and conditions of the Merger Documentation, (i)&nbsp;Wave Luxembourg surviving such merger and (ii)&nbsp;each Share outstanding immediately
prior to the consummation thereof being exchanged against into one (1)&nbsp;duly authorized, validly issued and fully paid share of Wave Luxembourg. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; means U.S. generally accepted accounting principles as in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GDPR</U>&#148; means the General Data Protection Regulation (EU) 2016/679. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Good Clinical Practices</U>&#148; means the FDA&#146;s standards for the design, conduct, performance, monitoring, auditing,
recording, analysis, and reporting of clinical trials contained in 21 C.F.R. Parts 50, 54, 56 and 812. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Good Laboratory
Practices</U>&#148; means the FDA&#146;s standards for conducting <FONT STYLE="white-space:nowrap">non-clinical</FONT> laboratory studies contained in 21 C.F.R. Part 58. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governance Resolutions</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.4(a)(ix)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Body</U>&#148; means any federal, state, provincial, local, municipal, foreign or other governmental authority,
including, any judicial, administrative or arbitral body, applicable securities exchange, or any department, minister, agency, commission, commissioner, board, subdivision, bureau, agency, instrumentality, court or other tribunal of any of the
foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hazardous Substance</U>&#148; means (a)&nbsp;any petroleum products or byproducts, radioactive materials, friable
asbestos or other similarly hazardous substances or (b)&nbsp;any waste, material or substance that is defined or regulated as a &#147;hazardous substance,&#148; &#147;hazardous material,&#148; &#147;hazardous waste,&#148; &#147;pollutant,&#148;
&#147;contaminant&#148; or terms of similar import under any Environmental Law or that can otherwise give rise to liability under any Environmental Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Healthcare Laws</U>&#148; means, to the extent related to the conduct of
Parent&#146;s business or the Company&#146;s business, as applicable, (a)&nbsp;the FDCA, and the regulations promulgated thereunder, (b)&nbsp;all federal and state fraud and abuse Laws, including, the federal Anti-Kickback Statute (42 U.S.C. &#167; <FONT
STYLE="white-space:nowrap">1320a-7b(b)),</FONT> the Stark Law (42 U.S.C. &#167; 1395nn), the civil False Claims Act (31 U.S.C. &#167; 3729 et seq.), <FONT STYLE="white-space:nowrap">Sections&nbsp;1320a-7</FONT> and
<FONT STYLE="white-space:nowrap">1320a-7a</FONT> of Title 42 of the United States Code and the regulations promulgated pursuant to such statutes, (c)&nbsp;the administrative simplification provisions of the Health Insurance Portability and
Accountability Act of 1996 (18 U.S.C. &#167;&#167;669, 1035, 1347 and 1518; 42 U.S.C. &#167;1320d et seq.) and the regulations promulgated thereunder, (d)&nbsp;Titles XVIII (42 U.S.C. &#167;1395 et seq.) and XIX (42 U.S.C. &#167;1396 et seq.) of the
Social Security Act and the regulations promulgated thereunder, (e)&nbsp;the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (42 U.S.C. <FONT STYLE="white-space:nowrap">&#167;1395w-101</FONT> et seq.) and the regulations
promulgated thereunder, (f)&nbsp;the <FONT STYLE="white-space:nowrap">so-called</FONT> federal &#147;Sunshine Law&#148; or Open Payments (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7h)</FONT> and state or local Laws regulating or
requiring reporting of interactions between medical device manufacturers and members of the healthcare industry and regulations promulgated thereunder and (g)&nbsp;Laws governing government pricing or price reporting programs and regulations
promulgated thereunder, including the Medicaid Drug Rebate Program (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1396r-8)</FONT> and any state supplemental rebate program, the Public Health Service Act (42 U.S.C. &#167; 256b), the VA Federal
Supply Schedule (38 U.S.C. &#167; 8126) or any state pharmaceutical assistance program or U.S. Department of Veterans Affairs agreement, and any successor government programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hedging Documentation</U>&#148; means, collectively, the 2020 Call Spread, 2021 Call Spread and 2023 Call Spread. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HIPAA</U>&#148; means collectively: (a)&nbsp;the Health Insurance Portability and Accountability Act of 1996 (Pub. L. <FONT
STYLE="white-space:nowrap">No.&nbsp;104-191),</FONT> including, but not limited, to its implementing rules and regulations with respect to privacy, security of health information, and transactions and code sets; (b)&nbsp;the Health Information
Technology for Economic and Clinical Health Act (Title XIII of the American Recovery and Reinvestment Act of 2009); and (c)&nbsp;the Omnibus Rule effective March&nbsp;26, 2013 (78 Fed. Reg. 5566), and other implementing rules and regulations at 45
CFR Parts 160 and 164 and related binding guidance from the United States Department of Health and Human Services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR
Act</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Incidental License</U>&#148; means
(i)&nbsp;permitted use right to confidential information in a nondisclosure agreement; (ii)&nbsp;license, assignment or waiver of rights with any current or former employee or contractor of the Company or any of its Subsidiaries for the benefit of
the Company or its Subsidiaries; (iii)&nbsp;rights granted under any standard form terms of use for any website of the Company or any of its Subsidiaries; (iv)&nbsp;a sales or marketing or similar Contract that includes a license to use the
Trademarks of the Company or any of its Subsidiaries for the purposes of promoting any Products; (v)&nbsp;a vendor Contract that includes permission for the vendor to identify the Company or any of its Subsidiaries as a customer of the vendor; or
(vi)&nbsp;a Contract to purchase or lease equipment, such as a photocopier, computer, or mobile phone that also contains a license of Intellectual Property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; means, with respect to any Person, without duplication:
(a)&nbsp;the principal, accreted value, accrued and unpaid interest, fees and prepayment premiums or penalties, unpaid fees or expenses and other monetary obligations in respect of (i)&nbsp;indebtedness of such Person for borrowed money, whether
current, short term or long term and whether secured or unsecured and (ii)&nbsp;indebtedness evidenced by notes, debentures, bonds, or other similar securities or instruments for the payment of which such Person is liable, (b)&nbsp;all obligations
of such Person issued or assumed as the deferred purchase price of property or services (other than trade payables or accruals incurred in the ordinary course of business), (c) all obligations of such Person for the reimbursement of any obligor on
any letter of credit, banker&#146;s acceptance, surety bonds or similar credit transaction, (d)&nbsp;all obligations of such Person under Finance Leases; (e)&nbsp;any liabilities or obligations with respect to interest rate swaps, collars, caps and
similar hedging obligations, (f)&nbsp;all obligations of the type referred to in <FONT STYLE="white-space:nowrap">sub-clauses&nbsp;(a)</FONT> through (e)&nbsp;of any Persons for the payment of which such Person is responsible or liable, directly or
indirectly, as obligor, guarantor, surety or otherwise, including guarantees of such obligations and (g)&nbsp;all obligations of the type referred to in clauses (a)&nbsp;though (f) of other Persons secured by (or for which the holder of such
obligations has a right, contingent or otherwise, to be secured by) any Lien on any property or asset of such Person (whether or not such obligation is assumed by such Person). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indemnified Party</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.5(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indentures</U>&#148; means, collectively, each of the 2020 Indenture, the 2021 Indenture and the 2023 Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Independent Directors</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.5(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Initial Expiration Time</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property</U>&#148; means all intellectual property rights and industrial property rights of every kind and description
in any jurisdiction worldwide, including rights in and to the following, in any jurisdiction worldwide: (i)&nbsp;Trademarks; (ii) Patents; (iii)&nbsp;Trade Secrets; (iv)&nbsp;Copyrights; and (v)&nbsp;Software. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intentional Breach</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.5(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intervening Event</U>&#148; means a material change, effect, event, circumstance, occurrence, or other matter that was not known to
the Company Board or any committee thereof on the date of this Agreement (or if known, the consequences of which were not known to the Company Board or any committee thereof as of the date of this Agreement), which change, effect, event,
circumstance, occurrence, or other matter, or any consequence thereof, becomes known to the Company Board or any committee thereof prior to the Acceptance Time; <U>provided</U>, <U>however</U>, that in no event will any Acquisition Proposal or any
inquiry, offer, or proposal that constitutes or would reasonably be expected to lead to an Acquisition Proposal constitute an Intervening Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>IP Contracts</U>&#148; means all Contracts under which (i)&nbsp;the Company or any of its Subsidiaries, as applicable, has obtained
from or granted to any third party (or agrees to obtain from or grant to any third party) any license, covenant not to sue, <FONT STYLE="white-space:nowrap">co-existence</FONT> agreement, settlement agreement or other right, title or interest in or
(ii)&nbsp;the Company or any of its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Subsidiaries, as applicable, is expressly restricted from using, in each case (i)&nbsp;and (ii) of this definition, any Intellectual Property that is material to the continued operation of the
business of the Company or any of its Subsidiaries, as applicable, as of the date of this Agreement, except for (A)&nbsp;Contracts for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Off-the-Shelf</FONT></FONT> Software,
(B)&nbsp;Contracts for open source software, (C)&nbsp;any Incidental License and <FONT STYLE="white-space:nowrap">(D)&nbsp;non-exclusive</FONT> licenses granted to customers of the Company or any of its Subsidiaries in the ordinary course of
business pursuant to the Company&#146;s or its Subsidiaries&#146; standard customer contracts (copies of the forms of which have been provided to Parent). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Key Employee</U>&#148; means any vice president or more senior employee of the Company or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Knowledge</U>&#148; of Parent or the Company, as applicable, means the actual knowledge of the respective individuals listed on the
Company Disclosure Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Law</U>&#148; means any supranational, foreign or U.S. federal, state or local law (including common
law), treaty, statute, code, order, ordinance, Permit, rule, regulation, or other requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body, and, for the sake of
clarity, includes, but is not limited to, Healthcare Laws and Environmental Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lease</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3.11(</U>b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liability</U>&#148; means, with respect to any Person, any liability or obligation of
that Person of any kind, character or description, whether known or unknown, absolute or contingent, accrued or unaccrued, asserted or unasserted, disputed or undisputed, liquidated or unliquidated, secured or unsecured, joint or several, due or to
become due, vested or unvested, executory, determined, determinable or otherwise, and whether or not the same is required to be accrued on the financial statements of that Person in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lien</U>&#148; means any lien, mortgage, security interest, pledge, encumbrance, deed of trust, security interest, claim, lease,
charge, option, preemptive right, subscription right, easement, servitude, proxy, voting trust or agreement, transfer restriction under any shareholder or similar agreement or restriction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liquidation</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.5(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liquidator</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.4(a)(iii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Measurement Date</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Merger Agreement</U>&#148; means the agreement substantially in the form set forth in Exhibit B attached hereto, with such changes as
may be reasonably agreed by Parent and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Merger Documentation</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5.10(a)(iii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Merger Resolutions</U>&#148; means the resolutions described in
<U>Section</U><U></U><U>&nbsp;2.4(a)(iv)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Merger Sub</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5.10(b)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Mergers</U>&#148; means, collectively, the First-Step Merger, the Second-Step
Merger and the Third-Step Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Minimum Tender Condition</U>&#148; has the meaning set forth in
<U>Annex</U><U></U><U>&nbsp;I</U>, <U>Paragraph</U><U></U><U>&nbsp;1(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Minority Exit Offering Period</U>&#148; has the
meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(f)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Minority Shareholders</U>&#148; means holders of Shares that were
not tendered pursuant to the Offer or, if applicable, in the Subsequent Offering Period (as it may be extended by the Minority Exit Offering Period). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Nasdaq</U>&#148; means The Nasdaq Stock Market LLC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan</U>&#148; means a Plan that is subject to the Laws of a jurisdiction other than
the U.S. (whether or not U.S. Law also applies). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Notice Period</U>&#148; means the period beginning at 5:00 p.m. Eastern Time on
the day of delivery by the Company to Parent of a Determination Notice (even if such Determination Notice is delivered after 5:00 p.m. Eastern Time) and ending on the fourth (4th) Business Day thereafter at 5:00 p.m. Eastern Time; <U>provided</U>
that with respect to any change in the financial terms or any other material terms of an Acquisition Proposal, the Company shall, in each case, deliver to Parent an additional Determination Notice and such additional Notice Period will begin at 5:00
p.m. Eastern Time on the day of delivery by the Company to Parent of a Determination Notice (even if such Determination Notice is delivered after 5:00 p.m. Eastern Time) and end on the second (2nd) Business Day thereafter at 5:00 p.m. Eastern Time
and the Company shall be required to comply with the requirements of <U>Section</U><U></U><U>&nbsp;5.3(e)</U> with respect to each such additional Determination Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>OECD Convention</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.20(g)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>OFAC</U>&#148; shall mean the Office of Foreign Assets Control of the U.S. Department of the Treasury. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Off-the-Shelf</FONT></FONT> Software</U>&#148; means software,
other than open source software, obtained from a third party (a)&nbsp;on general commercial terms and that continues to be widely available on such commercial terms and (b)&nbsp;was licensed for fixed payments of less than $250,000 in the aggregate
or annual payments of less than $250,000 per year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Offer</U>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Offer Commencement Date</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Offer Conditions</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Offer Consideration</U>&#148; has the meaning set forth in Recitals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Offer Commencement Date</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.1(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Offer Documents</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.1(h)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Open Source Code</U>&#148; means any Software that is distributed under &#147;open
source&#148; or &#147;free software&#148; terms or that is distributed under a license meeting the Open Source Definition (as promulgated by the Open Source Initiative) or the Free Software Definition (as promulgated by the Free Software
Foundation), the GPL, LGPL, Mozilla License, Apache License, Common Public License, BSD license or similar terms, including any Software distributed with any license term or condition that requires or conditions the use or distribution of such
Software on the disclosure, licensing or distribution of any source code for any portion of such Software or any derivative work of such Software. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Open Source License</U>&#148; means the licensing and other related terms and conditions pertaining to any Open Source Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Outside Date</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Owned Intellectual Property</U>&#148; means all Intellectual Property that is owned or purported to be owned by the Company or any of
its Subsidiaries, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent</U>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Patents</U>&#148; means issued patents (including issued utility and design patents), utility models, registered community designs,
registered industrial designs, certificates of invention, any pending applications for any of the foregoing, and invention disclosures and records of invention, including any divisionals, provisionals, revisions, supplementary protection
certificates, continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> reissues, <FONT STYLE="white-space:nowrap">re-examinations,</FONT> substitutions, extensions and renewals of any of
the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permits</U>&#148; means all approvals, authorizations, clearances, certificates, consents, licenses, orders and
permits and other similar authorizations of all Governmental Bodies and all other Persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Liens</U>&#148; means
(a)&nbsp;statutory Liens for current Taxes or other governmental charges not yet due and payable or the amount or validity of which is being contested in good faith by appropriate proceedings and for which appropriate reserves are established in the
financial statements in accordance with GAAP, (b)&nbsp;mechanics&#146;, carriers&#146;, workers&#146;, repairers&#146;, contractors&#146;, subcontractors&#146;, suppliers&#146; and similar statutory Liens arising or incurred in the ordinary course
of business in respect of the construction, maintenance, repair or operation of assets for amounts that are not delinquent or the amount or validity of which is being contested in good faith by appropriate proceedings and for which appropriate
reserves are established in the financial statements in accordance with GAAP or that do not, individually or in the aggregate, materially impair the occupancy, marketability or use of such property for the purposes for which it is currently used or
proposed to be used in connection with the Company&#146;s business, (c)&nbsp;zoning, entitlement, building and other land use regulations imposed by governmental agencies having jurisdiction over the Company Leased Real Property which are not
violated by the current use and operation of the Company Leased Real Property, (d) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
covenants, conditions, restrictions, easements and other similar matters of record affecting title to the Company Leased Real Property that do not materially impair the occupancy, marketability
or use of such leased real property for the purposes for which it is currently used or proposed to be used in connection with the Company&#146;s business, (e)&nbsp;Liens arising under workers&#146; compensation, unemployment insurance and social
security, (f)&nbsp;purchase money liens and liens securing rental payments under Finance Leases and (g)&nbsp;those matters identified in the Permitted Liens Section of the Company Disclosure Letter, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual, a partnership, a corporation, a limited liability company, an unlimited liability company, an
association, a joint stock company, a trust, a joint venture, an unincorporated organization, any other entity, a Governmental Body or any department, agency or political subdivision thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Personal Information</U>&#148; means data or information that (i)&nbsp;identifies, relates to, describes, is capable of being
associated with or could reasonably be linked, directly or indirectly, with a particular individual or household or (ii)&nbsp;is otherwise defined as &#147;personal data&#148; pursuant to the GDPR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Plan</U>&#148; means an &#147;employee benefit plan&#148; within the meaning of Section&nbsp;3(3) of ERISA and any other compensation
and benefit plan, policy, program, arrangement, or agreement, whether written or unwritten, funded or unfunded, subject to ERISA or not and covering one or more current or former officer, director, employee or independent contractor, including any
stock purchase, stock option, restricted stock, other equity or equity-based, phantom equity, severance, separation, retention, employment, consulting, change in control, bonus, incentive, deferred compensation, pension, retirement, supplemental
retirement, employee loan, health, dental, vision, workers&#146; compensation, collective bargaining, disability, life insurance, death benefit, health, welfare, vacation, paid time off, leave of absence, fringe or other benefit plan, policy,
program, arrangement, or agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Post-Offer Reorganization</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.7(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period</U>&#148; has the meaning
set forth in <U>Section</U><U></U><U>&nbsp;5.1(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Privacy Obligations</U>&#148; mean (i)&nbsp;applicable foreign or
domestic Laws relating to privacy or data security of Personal Information, including HIPAA, GDPR and the California Consumer Privacy Act of 2018 <FONT STYLE="white-space:nowrap">(AB-375)</FONT> and (ii)&nbsp;any contractual obligations or written
policies or terms of use of the Company or any of its Subsidiaries that are related to privacy, data protection or the Processing of Personal Information, in each case as and to the extent applicable to the operation of the businesses of the Company
or any of its Subsidiaries or to information regarding any of the employees or other personnel of the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Processing</U>&#148; has the meaning ascribed to it in the GDPR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Products</U>&#148; means (i)&nbsp;any product or service that the Company or any of its Subsidiaries is manufacturing, distributing,
supporting, marketing or selling and (ii)&nbsp;any product or service currently under preclinical or clinical development by the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prohibited Payment</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.20(g)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Proxy Statement</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.4(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Remedy</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5.6(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reorganization Threshold</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.4(a)(ii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representative</U>&#148; means the officers, employees, accountants, consultants,
legal counsel, financial advisors and agents and other representatives of a Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Repurchase Transaction</U>&#148; has the
meaning set forth in <U>Section</U><U></U><U>&nbsp;5.9(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sanctioned Country</U>&#148; shall mean, at any time, a country
or territory which is itself the subject or target of comprehensive Sanctions (at the time of this Agreement, Crimea, Cuba, Iran, North Korea and Syria). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sanctioned Person</U>&#148; shall mean any Person that is the subject of Sanctions, including (i)&nbsp;any Person listed in any
Sanctions-related list maintained by OFAC or the U.S. Department of State, the United Nations Security Council, the European Union, Her Majesty&#146;s Treasury of the United Kingdom, Switzerland or any European Union member state, (ii)&nbsp;any
Person located, organized, resident in or national of a Sanctioned Country or (iii)&nbsp;any Person 50% or more owned, directly or indirectly, or otherwise controlled by any such Person or Persons described in the foregoing clauses (i)&nbsp;and
(ii). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sanctions</U>&#148; shall mean economic or financial sanctions or trade embargoes imposed, administered or enforced from
time to time by the U.S. government through OFAC or the U.S. Department of State, the United Nations Security Council, the European Union or any European Union member state, Her Majesty&#146;s Treasury of the United Kingdom or Switzerland. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sarbanes-Oxley</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.10(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Schedule</U><U></U><U><FONT STYLE="white-space:nowrap">&nbsp;14D-9</FONT></U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Schedule TO</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.1(h)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC</U>&#148; means the Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Second Step Distribution</U>&#148; means the distribution of the proceeds of the Asset Sale by means of a liquidation distribution
(which may be an advance liquidation distribution, and which may be made in one or more installments) to the shareholders of the Company such that each holder of Shares that were not validly tendered pursuant to the Offer (including, if applicable,
during the Subsequent Offering Period, as it may be extended by the Minority Exit Offering Period) shall receive cash in an amount equal to the Offer Consideration multiplied by the number of Shares then held by such holder (without interest and
less any applicable withholding Taxes). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Second-Step Merger</U>&#148; means the merger of Wave Luxembourg with and into Wave
Bermuda as contemplated by the Merger Documentation, with, subject to the terms and conditions of the Merger Documentation, (i)&nbsp;Wave Bermuda surviving such merger and (ii)&nbsp;each Wave Luxembourg share outstanding immediately prior to the
consummation thereof being converted automatically into one (1)&nbsp;duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> common share of Wave Bermuda. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; shall mean the Securities Act of 1933. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Shareholder Litigation</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.14</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Shares</U>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Signing Transactions</U>&#148; means the Transactions, excluding (i)&nbsp;each transaction that requires the approval of the
Independent Directors pursuant to <U>Section</U><U></U><U>&nbsp;2.5(f)</U> and (ii)&nbsp;the transactions referred to under <U>Section</U><U></U><U>&nbsp;2.7(a)(vi)</U> through <U>Section</U><U></U><U>&nbsp;2.7(a)(xvii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Software</U>&#148; means any and all (i)&nbsp;computer programs, including any and all software implementations of algorithms, models
and methodologies, whether in source code or object code, (ii)&nbsp;databases and compilations, including any and all data and collections of data, whether machine readable or otherwise, including program files, data files, computer-related data,
field and data definitions and relationships, data definition specifications, data models, program and system logic, interfaces, program modules, routines, <FONT STYLE="white-space:nowrap">sub-routines,</FONT> algorithms, program architecture,
design concepts, system designs, program structure, sequence and organization, screen displays and report layouts, (iii)&nbsp;descriptions, flow charts and other work product used to design, plan, organize and develop any of the foregoing, screens,
user interfaces, report formats, firmware, development tools, templates, menus, buttons and icons and (iv)&nbsp;all documentation including user manuals and other training documentation related to any of the foregoing, and any improvements, updates,
upgrades or derivative works of any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsequent EGM</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.4(e)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsequent Offering Period</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.1(f)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; means, with respect to any Person, any corporation, partnership,
association, limited liability company, unlimited liability company or other business entity of which (a)&nbsp;if a corporation, a majority of the total voting power of shares of stock or other voting or equity interests entitled (without regard to
the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination
thereof or (b)&nbsp;if a partnership, association, limited liability company, or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any
Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority ownership interest in a partnership, association, limited liability company or other business
entity if such Person or Persons are allocated a majority of partnership, association, limited liability company or other business entity gains or losses or otherwise control the managing director, managing member, general partner or other managing
Person of such partnership, association, limited liability company or other business entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Superior Proposal</U>&#148; means a written Acquisition Proposal (provided that for
purposes of this definition, references to &#147;fifteen percent (15%) or more&#148; in the definition of &#147;Acquisition Proposal&#148; shall be deemed to be references to &#147;more than fifty percent (50%)&#148;) that did not result from a
material breach of <U>Section</U><U></U><U>&nbsp;5.3</U> that (a)&nbsp;the Company Board determines in good faith is reasonably likely to be consummated on the terms proposed and (b)&nbsp;the Company Board determines in good faith, after
consultation with its outside counsel and financial advisor, is more favorable to the Company, and its shareholders, employees and other stakeholders than the Transactions after giving effect to any changes to this Agreement proposed by Parent in
response to such Acquisition Proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Supplemental Indenture</U>&#148; and &#147;<U>Supplemental Indentures</U>&#148; have the
meanings set forth in <U>Section</U><U></U><U>&nbsp;5.9(f)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax</U>&#148; or &#147;<U>Taxes</U>&#148; means any and all
federal, state, local, or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental, customs duties, capital stock,
franchise, profits, withholding, social security (or similar, including U.S. Federal Insurance Contributions Act), unemployment, disability, real property, escheat, unclaimed property, personal property, sales, use, transfer, registration,
value-added, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT> minimum, estimated, or other tax of any kind or any charge of any kind in the nature of (or similar to) taxes whatsoever, including any secondary liability, interest,
penalty, or addition thereto, in each case whether disputed or not. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Returns</U>&#148; means any return, report, election,
designation, information return or other document (including schedules or any related or supporting information) filed or required to be filed with any Governmental Body or other authority in connection with the determination, assessment or
collection of any Tax or the administration of any Laws, regulations or administrative requirements relating to any Tax, including all information returns relating to Taxes of third parties, any claims for refund of Taxes and any amendments or
supplements to any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Third-Step Merger</U>&#148; means the merger of Merger Sub with and into Wave Bermuda as
contemplated by the Merger Documentation, with, subject to the terms and conditions of the Merger Documentation, (i)&nbsp;Wave Bermuda surviving such merger and (ii)&nbsp;each Wave Bermuda share outstanding immediately prior to the consummation
thereof, other than any such shares owned by Wave Bermuda as treasury shares or owned by Parent, Buyer or any other direct or indirect wholly owned Subsidiary of Parent or the Company or any direct or indirect wholly owned Subsidiary of the Company,
being converted into the right to receive an amount in cash equal to the Offer Consideration, without interest and less applicable withholding Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trade Secrets</U>&#148; means any and all proprietary or confidential information, including trade secrets, <FONT
STYLE="white-space:nowrap">know-how,</FONT> clinical and technical data, operational data, engineering information, invention and technical reports, pricing information, research and development information, processes, formulae, methods,
formulations, discoveries, specifications, designs, algorithms, plans, improvements, models and methodologies, and customer, distributor, consumer and supplier lists and data. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trademarks</U>&#148; means trademarks, service marks, corporate names, trade names,
brand names, product names, domain names, logos, slogans, trade dress and other indicia of source or origin, any applications and registrations for the foregoing and the renewals thereof, and all goodwill associated therewith and symbolized thereby.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transactions</U>&#148; means each of the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Treasury Regulations</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.10</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trustee</U>&#148; means the Bank of New York Mellon Trust Company, N.A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>UK Bribery Act</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.20(g)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>USA PATRIOT Act</U>&#148; shall mean the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and
Obstruct Terrorism Act of 2001, Public Law <FONT STYLE="white-space:nowrap">107-56,</FONT> as the same has been, or shall hereafter be, renewed, extended, amended or replaced. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>WARN</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.19(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Warrants</U>&#148; means, collectively, each of the 2020 Warrants, the 2021 Warrants and the 2023 Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Wave Bermuda</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.10(a)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Wave Luxembourg</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.10(a)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>WMGI</U>&#148; means Wright Medical Group, Inc. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>THE OFFER
</U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>The Offer</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Buyer shall, as promptly as reasonably practicable after the date of this Agreement, but in no event later than the twenty-fifth (25<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) Business Day following the date of this Agreement (unless another date is agreed in writing by the parties hereto) and, without the consent of the Company, not to be unreasonably withheld,
conditioned or delayed, no earlier than the twentieth (20<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) Business Day following the date of this Agreement, commence (within the meaning of Rule <FONT STYLE="white-space:nowrap">14d-2</FONT>
promulgated under the Exchange Act) the Offer. The obligations of Buyer to accept for payment, and pay for, any Shares validly tendered and not properly withdrawn pursuant to the Offer shall be subject to the satisfaction or waiver (to the extent
permitted under this Agreement) of the conditions set forth in Annex I (the &#147;<U>Offer Conditions</U>&#148;). The date on which Buyer commences the Offer is referred to as the &#147;<U>Offer Commencement Date</U>&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In accordance with the terms and conditions of this Agreement and subject to the
satisfaction or waiver (to the extent such waiver is permitted hereunder and not prohibited by applicable Law) of the Offer Conditions, Buyer shall (and Parent shall cause Buyer to), at or as promptly as practicable following the Expiration Time
(but in any event within two (2)&nbsp;Business Days thereafter), accept for payment (the time of acceptance for payment, the &#147;<U>Acceptance Time</U>&#148;) and, at or as promptly as practicable following the Acceptance Time (but in any event
within two (2)&nbsp;Business Days (calculated as set forth in Rule <FONT STYLE="white-space:nowrap">14d-1(g)(3)</FONT> promulgated under the Exchange Act) thereafter), pay (by delivery of funds to the depositary for the Offer) for all Shares validly
tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time (the &#147;<U>Closing</U>&#148;). The date on which the Closing occurs is referred to in this Agreement as the &#147;<U>Closing Date</U>&#148;. The Offer
Consideration payable in respect of each Share pursuant to the first sentence of this <U>Section</U><U></U><U>&nbsp;2.1(b)</U> shall be paid (without interest and less applicable withholding Taxes) on the terms and subject to the conditions of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Buyer expressly reserves the right at any time to, in its sole discretion, waive, in whole or in part, any of the Offer
Conditions and to make any change in the terms of, or conditions to, the Offer; <U>provided</U>, that, without the prior written consent of the Company, Buyer shall not (and Parent shall cause Buyer not to): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) waive or change the Minimum Tender Condition (except to the extent contemplated under <U>paragraph</U><U></U><U>&nbsp;1(a)</U> of
<U>Annex</U><U></U><U>&nbsp;I</U>); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) decrease the Offer Consideration; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) change the form of consideration to be paid in the Offer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) decrease the number of Shares sought in the Offer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) extend or otherwise change the Expiration Time, except as otherwise provided in this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) impose additional Offer Conditions or otherwise amend, modify or supplement any of the Offer Conditions or terms of the Offer in a
manner adverse to the holders of Shares; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) increase the Offer Consideration by an increment of less than $0.10 per Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Offer shall initially expire at 9:00 a.m. (Eastern Time), or at such other time as the parties hereto may mutually agree, on the date
that is fifty (50)&nbsp;Business Days (calculated in accordance with Rule <FONT STYLE="white-space:nowrap">14d-1(g)(3)</FONT> under the Exchange Act) following the commencement of the Offer (unless another date is agreed in writing by the parties
hereto); provided that in no event shall such expiration time occur prior to the date of the EGM (such initial expiration date and time of the Offer, the &#147;<U>Initial Expiration Time</U>&#148;) or, if the Offer has been extended pursuant to and
in accordance with <U>Section</U><U></U><U>&nbsp;2.1(e)</U>, the date and time to which the Offer has been so extended (the Initial Expiration Time, or such later expiration date and time to which the Offer has been so extended, the
&#147;<U>Expiration Time</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Subject to <U>Article</U><U></U><U>&nbsp;VI</U>, Buyer may or shall (in which case
Parent shall cause Buyer to), as applicable, extend the Offer from time to time as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Buyer shall (and Parent shall cause Buyer
to) extend the Offer for the minimum period as required by any rule, regulation, interpretation or position of the SEC, the staff thereof, or Nasdaq, as applicable to the Offer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) if, at the then-scheduled Expiration Time, any of the Offer Conditions has not either been (A)&nbsp;satisfied or (B)&nbsp;waived by
Buyer (to the extent such waiver is permitted under this Agreement or applicable Law), then Buyer shall (and Parent shall cause Buyer to) extend the Offer on one or more occasions in consecutive periods of up to ten (10)&nbsp;Business Days each
(with each such period to end at 5:00 p.m. (Eastern Time) on the last Business Day of such period) (or such other duration as may be agreed to by Buyer and the Company) in order to permit the satisfaction of such Offer Condition(s); <U>provided</U>,
that if Buyer determines in good faith, after consultation with its outside legal counsel, that at any then-scheduled Expiration Time, the Offer Condition set forth in <U>paragraph 1(b)</U> of <U>Annex I</U> is not reasonably likely to be satisfied
within such ten (10)&nbsp;Business Day extension period, then Buyer may extend the Offer on such occasion for periods of up to twenty (20)&nbsp;Business Days; <U>provided</U>, <U>further</U>, that (x)&nbsp;Buyer shall not be required to, and shall
not without the prior written consent of the Company, extend the Offer to a date later than the Outside Date (as the Outside Date may be extended pursuant to <U>Section</U><U></U><U>&nbsp;6.2(b)</U>) and (y)&nbsp;if the only remaining unsatisfied
Offer Condition is the Minimum Tender Condition, Buyer shall not be required to extend the Offer on more than two (2)&nbsp;occasions in consecutive periods of up to ten (10)&nbsp;Business Days each (with each such period to end at 5:00 p.m. (Eastern
Time) on the last Business Day of such period) (or such other duration as may be agreed to by Buyer and the Company); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Buyer may
extend the Offer to such other date and time as may be mutually agreed by Parent and the Company in writing; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Buyer may extend
the Offer to the Business Day immediately following the date that is thirty (30)&nbsp;calendar days after the date of the EGM or Subsequent EGM at which the Merger Resolutions are approved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Following the Acceptance Time, Buyer shall (and Parent shall cause Buyer to) (and the Offer Documents shall so indicate) provide a
subsequent offering period (&#147;<U>Subsequent Offering Period</U>&#148;) in accordance with Rule <FONT STYLE="white-space:nowrap">14d-11</FONT> promulgated under the Exchange Act of not less than ten (10)&nbsp;Business Days (calculated in
accordance with Rule <FONT STYLE="white-space:nowrap">14d-1(g)(3)</FONT> promulgated under the Exchange Act). In the event that prior to the expiration of the Subsequent Offering Period, Buyer or Parent has publicly announced its intention to,
subject to the terms of this Agreement, effectuate the Asset Sale, Buyer shall (and Parent shall cause Buyer to) (and the Offer Documents shall so indicate) extend the Subsequent Offering Period for at least five (5)&nbsp;Business Days to permit any
remaining Minority Shareholders to tender their Shares in exchange for the Offer Consideration (such extension, the &#147;<U>Minority Exit Offering Period</U>&#148;). Notwithstanding anything to the contrary contained herein, in the event that
promptly following the Expiration Time, Buyer or Parent has publicly announced its intention to, subject to the terms of this Agreement, effectuate the Mergers, Buyer shall not be required to provide a Subsequent Offering Period (or, for the
avoidance of doubt, a Minority Exit Offering Period), but may do so if Buyer chooses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Offer may not be terminated prior to the Initial Expiration Time or the
then-scheduled Expiration Time (as the same may be extended pursuant to <U>Section</U><U></U><U>&nbsp;2.1(e)</U>) unless this Agreement is validly terminated pursuant to <U>Article</U><U></U><U>&nbsp;VI</U>. If this Agreement is validly terminated
pursuant to <U>Article</U><U></U><U>&nbsp;VI</U>, Buyer shall (and Parent shall cause Buyer to) promptly (and in any event within twenty-four (24)&nbsp;hours following such valid termination) terminate the Offer and not acquire any Shares pursuant
thereto. If the Offer is terminated in accordance with this Agreement by Parent prior to the acceptance for payment and payment for Shares tendered pursuant to the Offer, Buyer shall (and Parent shall cause Buyer to) as promptly as practicable, and
in any event within three (3)&nbsp;Business Days of the termination, return, and shall cause any depositary acting on behalf of Buyer to return, in accordance with applicable Law, all tendered Shares to the registered holders thereof. Nothing in
this <U>Section</U><U></U><U>&nbsp;2.1(g)</U> shall affect any termination rights under <U>Article</U><U></U><U>&nbsp;VI</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) As soon
as practicable on the Offer Commencement Date, Parent and Buyer shall (i)&nbsp;file or cause to be filed with the SEC a Tender Offer Statement on Schedule TO with respect to the Offer (together with all amendments and supplements thereto and
including exhibits thereto, the &#147;<U>Schedule TO</U>&#148;), which contains or incorporates by reference an offer to purchase and a related letter of transmittal and other appropriate ancillary offer documents required to be included therein
(such Schedule TO and the documents included therein pursuant to which the Offer will be made, together with any amendments or supplements thereto and including exhibits thereto, the &#147;<U>Offer Documents</U>&#148;) and (ii)&nbsp;cause the Offer
Documents to be disseminated to holders of Shares to the extent required by applicable United States federal securities Laws and any other applicable Law. The Company shall furnish promptly to Parent and Buyer all information concerning the Company
required by the Exchange Act and applicable Law, or as reasonably requested by Parent, to be set forth in the Offer Documents. Each of Parent and Buyer, on the one hand, and the Company, on the other hand, agrees promptly to correct any information
provided by it for inclusion or incorporation by reference in the Schedule TO and the Offer Documents if and to the extent that such information has become (or has become known to be) false or misleading in any material respect. Parent and Buyer
shall use their reasonable best efforts to cause the Schedule TO as so corrected to be filed with the SEC and the Offer Documents as so corrected to be disseminated to holders of Shares, in each case to the extent required by applicable United
States federal securities Laws and any other applicable Law. Parent and Buyer shall give the Company and its counsel a reasonable opportunity to review and comment on the Schedule TO and the Offer Documents each time before any such document is
filed with the SEC, and Parent and Buyer shall give due consideration to all reasonable additions, deletions or changes to such documents (and any amendments thereto) suggested thereto by the Company and its counsel. Parent and Buyer shall provide
the Company and its counsel with (A)&nbsp;any comments or other communications, whether written or oral, that Parent and Buyer or their counsel may receive from time to time from the SEC or its staff or other Governmental Bodies with respect to the
Schedule TO or the Offer Documents promptly after receipt of those comments or other communications and (B)&nbsp;a reasonable opportunity to participate in the responses of Parent and Buyer to those comments and to provide comments on those
responses (and Parent and Buyer shall give due consideration to all reasonable additions, deletions or changes to such responses suggested by the Company and its counsel), including by participating with Parent and Buyer or their counsel in any
discussions or meetings with the SEC or other Governmental Bodies to the extent such participation is not prohibited by the SEC or other Governmental Bodies. The parties hereto agree that, notwithstanding the notice provisions of this Agreement,
communications with respect to the Offer Documents, including communications related to any SEC comments, may be made on behalf of each party by email through their respective counsel. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Parent shall provide or cause to be provided to Buyer on a timely basis the funds
necessary to purchase any Shares that Buyer becomes obligated to purchase pursuant to the Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Company Action</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall promptly (and in any event within five (5)&nbsp;Business Days after the date of this Agreement) cause its transfer
agent to furnish Parent and Buyer with (i)&nbsp;mailing labels containing the names and addresses of its record holders of Shares, (ii)&nbsp;listings and computer file containing the names and addresses of all record holders of Shares and lists of
securities positions of Shares held in stock depositories and (iii)&nbsp;copies of all lists of shareholders, security position listings and computer files in the Company&#146;s possession or control regarding the beneficial owners of Shares, as of
the most recent practicable date, and shall provide to Parent and Buyer such additional information (including updated lists of shareholders, mailing labels and lists of securities positions) and such other assistance as Parent or Buyer may
reasonably request in connection with the Offer. In the event that the Company is prohibited from providing any such information, (A)&nbsp;it shall request permission from the applicable shareholders to provide such information to Parent and Buyer
and (B)&nbsp;if the information requested is not received at least five (5)&nbsp;Business Days after the date of this Agreement, the Company shall deliver to such shareholders all information that would otherwise be required to be provided by Parent
or Buyer to such shareholders of the Company in connection with the Offer, and, notwithstanding this <U>Article II</U>, neither Parent nor Buyer shall have any obligation under this Agreement to deliver such information to such shareholders. Except
as required by applicable Law, and except for such steps as are necessary to disseminate the Offer Documents and any other documents necessary to consummate the Offer, (i)&nbsp;Parent and its Affiliates and Representatives shall hold in confidence
the information contained in such labels, listings and files, shall use such information only in connection with the Transactions, and (ii)&nbsp;if this Agreement is terminated, Parent and Buyer shall deliver to the Company and shall use their
reasonable best efforts to cause their Affiliates and Representatives to deliver to the Company all copies and any extracts or summaries from such information then in their possession. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) On the Offer Commencement Date, the Company shall, as promptly as practicable following the filing of the Schedule TO, file with the SEC
and disseminate to holders of Shares, in each case as and to the extent required by applicable United States federal securities Laws and any other applicable Law, a Solicitation/Recommendation Statement on Schedule
<FONT STYLE="white-space:nowrap">14D-9</FONT> (together with any amendments or supplements thereto and including exhibits thereto, the &#147;<U>Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT></U>&#148;) that, subject to
<U>Section</U><U></U><U>&nbsp;5.3(e)(ii)</U>, shall reflect the Company Board Recommendation. Parent and Buyer shall furnish promptly to the Company all information concerning Parent, Buyer or any of their applicable Affiliates required by the
Exchange Act and other applicable Law, or as reasonably requested by the Company, to be set forth in the Schedule <FONT STYLE="white-space:nowrap">14D-9.</FONT> Each of the Company, on the one hand, and Parent and Buyer, on the other hand, agrees
promptly to correct any information provided by it for inclusion or incorporation by reference in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> if and to the extent that it has become (or has become known to be) false or misleading in any material respect. The Company shall use
reasonable best efforts to cause the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> as so corrected to be filed with the SEC and to be disseminated to holders of Shares, in each case to the extent required by applicable United States federal
securities Laws and other applicable Law. Except to the extent any amendments relate to a Change of Board Recommendation or relate to a &#147;stop, look and listen&#148; or similar communication of the type contemplated by Rule <FONT
STYLE="white-space:nowrap">14d-9(f)</FONT> under the Exchange Act, the Company shall give Parent, Buyer and their counsel a reasonable opportunity to review and comment on the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> each time before
it is filed with the SEC, and the Company shall give due consideration to all reasonable additions, deletions or changes to such document (and any amendments thereto) suggested thereto by Parent, Buyer and their counsel. Except to the extent any
comments or communications relate to a Change of Board Recommendation or a &#147;stop, look and listen&#148; or similar communication of the type contemplated by Rule <FONT STYLE="white-space:nowrap">14d-9(f)</FONT> under the Exchange Act, the
Company shall provide Parent, Buyer and their counsel with (i)&nbsp;any comments or other communications, whether written or oral, that the Company or its counsel may receive from time to time from the SEC or its staff or other Governmental Bodies
with respect to the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> promptly after receipt of those comments or other communications and (ii)&nbsp;a reasonable opportunity to participate in the Company&#146;s responses to those comments and
to provide comments on those responses (and the Company shall give due consideration to all reasonable additions, deletions or changes to such responses suggested by Parent, Buyer and their counsel), including by participating with the Company or
its counsel in any discussions or meetings with the SEC or other Governmental Bodies to the extent such participation is not prohibited by the SEC or other Governmental Bodies. The parties hereto agree that, notwithstanding the notice provisions of
this Agreement, communications with respect to the Schedule <FONT STYLE="white-space:nowrap">14D-9,</FONT> including communications related to any SEC comments, may be made on behalf of each party by email through their respective counsel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Treatment of Equity Awards</U><U>; Company ESPP</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each option to purchase Shares, other than awards under the Company&#146;s Amended and Restated Employee Stock Purchase Plan (the
&#147;<U>Company ESPP</U>&#148;) (each such option, a &#147;<U>Company Stock Option</U>&#148;), each restricted stock unit (each, a &#147;<U>Company RSU</U>&#148;), each performance share unit (each, a &#147;<U>Company PSU</U>&#148;), in each case
that was granted under a Company Equity Plan or is an inducement stock option grant listed on <U>Section</U><U></U><U>&nbsp;3.3(c)</U> of the Company Disclosure Letter (whether or not it is identified as an inducement grant thereon) (the Company
Stock Options, the Company RSUs and the Company PSUs are referred to collectively as the &#147;<U>Company Equity Awards</U>&#148;), and that is outstanding and unvested immediately prior to the Acceptance Time, whether or not then subject to any
performance or other condition, will vest in full at the Acceptance Time (except as set forth in <U>Section</U><U></U><U>&nbsp;5.1(b)</U> of the Company Disclosure Letter), with any applicable performance conditions associated with any such Company
Equity Award deemed to have been achieved at (i)&nbsp;maximum performance with respect to Company PSUs for which the applicable performance period has been completed but the Company PSUs have not yet been paid as of the Acceptance Time and
(ii)&nbsp;maximum performance measured as of the Acceptance Time with respect to Company PSUs for which the applicable performance period has not yet been completed as of the Acceptance Time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Company Stock Option that is outstanding immediately prior to the Closing will be
cancelled, and, in exchange therefor, the holder of such cancelled Company Stock Option will be entitled to receive (without interest), in consideration of the cancellation of such Company Stock Option, an amount in cash (less applicable Tax
withholdings pursuant to <U>Section</U><U></U><U>&nbsp;2.10</U>) equal to the product of (x)&nbsp;the total number of Shares subject to the unexercised portion of such Company Stock Option immediately prior to the Closing (determined after giving
effect to the accelerated vesting described in <U>Section</U><U></U><U>&nbsp;2.3(a)</U> above) multiplied by (y)&nbsp;the excess, if any, of the Offer Consideration over the applicable exercise price per Share under such Company Stock Option. For
the avoidance of doubt, if the exercise price payable in respect of a Share underlying a Company Stock Option equals or exceeds the Offer Consideration, such Company Stock Option shall be cancelled for no consideration immediately prior to the
Closing and the holder thereof shall have no further rights with respect thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Company RSU that is outstanding immediately
prior to the Closing will be cancelled, and, in exchange therefor, the holder of such cancelled Company RSU will be entitled to receive (without interest) an amount in cash (less applicable Tax withholdings pursuant to
<U>Section</U><U></U><U>&nbsp;2.10</U>) equal to the product of (x)&nbsp;the total number of Shares deliverable under such Company RSU as of immediately prior to the Closing (determined after giving effect to the accelerated vesting described in
<U>Section</U><U></U><U>&nbsp;2.3(a)</U> above) multiplied by (y)&nbsp;the Offer Consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each Company PSU that is outstanding
as of immediately prior to the Closing will be cancelled and, in exchange therefor, each holder of such cancelled Company PSU will be entitled to receive (without interest) an amount in cash (less applicable Tax withholdings pursuant to
<U>Section</U><U></U><U>&nbsp;2.10</U>) equal to the product of (x)&nbsp;the total number of Company PSUs as of immediately prior to the Closing (determined after giving effect to the accelerated vesting described in
<U>Section</U><U></U><U>&nbsp;2.3(a)</U> above and after the determination of the deemed achievement of applicable performance conditions as described above) multiplied by (y)&nbsp;the Offer Consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Subject to <U>Section</U><U></U><U>&nbsp;2.10</U>, Parent shall cause the Company or its applicable Subsidiary or Affiliate to make all
payments to former holders of Company Equity Awards required under <U>Section</U><U></U><U>&nbsp;2.3(a)</U> &#150; <U>(d)</U> as promptly as practicable after the Closing, and in any event, no later than five (5)&nbsp;Business Days after the
Closing; <U>provided</U> that such payment with respect to Company Equity Awards shall be made at such other time or times following the Closing consistent with the terms of the applicable award agreement to the extent necessary to avoid the
imposition of additional income tax under Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company shall continue to operate the Company ESPP in
accordance with its terms and past practice for the Offering Period (as defined in the Company ESPP) in effect on the date of this Agreement. The Company shall take all actions necessary and appropriate (i)&nbsp;to suspend the commencement of any
future Offering Period (as defined in the Company ESPP) following the date of this Agreement unless and until this Agreement is terminated and (ii)&nbsp;to terminate the Company ESPP as of the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Prior to the Closing, the Company shall use its reasonable best efforts to provide such
notice, if any, to the extent required under the terms of any of the Company Equity Plans, obtain any necessary consents, adopt applicable resolutions, amend the terms of any of the Company Equity Plans or any outstanding awards thereunder and take
all other appropriate actions to: (i)&nbsp;give effect to the transactions contemplated herein, including the treatment contemplated under this <U>Section</U><U></U><U>&nbsp;2.3</U>; (ii) terminate each of the Company Equity Plans as of the Closing;
and (iii)&nbsp;ensure that after the Closing, no holder of a Company Equity Award, any beneficiary thereof nor any other participant in any of the Company Equity Plans or the Company ESPP shall have any right thereunder to acquire any Shares of the
Company or to receive any payment or benefit with respect to any award previously granted under any of the Company Equity Plans or with respect to the Company ESPP, except as provided in this <U>Section</U><U></U><U>&nbsp;2.3</U>. The Company shall
provide Parent with documentation evidencing the completion of the foregoing actions (the form and substance of such documentation shall be subject to review and comment by Parent, and the Company shall consider such comments in good faith) no later
than ten (10)&nbsp;Business Days preceding the Closing. If requested by Parent, the parties hereto shall, to the extent necessary to minimize the Tax impact to holders of Company Equity Awards of the provisions set forth in this
<U>Section</U><U></U><U>&nbsp;2.3</U>, cooperate in good faith prior to the Acceptance Time to develop a mechanism with respect to Company Equity Awards held by individuals subject to Taxes imposed by the Laws of a country other than the United
States, provided in each case that (i)&nbsp;such mechanism does not result in a significant cost to the Company or its Subsidiaries, (ii)&nbsp;any such mechanism shall be permitted pursuant to the applicable Company Equity Plan and (iii)&nbsp;the
Company shall not be obligated to enter into any agreement that shall adversely affect the amount or timing payable thereunder to such individuals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4 <U>Extraordinary General Meeting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the provisions of this <U>Section</U><U></U><U>&nbsp;2.4</U>, the Company shall hold an extraordinary general meeting of its
shareholders (the &#147;<U>EGM</U>&#148;) as promptly as practicable to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) provide information regarding the Offer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) adopt a resolution to, subject to (A)&nbsp;the Acceptance Time having occurred and (B)&nbsp;the number of Shares validly tendered in
accordance with the terms of the Offer (including, if applicable, Shares tendered during the Subsequent Offering Period, as it may be extended by the Minority Exit Offering Period) and not properly withdrawn, together with the Shares owned by Parent
or any of its wholly owned Subsidiaries, representing at least eighty percent (80%) of the Company&#146;s issued and outstanding capital (<I>geplaatst en uitstaand kapitaal</I>) (the &#147;<U>Reorganization Threshold</U>&#148;), approve the asset
sale as contemplated by the Asset Sale Documentation (the &#147;<U>Asset Sale</U>&#148;) as required under Section&nbsp;2:107a of the DCC; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) adopt a resolution to, subject to (A)&nbsp;the Acceptance Time having occurred, (B)&nbsp;the Reorganization Threshold having been
achieved and (C)&nbsp;the Asset Sale having been completed, (1)&nbsp;dissolve (<I>ontbinden</I>) the Company in accordance with Section&nbsp;2:19 of the DCC and (2)&nbsp;appoint as liquidator (the &#147;<U>Liquidator</U>&#148;) a foundation
(<I>stichting</I>) to be incorporated under Dutch Law and approve reimbursement of the Liquidator&#146;s reasonable salary and costs (provided that such reimbursement will be subject to the approval of the Independent Directors not to be
unreasonably withheld, conditioned or delayed) and (3)&nbsp;appoint an Affiliate of Buyer as the custodian of the books and records of the Company in accordance with Section&nbsp;2:24 of the DCC; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) adopt a resolution to, subject to (A)&nbsp;the Acceptance Time having occurred and
(B)&nbsp;the Reorganization Threshold having been achieved, to amend the articles of association of the Company to include a provision determining the compensation for shareholders who will be voting against the resolution for the First-Step Merger
and filing a request for compensation attached as <U>Annex II(A)</U> (Deed of Amendment for Price Determination), and to approve the Mergers as contemplated by the Merger Agreement as provided for under Section&nbsp;2:309 et seq. of the DCC; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) adopt one or more resolutions effective upon the Acceptance Time to provide full and final discharge to each member of the Company Board
for their acts of management or supervision, as applicable, up to the date of the EGM; <U>provided</U> that such discharge will be limited to the extent provided by general principles of Dutch law as in effect from time to time; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) adopt one or more resolutions to (A)&nbsp;convert the Company from a public limited liability company (<I>naamloze vennootschap</I>)
into a private limited liability company (<I>besloten vennootschap met beperkte aansprakelijkheid</I>) and amend the articles of association of the Company substantially in accordance with the draft of the amended articles of association attached as
<U>Annex II(B)</U> (Amended Articles of Association of the Company after Conversion) and which will be executed and become effective as soon as practicable following Closing if elected by Buyer and (B)&nbsp;amend the articles of association of the
Company substantially in accordance with the draft of the amended articles of association attached as <U>Annex II(C)</U> (Amended Articles of Association of the Company after Delisting), which will be executed and become effective as soon as
practicable following the delisting of the Company and the Shares from Nasdaq, if elected by Buyer; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) adopt a resolution, subject to
Closing and effective on the date elected by Parent, if any, to amend the articles of association of the Company to align the financial year of the Company with the financial year reckoned by Buyer attached as <U>Annex II(D)</U> (Financial Year Deed
of Amendment); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) adopt one or more resolutions, subject to Closing, to effectuate and complete a statutory <FONT
STYLE="white-space:nowrap">spin-off</FONT> (<I>afsplitsing</I>) of the Company as a result of which all or part of the Company&#146;s assets or liabilities, as elected by Buyer, will be spun into a private company with limited liability (<I>besloten
vennootschap met beperkte aansprakelijkheid</I>) organized under the Laws of the Netherlands that is wholly owned by the Company (the &#147;<U>Demerger</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) adopt one or more resolutions effective upon the Closing to appoint the Buyer Directors to replace the resigning directors of the
Company Board and to accept the resignations of the resigning directors of the Company Board (together with the resolutions to be adopted pursuant to <U>Section</U><U></U><U>&nbsp;2.4(a)(vi)</U> and <U>Section</U><U></U><U>&nbsp;2.4(a)(vii)</U>, the
&#147;<U>Governance Resolutions</U>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) conduct such other business as may properly come before the meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As promptly as practicable after the date of this Agreement but, in no event later than
the forty-fifth (45th) Business Day after the date of this Agreement, the Company shall prepare and file with the SEC a preliminary proxy statement in connection with the EGM (the &#147;<U>Proxy Statement</U>&#148;) and any other appropriate
materials for the EGM (together with the Proxy Statement and with any amendments and supplements thereto and any other documents required, the &#147;<U>EGM Materials</U>&#148;) relating to the matters set forth in
<U>Section</U><U></U><U>&nbsp;2.4(a)</U>. Subject to <U>Section</U><U></U><U>&nbsp;5.3(e)(ii)</U>, the Company shall include the Company Board Recommendation in the EGM Materials. Parent and Buyer shall cooperate with the Company in the preparation
of the EGM Materials and furnish promptly to the Company all information concerning Parent, Buyer and any of their Affiliates required to be set forth in the EGM Materials. The Company shall provide Parent, Buyer and their counsel with a reasonable
opportunity to review and comment on the EGM Materials (and any amendments thereto) each time prior to their filing with the SEC and/or dissemination to the shareholders of the Company, as applicable, and the Company shall give due consideration to
all reasonable additions, deletions or changes to such documents (and any amendments thereto) suggested thereto by Parent, Buyer and their counsel. The Company shall provide Parent, Buyer and their counsel, to the extent not prohibited under
applicable Law, with (i)&nbsp;any comments or other communications, whether written or oral, that the Company or its counsel may receive from time to time from the SEC or any other Governmental Bodies with respect to the EGM Materials promptly after
receipt of those comments or other communications and (ii)&nbsp;a reasonable opportunity to participate in the Company&#146;s response to those comments and to provide comments on that response (and the Company shall give due consideration to all
reasonable additions, deletions or changes to such response proposed by Parent, Buyer and their counsel), including by participating with the Company or its counsel in any discussions or meetings with the SEC or any other Governmental Bodies to the
extent such participation is not prohibited by the SEC or the applicable Governmental Body. The parties hereto agree that, notwithstanding the notice provisions of this Agreement, communications with respect to the Proxy Statement, including
communications related to any SEC comments, may be made on behalf of each party by email through their respective counsel. Promptly following the later of (i)&nbsp;confirmation by the SEC that it has no further comments on the Proxy Statement and
(ii)&nbsp;the expiration of the ten <FONT STYLE="white-space:nowrap">(10)-day</FONT> waiting period contemplated by Rule <FONT STYLE="white-space:nowrap">14a-6(a)</FONT> promulgated by the SEC, the Company shall cause the Proxy Statement in
definitive form to be filed with the SEC and mailed to the Company&#146;s shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall consult with Parent and
Buyer regarding the date of the EGM (or any Subsequent EGM) and, unless this Agreement is terminated in accordance with <U>Article VI</U>, shall not cancel, postpone or adjourn the EGM (or any Subsequent EGM) without the prior written consent of
Parent and Buyer; <U>provided</U>, that the Company may, following reasonable consultation with Parent and Buyer, and, to the extent requested in writing by Parent and Buyer, the Company shall, adjourn, postpone or cancel and reconvene the EGM (or
any Subsequent EGM) solely to the extent reasonably necessary (x)&nbsp;to ensure that any supplement or amendment to the relevant EGM Materials that the Company Board, after consultation with outside counsel, reasonably determines is necessary to
comply with applicable Law is made available to the Company&#146;s shareholders in advance of the EGM (and any Subsequent EGM) or (y)&nbsp;on no more than two (2)&nbsp;occasions of not more than ten (10)&nbsp;Business Days each, to solicit
additional proxies in favor of the approvals set forth in <U>Section</U><U></U><U>&nbsp;2.4(a)</U>, if as of the date of the scheduled EGM (or any Subsequent EGM) there are not sufficient proxies that have been received approving such matters. In
the event the EGM (or any Subsequent EGM) is adjourned, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
postponed or cancelled and reconvened pursuant to the foregoing proviso, the Company shall duly give notice of and reconvene the EGM or such Subsequent EGM on a date scheduled by mutual agreement
of the Company, on the one hand, and Parent and Buyer, on the other hand, acting reasonably, or, in the absence of such agreement, as soon as practicable following the date of such adjournment, postponement or cancellation but, in any event, no
later than the day that is thirty-five (35)&nbsp;days following the date of such adjournment, postponement or cancellation (or, in the case of any Subsequent EGM, a date that shall be prior to the date on which the Expiration Time shall occur). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company shall ensure that the EGM (and any Subsequent EGM) is called, noticed, convened, held and conducted in compliance in all
material respects with all applicable Laws. Without limiting the foregoing, prior to holding the EGM (or any applicable Subsequent EGM), the Company will comply with all applicable requirements with respect to the holding of an EGM (or Subsequent
EGM, if applicable) to act upon the Merger Resolutions, including the <FONT STYLE="white-space:nowrap">pre-meeting</FONT> filing and publication requirements of the DCC with respect to the First-Step Merger (collectively, the &#147;<U>Dutch Merger
Publication</U>&#148;). Notwithstanding anything to the contrary in this <U>Section</U><U></U><U>&nbsp;2.4</U>, the date of the Dutch Merger Publication shall be on a date reasonably selected by Parent and the Company, and the EGM (or Subsequent
EGM, if applicable) shall be held in compliance with all applicable Laws as promptly as practicable after the date of the Dutch Merger Publication. The approval of the matters set forth in <U>Section</U><U></U><U>&nbsp;2.4(a)(i)-(viii)</U> shall be
the only matters that the Company shall propose to be acted on by the shareholders of the Company at the EGM (and any Subsequent EGM), unless otherwise reasonably proposed by the Company and approved in advance in writing by Parent and Buyer (such
approval not to be unreasonably withheld, conditioned or delayed); <U>provided</U>, that the Company may hold the EGM or Subsequent EGM simultaneously with the Company&#146;s annual meeting if the Company otherwise complies with the timing
requirements for the EGM or Subsequent EGM set forth in this <U>Section</U><U></U><U>&nbsp;2.4</U>, including the obligation to hold such meeting as promptly as practicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything to the contrary in this Agreement, if the Company Board determines in its reasonable discretion that any
additional shareholders resolutions should be adopted in order to approve any of the Signing Transactions, or if the Governance Resolutions, the Asset Sale Resolutions, the Merger Resolutions or the Demerger Resolutions have not been adopted at the
EGM, then, in each case, the Company shall, following consultation with Parent and Buyer, duly call and give notice of another EGM (a &#147;<U>Subsequent EGM</U>&#148;), which will take place at a date determined by the Company and reasonably
acceptable to Parent and Buyer and not later than a date that is prior to the date of the Expiration Time, at which the Governance Resolutions, the Asset Sale Resolutions, the Merger Resolutions or the Demerger Resolutions, or the additional
resolutions as referred to above will be considered or reconsidered, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Without limiting the generality of the
foregoing, but subject to the Company&#146;s rights to terminate this Agreement in accordance with <U>Article</U><U></U><U>&nbsp;VI</U> the Company agrees that (i)&nbsp;its obligation to duly call, give notice of, convene and hold the EGM (and any
Subsequent EGM) in accordance with and subject to the terms hereof and (ii)&nbsp;its obligations pursuant to this <U>Section</U><U></U><U>&nbsp;2.4</U>, in each case, will not be affected by the commencement, public proposal, public disclosure or
communication to the Company of any Acquisition Proposal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(whether or not a Superior Proposal) or any Change of Board Recommendation. Unless this Agreement is validly terminated in accordance with <U>Article</U><U></U><U>&nbsp;VI</U>, the Company agrees
that it shall not submit to the vote of the shareholders of the Company any Acquisition Proposal (whether or not a Superior Proposal) or any matters relating thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except to the extent there has been a Change of Board Recommendation, at and prior to the EGM (and any Subsequent EGM), the Company shall
use its reasonable best efforts to secure the approval of the matters set forth in <U>Section</U><U></U><U>&nbsp;2.4(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5 <U>Directors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent, Buyer and the Company shall use their respective reasonable best efforts (including, in the case of the Company, obtaining the
necessary resignations of existing directors) to ensure that the Company Board will, upon the Closing, be comprised of at least seven (7)&nbsp;directors, (i) at least five (5)&nbsp;of whom may be designated in writing by Parent and Buyer (the
&#147;<U>Buyer Directors</U>&#148;), in their sole discretion, as soon as reasonably practicable and in any event prior to convening the EGM, and (ii)&nbsp;at least two (2)&nbsp;of whom shall initially be current
<FONT STYLE="white-space:nowrap">non-executive</FONT> directors of the Company designated by the Company and Buyer by mutual written agreement (if and to the extent that they shall agree to continue to serve on the Company Board after the Closing),
and who are at all times independent from Parent and Buyer and at all times qualify as independent in accordance with the independence standards set forth in the Dutch Corporate Governance Code 2016; <U>provided</U>, that, if and to the extent that
the current <FONT STYLE="white-space:nowrap">non-executive</FONT> directors of the Company do not agree to serve on the Company Board after the Closing, Buyer shall (and Parent shall cause Buyer to) designate replacement directors who are at all
times independent from Parent and Buyer and who at all times qualify as independent in accordance with the independence standards set forth in the Dutch Corporate Governance Code 2016, as promptly as reasonably practicable and in any event prior to
convening the EGM (the directors so designated, &#147;<U>Independent Directors</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Independent Director shall resign
from, and the Company shall take such other action reasonably necessary to ensure that each such Independent Director ceases to be a director of, the Company Board upon the earliest to occur of (i)&nbsp;such time after the Acceptance Time as Buyer
and its Affiliates, in the aggregate, own one hundred percent (100%) of the issued and outstanding Shares, including, for the avoidance of doubt, pursuant to the Mergers and (ii)&nbsp;the Second Step Distribution having been made and the subsequent
liquidation and dissolution of the Company (the &#147;<U>Liquidation</U>&#148;) having been completed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If, at any time after the
Closing, an Independent Director resigns from, or otherwise ceases to be a member of the Company Board, or ceases to be independent (in accordance with the independence standards set forth in the Dutch Corporate Governance Code 2016) from Parent or
Buyer, in each case, prior to the date of resignation contemplated by <U>Section</U><U></U><U>&nbsp;2.5(b)</U>, Parent shall procure that the respective Independent Director is replaced by a new director who is independent from Parent and Buyer and
at all times qualifies as independent in accordance with the independence standards set forth in the Dutch Corporate Governance Code 2016. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent and Buyer shall supply to the Company in writing any information regarding the
Buyer Directors, and (to the extent applicable) those Independent Directors designated by Buyer, as required by applicable Laws in connection with the appointment of the Buyer Directors, and (to the extent applicable) those Independent Directors
designated by Buyer, to the Company Board, and Parent and Buyer shall be solely responsible for any such information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) In addition to
the discharge contemplated by <U>Section</U><U></U><U>&nbsp;2.4(a)(v)</U>, Buyer shall (i)&nbsp;at the first annual or extraordinary general meeting of shareholders of the Company held after the Closing, cause all members of the Company Board
resigning effective upon the Acceptance Time to be fully and finally discharged for their acts of management or supervision, as applicable and (ii)&nbsp;at the first annual or extraordinary general meeting of shareholders of the Company held after
the resignation of an Independent Director, cause such Independent Directors to be fully and finally discharged for his or her acts of supervision; <U>provided</U>, that such discharge will be limited to the extent provided by general principles of
Dutch law as in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding any other required vote, the affirmative vote of the Independent Directors
shall also be required for approving: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any restructuring that would reasonably be expected to lead to a dilution of the shareholdings
of the Minority Shareholders, other than (A)&nbsp;pursuant to a rights issue by the Company or any other share issue where the Minority Shareholders have been offered an opportunity to subscribe pro rata in accordance with their then existing
shareholding in the Company (<I>voorkeursrecht</I>), (B) the Asset Sale, the Second Step Distribution and the Liquidation, (C)&nbsp;the Mergers or (D)&nbsp;the Compulsory Acquisition; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any other form of unequal treatment that prejudices or would reasonably be expected to prejudice or negatively affect the value of the
Shares or voting rights attached to the Shares held by the Minority Shareholders, but in any event not including (A)&nbsp;the Asset Sale, the Second Step Distribution and the Liquidation, (B)&nbsp;the Mergers or (C)&nbsp;the Compulsory Acquisition.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6 <U>Further Actions</U>. If requested by the other party, the Company, on the one hand, or Parent and Buyer, on the other
hand, as applicable, shall take, as of the date of this Agreement or as soon thereafter as is reasonably practicable, the following actions to the extent reasonably necessary or desirable to implement, commence, consummate or otherwise effect
(i)&nbsp;the Asset Sale, the Liquidation and the Second Step Distribution and (ii)&nbsp;the Mergers (in each case, to the extent any such actions, transactions or matters are elected to be effectuated by Parent or Buyer), as the case may be: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) in the case of a request to the Company, (i)&nbsp;the convening of the necessary meetings of the Company&#146;s general meeting and the
Company Board or any committee thereof (including the EGM (and any Subsequent EGM) referenced in, and to the extent required by, <U>Section</U><U></U><U>&nbsp;2.4</U>) and (ii)&nbsp;the consideration, adoption and approval of any applicable
resolutions of the Company Board or any committee thereof as necessary or desirable to convene the EGM (and any Subsequent EGM) referenced and to the extent required by, in <U>Section</U><U></U><U>&nbsp;2.4</U>, in each case as set forth in
<U>Section</U><U></U><U>&nbsp;2.4</U>, subject to <U>Section</U><U></U><U>&nbsp;2.7</U>; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) in the case of a request to Buyer and the Company, subject to
<U>Section</U><U></U><U>&nbsp;2.7</U>, the execution of any and all reasonably requested documents, agreements, resolutions or deeds that are necessary or desirable to effectuate (i)&nbsp;the Asset Sale and the Liquidation and Second Step
Distribution and (ii)&nbsp;the Mergers, and the filing or registration of any or all of such documents, agreements or deeds with the appropriate Governmental Bodies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7 <U>Post-Offer Reorganization</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Following the later of the Closing or, if applicable, the closing of the Subsequent Offering Period, as it may be extended by the Minority
Exit Offering Period, Parent or Buyer may (but for the avoidance of doubt, shall not be required to) effectuate, or cause to be effectuated, in which case the Company and its Subsidiaries shall effectuate a corporate reorganization (the
&#147;<U>Post-Offer Reorganization</U>&#148;) of the Company and its Subsidiaries, which will be (x)&nbsp;a Post-Offer Reorganization identified in <U>Section</U><U></U><U>&nbsp;2.7(a)(i)</U>, <U>(ii)</U>, <U>(iii)</U>, <U>(iv)</U>, <U>(v)</U> or
<U>(xiv)</U> (or any combination of the foregoing), or (y)&nbsp;with the Company&#146;s prior written consent (such consent not to be unreasonably withheld) and if permissible under applicable Law, at Parent&#146;s or Buyer&#146;s election shall be
comprised of any of the following other Post-Offer Reorganizations (it being understood that, as of the date hereof, Parent and Buyer have a preference for effectuating the Mergers): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the Asset Sale together with, and conditioned upon, the Liquidation and Second Step Distribution; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the Mergers; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) if
permissible under applicable Law, the commencement by Buyer of the Compulsory Acquisition; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) an election by the Company pursuant to
U.S. Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;301.7701-3</FONT> to be classified as a partnership or as a disregarded entity, as reasonably determined by Buyer or Parent; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) the Demerger; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) a
statutory legal merger (<I>juridische fusie</I>) in accordance with Article 2:309 et seq. of the DCC between the Company (as the disappearing company) and Buyer (as the acquiring company), pursuant to which merger the shareholders of the Company
shall receive shares of Buyer (&#147;<U>Buyer Shares</U>&#148;), cash or receivables in accordance with Article 2:325 of the DCC (or a mix of any of the foregoing), upon which merger the holders of the Buyer Shares shall be granted the right to
exchange Buyer Shares with Parent, or an Affiliate of Parent, for securities of Parent at any time before a date to be set by Parent or Buyer, after which date the Buyer Shares shall be redeemed; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) a statutory (cross-border or domestic) legal (bilateral or triangular) merger (<I>juridische</I> (<I>driehoeks</I>-) <I>fusie</I>) in
accordance with Article 2:309 et seq. of the DCC between the Company, Buyer and/or any Affiliate of Parent; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) a statutory legal (bilateral or triangular) demerger (<I>juridische</I>
(<I>driehoeks</I>-) <I>splitsing</I>) of the Company in accordance with Article 2:334a et seq. of the DCC; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) a contribution of cash
and/or assets by Buyer, Parent or by any Affiliate of Parent in exchange for ordinary shares in the Company&#146;s share capital, in which circumstances the <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights (<I>voorkeursrechten</I>), if
any, of the Minority Shareholders could be excluded; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) a sale and transfer of assets and Liabilities (A)&nbsp;by the Company or a
Subsidiary of the Company to Buyer, Parent or an Affiliate of Parent or (B)&nbsp;by Buyer, Parent or any Affiliate of Parent to the Company or any Subsidiary of the Company, on terms substantially similar to the terms agreed for the Asset Sale to
the extent this relates to substantially all of the assets and Liabilities of the Company and its Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) a distribution of
proceeds, cash and/or assets to the shareholders of the Company or share buybacks; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) a dissolution and/or liquidation of the
Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) a subsequent public offer for any Shares held by the Minority Shareholders; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) a conversion of the Company into a private company with limited liability (<I>besloten vennootschap met beperkte
aansprakelijkheid</I>); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv) any transaction, including a sale and/or transfer of any or all assets, between the Company and its
Affiliates or between the Company, on the one hand, and Buyer or Parent, on the other hand, or their respective Affiliates (including any newly formed private company with limited liability (<I>besloten vennootschap met beperkte
aansprakelijkheid</I>) organized under the Laws of the Netherlands), with the objective of preserving or utilizing any carry forward Tax losses available to the Company, Parent, Buyer or any of their respective Affiliates; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvi) any transactions, restructurings, share issues, procedures and/or proceedings in relation to the Company and/or one or more of its
Affiliates required to effect the aforementioned transactions; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvii) any combination of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If (i)&nbsp;the Asset Sale Resolutions have been adopted at the EGM or any Subsequent EGM and (ii)&nbsp;the Reorganization Threshold has
been achieved and the Closing has occurred, Parent and Buyer may require the Company to enter into, and in which case the Company shall enter into, the Asset Sale Agreement (together with all amendments reasonably agreed between the parties hereto,
the &#147;<U>Asset Sale Documentation</U>&#148;) and, subject to the conditions of this <U>Section</U><U></U><U>&nbsp;2.7</U> and the Asset Sale Documentation, the parties hereto shall promptly implement the Asset Sale, and take the steps to
complete the actions and transactions set forth in the Asset Sale Documentation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent, Buyer and the Company have agreed that, to the extent Parent or Buyer determines
to effectuate the Asset Sale in accordance with the terms of this Agreement, then promptly following completion of the Asset Sale, Parent, Buyer and the Company shall implement the Liquidation, which will result in the Second Step Distribution, in
each case in accordance with the terms and conditions of the Asset Sale Documentation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If (i)&nbsp;the Merger Resolutions have been
adopted at the EGM or any Subsequent EGM and (ii)&nbsp;the Reorganization Threshold has been achieved and the Closing has occurred, Parent and Buyer may, subject to the conditions of this <U>Section</U><U></U><U>&nbsp;2.7</U> and the Mergers
Documentation, require the Company to consummate the Mergers, and, subject to the conditions of this <U>Section</U><U></U><U>&nbsp;2.7</U> and the Mergers Documentation, the parties hereto shall promptly implement the Mergers, and take the steps to
complete the actions and transactions set forth in the Mergers Documentation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything to the contrary contained in
this <U>Section</U><U></U><U>&nbsp;2.7</U>, a Post-Offer Reorganization described in <U>Section</U><U></U><U>&nbsp;2.7(a)(i)</U> through <U>Section</U><U></U><U>&nbsp;2.7(a)(iii)</U>, if completed, will ultimately result in all Minority Shareholders
being offered or receiving in such Post-Offer Reorganization, for each Share then held, cash in an amount equal to the Offer Consideration (without interest and less applicable withholding Taxes), unless the Compulsory Acquisition is commenced by
Buyer, in which case the amount received for each Share not tendered pursuant to the Offer (including, if applicable, during the Subsequent Offering Period, as it may be extended by the Minority Exit Offering Period) will be determined by the
Enterprise Chamber of the Amsterdam Court of Appeals (<I>Ondernemingskamer van het gerechtshof Amsterdam</I>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Buyer and the Company
shall use their respective reasonable best efforts to (i)&nbsp;procure that the board of directors of the Liquidator will, as from the moment of its incorporation, consist of one or more professional liquidator(s) or similar service provider(s)
(natural person(s) or a professional liquidator service provider(s)) and (ii)&nbsp;reach agreement with such service provider as soon as practicable after the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) If (i)&nbsp;the Demerger Resolutions have been adopted at the EGM or any Subsequent EGM, (ii)&nbsp;the Reorganization Threshold has been
achieved and the Closing has occurred, and (iii)&nbsp;Buyer has elected to implement the Mergers or the Asset Sale, Parent or Buyer may require the Company to consummate the Demerger, and the parties hereto shall promptly implement the Demerger.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8 <U>Section 16 Matters</U>. Prior to the Acceptance Time, the Company Board shall take all necessary and appropriate
action to approve, for purposes of Section&nbsp;16(b) of the Exchange Act and the related rules and regulations thereunder, the disposition by Company directors and officers of any Shares and Company Equity Awards in the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9 <U>Certain Adjustments</U>. Without limiting the other provisions of this Agreement, in the event that, during the period
between the date of this Agreement and the Expiration Time, the number of outstanding Shares or securities convertible or exchangeable into or exercisable for Shares is changed into a different number of Shares or securities or a different class as
a result of a reclassification, stock split (including a reverse stock split), stock dividend or distribution, recapitalization, merger, issuer tender or exchange offer or other similar </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transaction, then the Offer Consideration and any other amounts payable pursuant to this Agreement will be equitably adjusted, without duplication, to reflect such change; <U>provided</U>, that,
in any case, nothing in this <U>Section</U><U></U><U>&nbsp;2.9</U> will be construed to permit the Company to take any action with respect to its securities that is prohibited by the terms of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10 <U>Withholding</U>. The parties hereto and any third-party paying agent are entitled to deduct and withhold from any amounts
payable or otherwise deliverable pursuant to this Agreement such amounts as are required to be deducted and withheld therefrom under the United States Internal Revenue Code of 1986 (the &#147;<U>Code</U>&#148;), or the Treasury Regulations
thereunder (the &#147;<U>Treasury Regulations</U>&#148;), or any other Tax Law. Any compensatory amounts payable pursuant to or contemplated by this Agreement, including pursuant to <U>Section</U><U></U><U>&nbsp;2.3</U>, will be remitted to the
applicable payor for payment to the applicable Person through regular payroll procedures, as applicable. To the extent that any amounts are so deducted, withheld and paid to the applicable Governmental Body, such amounts will be treated for all
purposes under this Agreement as having been paid to the Person to whom such amounts would otherwise have been paid. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except (a)&nbsp;other than with respect to <U>Sections 3.1</U>, <U>3.2</U>, <U>3.3</U>, <U>3.4</U>, <U>3.5</U> and <U>3.6</U>, as otherwise
disclosed in Company SEC Documents filed with (or furnished to) the SEC on or after January&nbsp;1, 2018 and at least one (1)&nbsp;Business Day prior to the date hereof and to the extent publicly available on the SEC&#146;s Electronic Data Gathering
Analysis and Retrieval system (excluding any disclosures in &#147;risk factors&#148; or otherwise relating to or in any &#147;forward-looking statements&#148; legend or other statements that are cautionary, predictive or forward-looking in nature)
or (b)&nbsp;as otherwise disclosed in the particular section or subsection of the confidential disclosure letter delivered by the Company to Parent and Buyer prior to the execution and delivery of this Agreement (the &#147;<U>Company Disclosure
Letter</U>&#148;) (it being understood and agreed that any disclosure set forth in one section or subsection of the Company Disclosure Letter also shall be deemed to apply to each other section and subsection of this Agreement to which its
applicability is reasonably apparent on its face from the text of such disclosure), the Company represents and warrants to Parent and Buyer as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Organization and Corporate Power</U>. The Company is duly organized and validly existing under the Laws of The
Netherlands, with all necessary corporate power and authority to enter into this Agreement and perform its obligations hereunder. Each of the Subsidiaries of the Company is a corporation or other entity validly existing under the Laws of the
jurisdiction of its incorporation or organization. Each of the Company and its Subsidiaries has all requisite corporate power and authority and all authorizations, licenses and Permits necessary to own, lease and operate its properties and to carry
on its business as it is now being conducted, except where the failure to hold such authorizations, licenses and Permits has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Each of the Company and its Subsidiaries is duly qualified or authorized to do business and is in good standing in every jurisdiction (to the extent such concept exists in such jurisdiction) in which its ownership of property or the conduct of its
business as now conducted makes such qualification or authorization necessary, except where the failure to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be so qualified, authorized or in good standing has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. True and complete
copies of the Company Organizational Documents as in effect as of the date of this Agreement, have been heretofore made available to Parent and Buyer. Such Company Organizational Documents are currently in full force and effect, and the Company is
not in violation of any of the provisions thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Authorization; Valid and Binding Agreement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The execution, delivery and performance by the Company of this Agreement, and the consummation by the Company and its applicable
Subsidiaries of the Signing Transactions, including the Offer, the Compulsory Acquisition, the Asset Sale, the Second Step Distribution, the Liquidation and the Mergers, are within the corporate powers of the Company and its applicable Subsidiaries
and have been duly and validly authorized by all necessary corporate action on the part of the Company and its Subsidiaries and, except as contemplated by <U>Section</U><U></U><U>&nbsp;5.10</U>, no other corporate proceedings on the part of the
Company or such Subsidiaries and, except for the approvals to be sought at the EGM as described in <U>Section</U><U></U><U>&nbsp;2.4(a)(i)-(viii)</U>, no shareholder votes are necessary to authorize this Agreement or to consummate the Signing
Transactions. This Agreement has been duly executed and delivered by the Company and, assuming due authorization, execution and delivery hereof by Parent and Buyer, this Agreement constitutes a legal, valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At a meeting duly called and
held, the Company Board unanimously (i)&nbsp;determined that this Agreement and the Signing Transactions are in the best interests of the Company, its business and its shareholders, employees and other relevant stakeholders, (ii)&nbsp;approved and
adopted this Agreement (including the execution, delivery and performance thereof) and approved the Signing Transactions and (iii)&nbsp;resolved, on the terms and subject to the conditions set forth in this Agreement, including
<U>Section</U><U></U><U>&nbsp;5.3</U>, to support the Offer and the other Signing Transactions and to recommend acceptance of the Offer by the shareholders of the Company and to recommend approval and adoption of the matters set forth in
<U>Section</U><U></U><U>&nbsp;2.4(a)</U> (such recommendation, the &#147;<U>Company Board Recommendation</U>&#148;) and such recommendation is not required to be conditioned on works council consultation or approval. As of the date of this
Agreement, none of the aforesaid actions by the Company Board has been amended, rescinded or modified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3
<U>Capitalization</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The authorized share capital of the Company consists of 320&nbsp;million Shares of which, as of the close of
business on November&nbsp;1, 2019 (the close of business on such date, the &#147;<U>Measurement Date</U>&#148;), 126,900,005 Shares were issued and outstanding, and no Shares were held by the Company. From the Measurement Date through the date of
this Agreement, there have been no issuances of any Shares other than issuances of Shares (i)&nbsp;pursuant to the exercise, vesting or settlement, as applicable, of any Company Equity Awards outstanding as of the Measurement Date in accordance with
the terms of such Company Equity Awards or (ii)&nbsp;under the Company ESPP in accordance with its terms. No Subsidiary of the Company owns any shares or other securities of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All issued and outstanding Shares, and all Shares that are subject to issuance, upon
issuance in accordance with the terms and subject to the conditions specified in the instruments under which they are issuable (i)&nbsp;are, or upon issuance will be, duly authorized, validly issued, fully paid and
<FONT STYLE="white-space:nowrap">non-assessable</FONT> and (ii)&nbsp;are not, or upon issuance will not be, subject to any preemptive rights. All of the outstanding Shares have been sold pursuant to an effective registration statement filed under
the Securities Act or an appropriate exemption therefrom. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Section</U><U></U><U>&nbsp;3.3(c)</U> of the Company Disclosure Letter
sets forth a true and complete list as of the Measurement Date of the outstanding Company RSUs, Company PSUs, Company Stock Options and the number of the Shares reserved for issuance pursuant to the Company ESPP, including, with respect to each
award of Company RSUs, Company PSUs, or Company Stock Options, (i)&nbsp;the number of the Shares subject thereto (assuming, in the case of Company PSUs, performance conditions associated with such Company PSUs were deemed to have been achieved at
maximum performance levels), (ii) the holder thereof and country of residence (if outside the U.S.), (iii) the date of grant, (iv)&nbsp;the exercise price (if any), (v) the amount vested and outstanding and the amount unvested and outstanding as of
October&nbsp;1, 2019, and (vi)&nbsp;the Company Equity Plan pursuant to which the award was made. Each grant of a Company Stock Options was duly authorized no later than the Company Option Grant Date by all necessary corporate action, including, as
applicable, approval by the Company Board (or a duly constituted and authorized committee thereof or other authorized designee). The Company does not have any liability in respect of any Company Stock Option that was granted with a per share
exercise price that was less than the fair market value of a Share on the applicable Company Option Grant Date, and the Company has not granted any Company Stock Options that are subject to the provisions of Section&nbsp;409A of the Code. Each grant
of a Company Equity Award was made in all material respects in accordance with (i)&nbsp;the terms of the applicable Company Equity Plan, (ii)&nbsp;all applicable securities Laws, including the Nasdaq Listing Rules, (iii)&nbsp;the Code and
(iv)&nbsp;all other applicable Laws. The Company has the requisite authority under the terms of the applicable Company Equity Plan, the applicable award agreements and any other applicable Contract to take the actions contemplated by
<U>Section</U><U></U><U>&nbsp;2.3</U> and the treatment of Company Equity Awards described in <U>Section</U><U></U><U>&nbsp;2.3</U>, shall, as of the Closing, be binding on the holders of Company Equity Awards purported to be covered thereby. As of
the Measurement Date, other than with respect to Company Stock Options, Company RSUs, Company PSUs and the number of the Shares reserved for issuance pursuant to the Company ESPP, there were no other equity or equity-based awards outstanding, and
the Company has granted no other such awards between the Measurement Date and the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As of the Measurement Date,
there were 451,037 Shares reserved for issuance upon exercise of the Warrants, assuming the net exercise of the Warrants using a price per Share equal to $30.75. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Before giving effect to any &#147;make-whole&#148; adjustment as provided by the
Indentures, the Conversion Rate (as defined in the 2020 Indenture) of the 2020 Notes is 33.3949 Shares per $1,000 aggregate principal amount of 2020 Notes, the Conversion Rate (as defined in the 2021 Indenture) of the 2021 Notes is 46.8165 Shares
per $1,000 aggregate principal amount of 2021 Notes and the Exchange Rate (as defined in the 2023 Indenture) of the 2023 Notes is 29.9679 Shares per $1,000 aggregate principal amount of 2023 Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) From and after the date of entry into the Hedging Documentation through the date of this Agreement, no event or circumstance has occurred
that has resulted in an adjustment, or that has resulted in any of the 2020 Dealers, 2021 Dealers or 2023 Dealers having the right to terminate, cancel or make any adjustment, to the terms of the Hedging Documentation or any transaction thereunder.
The Company has not received any notice or indication that any of the 2020 Dealers, 2021 Dealers or 2023 Dealers believe that any event or circumstance has occurred that has resulted or will result in any of the 2020 Dealers, 2021 Dealers or 2023
Dealers having the right to terminate, cancel or make any adjustment to the terms of the Hedging Documentation or any transaction thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Cash Make-Whole Premium (as defined in the Indentures) tables set forth in Section&nbsp;14.03 of each of the Indentures are current as
of the date of this Agreement, taking into account any adjustments that were required to have been made to such tables prior to the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Except as disclosed in this <U>Section</U><U></U><U>&nbsp;3.3</U> or set forth in <U>Section</U><U></U><U>&nbsp;3.3(h)</U> of the Company
Disclosure Letter, the Company has no outstanding (i)&nbsp;shares in the share capital, equity interests or other ownership or voting interests of the Company, (ii)&nbsp;securities convertible or exchangeable, directly or indirectly, into shares in
the share capital, equity interests or other ownership or voting interests of the Company or any of its Subsidiaries, (iii)&nbsp;options, warrants, purchase rights, subscription rights, preemptive rights, conversion rights, exchange rights, calls,
puts, rights of first refusal or other contracts or other securities or rights, restricted stock awards, restricted stock unit awards, convertible securities, agreements, arrangements or commitments of any kind that obligate the Company or any of
its Subsidiaries to issue, transfer, register or sell, or cause to be issued, transferred, registered or sold, any shares in the share capital, equity or other ownership or voting interests of the Company or any of its Subsidiaries or securities
convertible into or exchangeable for such shares or interests, or that obligate the Company or any Subsidiary of the Company to grant, extend or enter into such options, warrants, purchase rights, subscription rights, preemptive rights, conversion
rights, exchange rights, calls, puts, rights of first refusal or other contracts or other securities or rights, restricted stock awards, restricted stock unit awards, convertible securities, agreements, arrangements or commitments, (iv)&nbsp;or
authorized equity or equity-based compensation awards, including any stock appreciation, phantom stock, profit participation, security-based performance units or other security rights issued by the Company or any of its Subsidiaries, or other
agreements, arrangements or commitments of any character (contingent or otherwise) to which the Company or any of its Subsidiaries is a party, in each case pursuant to which any Person is entitled to receive any payment from the Company or any
Subsidiary of the Company based in whole or in part on the value of any shares in the share capital, equity interests or other ownership or voting interests of the Company or any of its Subsidiaries, (v)&nbsp;bonds, debentures, notes or other
indebtedness of the Company having the right to vote on any matters on which the Company&#146;s shareholders may vote or shareholder agreements, voting trusts or similar agreements with any Person to which the Company or any of its Subsidiaries is a
party, including any such agreements or trusts (A)&nbsp;restricting the transfer of the shares in the share capital, equity interests or other ownership or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
voting interests of the Company or any of its Subsidiaries or (B)&nbsp;affecting the voting rights of shares in the share capital, equity interests or other ownership or voting interests of the
Company or any of its Subsidiaries and (vi)&nbsp;obligations of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire shares in the share capital, equity interests or other ownership or voting interests of the Company or
any of its Subsidiaries, or any securities representing the right to purchase or otherwise receive any shares in the share capital, equity interests or other ownership or voting interests of the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Subsidiaries</U>. <U>Section</U><U></U><U>&nbsp;3.4</U> of the Company Disclosure Letter lists all of the Subsidiaries of
the Company, and for each Subsidiary of the Company, the state or country of formation. All of the issued and outstanding shares of capital stock or equivalent equity interests of each of the Company&#146;s Subsidiaries are (i)&nbsp;owned of record
and beneficially, directly or indirectly, by the Company free and clear of all Liens (other than Permitted Liens) and (ii)&nbsp;duly authorized and validly issued and are fully paid, nonassessable and free of preemptive rights. Except for the direct
or indirect Subsidiaries of the Company and investments in marketable securities and cash equivalents, neither the Company nor any of its Subsidiaries (i)&nbsp;owns directly or indirectly any shares of capital stock, equity interests or other
ownership or voting interests, or any securities or obligations convertible into or exchangeable or exercisable for such shares or interests, in any Person or (ii)&nbsp;has any obligation or has made any commitment to acquire any shares in the share
capital, equity interests or other ownership or voting interests in any Person or to provide funds to or make any investment (in the form of a loan, capital contribution or otherwise) in any Person, except as expressly contemplated by
<U>Section</U><U></U><U>&nbsp;5.10(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5 <U>No Breach</U>. The execution, delivery and performance of this Agreement
by the Company and the consummation of the Transactions do not and will not (a)&nbsp;conflict with or violate any provision of the (i)&nbsp;Company Organizational Documents or (ii)&nbsp;the organizational documents of any Subsidiary of the Company,
(b)&nbsp;assuming compliance with the matters referred to in <U>Section</U><U></U><U>&nbsp;3.6</U>, conflict with or violate any Law, order, judgment or decree to which the Company, its Subsidiaries or any of their properties or assets is subject,
except any conflicts, violations, breaches, defaults or other occurrences which, have not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, or&nbsp;(c)&nbsp;assuming compliance
with the matters referred to in <U>Section</U><U></U><U>&nbsp;3.6</U>, conflict with or result in any breach of any provision of, or loss of any benefit, or constitute a default (with or without notice or lapse of time, or both) under, result in a
violation of, give rise to a right of termination, cancellation or acceleration of or require the Consent of, notice to or filing with any third party pursuant to any of the terms or provisions of any Contract to which the Company or any of its
Subsidiaries is a party or by which any property or asset of the Company or any of its Subsidiaries is bound or affected, or result in the creation of a Lien, other than any Permitted Liens, upon any of the property or assets of the Company or any
of its Subsidiaries, except, as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6 <U>Consents</U>. Except for (a)&nbsp;the applicable requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976
(the &#147;<U>HSR Act</U>&#148;) and any other Antitrust Laws of other jurisdictions, (b)&nbsp;applicable requirements of the Exchange Act and the Securities Act, (c)&nbsp;any filings required by, or compliance with the rules and regulations of,
Nasdaq or the New York Stock Exchange, (d)&nbsp;the filing of applications, registrations, declarations, listings, reports, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
submissions, amendments, modifications, consents, approvals, clearances, authorizations, notices and other documents, as required by the FDA, the U.S. Drug Enforcement Administration and any
other federal, state, local or foreign Governmental Body that is concerned with or regulates the marketing, sale, use, handling and control, safety, efficacy, reliability or manufacturing of medical devices or is concerned with or regulates public
health care programs, (e)&nbsp;any filings with the relevant authorities of other states in which the Company or any of its Subsidiaries is qualified to do business or state securities or &#147;blue sky&#148; laws of various states, and (f)&nbsp;any
notices, reports or other filings to be made by Wave Luxembourg and Wave Bermuda in connection with the Mergers, neither the Company nor any of its Subsidiaries are required to submit any material notice, report or other filing with any Governmental
Body in connection with the execution, delivery or performance by them of this Agreement or the consummation of the Transactions. Other than the approvals to be sought at the EGM as described in <U>Section</U><U></U><U>&nbsp;2.4(a)(i)-(viii)</U> or
as stated in the immediately preceding sentence in clauses (a) &#150; (f), no consent, approval, license, permit, waiver, order or authorization (a &#147;<U>Consent</U>&#148;) of, registration, declaration or filing with or notice to any
Governmental Body or any other party or Person is required to be obtained or made by or with respect to the Company or any of its Subsidiaries in connection with its execution, delivery and performance of this Agreement or the consummation of the
Transactions, except for those Consents, registrations, declarations, filings or notices the failure of which to be obtained or made has not, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7 <U>SEC Reports; Disclosure Controls and Procedures</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since January&nbsp;1, 2017, the Company has timely filed with (or furnished to) the SEC all forms, reports, schedules, statements,
exhibits and other documents (including exhibits, financial statements and schedules thereto and all other information incorporated therein and amendments and supplements thereto) required to be filed (or furnished) by the Company under the Exchange
Act or the Securities Act (collectively, the &#147;<U>Company SEC Documents</U>&#148;). No Subsidiary of the Company is required to file any form, report or other document with the SEC. As of their respective filing (or furnishing) dates (or, if
amended, supplemented or superseded by a filing prior to the date of this Agreement, then on the date of such amendment, supplement or superseding filing): (i) each of the Company SEC Documents complied in all material respects with the applicable
requirements of the Exchange Act and the Securities Act, as in effect on the date so filed (or furnished), and (ii)&nbsp;at the time of filing, none of the Company SEC Documents contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Each Company SEC Document that is a registration statement as of the date
such registration statement or amendment became effective prior to the date of this Agreement, did not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the
statements made therein not misleading. As of the date of this Agreement, there are no amendments or modifications to Company SEC Documents that were required to be filed with (or furnished to) the SEC prior to the date of this Agreement, but that
have not yet been filed with (or furnished to) the SEC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The financial statements (not including the Dutch statutory accounts) contained in the
Company SEC Documents (i)&nbsp;complied in all material respects with the applicable accounting requirements and with the published rules and regulations of the SEC applicable thereto, (ii)&nbsp;were prepared in accordance with GAAP, applied on a
consistent basis throughout the periods covered (except as may be indicated in the notes to such financial statements or, in the case of unaudited statements, as permitted by Form <FONT STYLE="white-space:nowrap">10-Q</FONT> of the Exchange Act) and
(iii)&nbsp;fairly presented in all material respects the consolidated financial position of the Company and its consolidated Subsidiaries as of the respective dates thereof and the consolidated shareholders&#146; equity, results of operations and
cash flows of the Company and its consolidated Subsidiaries for the periods covered thereby (subject, in the case of unaudited statements, to the absence of footnote disclosure and to normal and recurring
<FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments which, individually or in the aggregate, are not material in amount). The Company&#146;s statutory accounts filed with the Trade Register in Amsterdam, the Netherlands are prepared
in all material respects in accordance with International Financial Reporting Standards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company has designed and maintains a
system of internal control over financial reporting (as defined in Rules 13a&#150;15(f) and 15d&#150;15(f) of the Exchange Act) sufficient to provide reasonable assurance regarding the reliability of the Company&#146;s financial reporting. The
Company has designed and maintains disclosure controls and procedures (as defined in Rules 13a&#150;15(e) and 15d&#150;15(e) of the Exchange Act) to ensure that all information required to be disclosed by the Company in the reports that it files or
submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#146;s rules and forms and is accumulated and communicated to the Company&#146;s management as appropriate to allow timely
decisions regarding required disclosure and has designed and maintains controls and procedures designed to enable the principal executive officer and principal financial officer of the Company to make the certifications required by Section&nbsp;302
and Section&nbsp;906 of Sarbanes-Oxley with respect to such reports. The Company has disclosed, based on its most recent evaluation of its disclosure controls and procedures and internal control over financial reporting prior to the date of this
Agreement, to the Company&#146;s auditors and the audit committee of the Company Board (and made available to Parent a summary of the significant aspects of such disclosure, if any)&nbsp;(i) any &#147;significant deficiencies&#148; and
&#147;material weaknesses&#148; (as such terms are defined in Auditing Standard No.&nbsp;5 of the Public Company Accounting Oversight Board, as in effect on the date of this Agreement) in the design or operation of its internal control over
financial reporting that are reasonably likely to adversely affect the Company&#146;s ability to record, process, summarize and report financial information and (ii)&nbsp;any fraud, whether or not material, that involves management or other
employees who have a significant role in the Company&#146;s internal control over financial reporting. Since December&nbsp;30, 2018, any material change in internal control over financial reporting required to be disclosed in any Company SEC
Document has been so disclosed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Since January&nbsp;1, 2017, (i) neither the Company nor any of its Subsidiaries nor, to the Knowledge
of the Company, any director, officer, employee, auditor, accountant or Representative of the Company or any of its Subsidiaries has received any material written or, to the Knowledge of the Company, oral complaint, allegation, assertion or claim
regarding the accounting, auditing practices, procedures, methodologies or methods of the Company or any of its Subsidiaries or their respective internal accounting controls or any material complaint, allegation, assertion or claim that the Company
or any of its Subsidiaries has engaged in questionable or unlawful accounting or auditing practices and (ii)&nbsp;no attorney representing the Company or any of its Subsidiaries, whether or not employed by the Company or any of its
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Subsidiaries, has reported evidence of a violation of securities Laws, breach of fiduciary duty or similar violation by the Company or any of its Subsidiaries or any of their respective officers,
directors, employees or agents to the Company Board or any committee thereof or to the general counsel or chief executive officer of the Company pursuant to the rules of the SEC adopted under Section&nbsp;307 of Sarbanes-Oxley. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Prior to the date of this Agreement, the Company has made available to Parent complete and correct copies of all comment letters from the
SEC since January&nbsp;1, 2017 through the date of this Agreement with respect to any of the Company SEC Documents, together with all written responses of the Company thereto. As of the date of this Agreement, there are no outstanding or unresolved
comments in comment letters received from the SEC staff with respect to any of the Company SEC Documents, and, to the Knowledge of the Company, none of the Company SEC Documents is subject to ongoing SEC review. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To the Knowledge of the Company, as of the date of this Agreement, there are no (i)&nbsp;SEC inquiries or investigations or
(ii)&nbsp;other inquiries or investigations by Governmental Bodies or internal investigations pending or threatened, in each case regarding any accounting practices of the Company or any of its Subsidiaries or any malfeasance by any director or
executive officer of the Company or any of its Subsidiaries. Since January&nbsp;1, 2017 through the date of this Agreement, there have been no material internal investigations regarding accounting, auditing or revenue recognition discussed with,
reviewed by or initiated at the direction of the chief executive officer, chief financial officer, chief accounting officer or general counsel of the Company, the Company Board or any committee thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Neither the Company nor any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, <FONT
STYLE="white-space:nowrap">off-balance</FONT> sheet partnership or any similar Contract (including any Contract or arrangement relating to any transaction or relationship between or among the Company and any of its Subsidiaries, on the one hand, and
any unconsolidated affiliate, on the other hand), including any structured finance, special purpose or limited purpose entity or Person, or any <FONT STYLE="white-space:nowrap">&#147;off-balance</FONT> sheet arrangements&#148; (as defined in
Item&nbsp;303(a) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act), where the result, purpose or effect of such Contract is to avoid disclosure of any material transaction involving, or material liabilities of, the
Company or any of its Subsidiaries in the Company SEC Documents (including any audited financial statements and unaudited interim financial statements of the Company included therein). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8 <U>No Undisclosed Liabilities</U>. Except (a)&nbsp;as and to the extent disclosed or reserved against on the unaudited
consolidated balance sheet of the Company as of June&nbsp;30, 2019 that is included in the Company SEC Documents, (b)&nbsp;as incurred after June&nbsp;30, 2019 in the ordinary course of business consistent with past practice, (c)&nbsp;incurred in
connection with this Agreement or the Transactions or professional fees and other similar costs and expenses incurred in connection with negotiations with other entities regarding similar potential transactions or (d)&nbsp;as set forth in
<U>Section</U><U></U><U>&nbsp;3.8</U> of the Company Disclosure Letter, the Company, together with its Subsidiaries, does not have any material liabilities or obligations of any nature, whether known or unknown, absolute, accrued, contingent or
otherwise and whether due or to become due, in each case whether or not required by GAAP to be reflected or reserved against in the consolidated balance sheet of the Company and its Subsidiaries (or disclosed in the notes to such balance sheet).
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.9 <U>Absence of Certain Developments</U>. From the Company Balance Sheet Date
to the date of this Agreement, there has not been any event, circumstance, occurrence, effect, fact, development or change that has had, or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Except in connection with the Transactions or as set forth on <U>Section</U><U></U><U>&nbsp;3.9</U> of the Company Disclosure Letter, since the Company Balance Sheet Date, the Company and its Subsidiaries have carried on and operated their
respective businesses in all material respects in the ordinary course of business consistent with past practice, and neither the Company nor its Subsidiaries has taken, committed or agreed to take any actions that would have been prohibited by
<U>Section</U><U></U><U>&nbsp;5.1(b)</U> (other than <U>Section</U><U></U><U>&nbsp;5.1(b)(ii)</U>, (iii), (vi), (vii) (solely with respect to Subsidiaries of the Company), (x) and (xvii)) if such covenants had been in effect as of the Company
Balance Sheet Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10 <U>Compliance with Laws</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and its Subsidiaries are, and have been since January&nbsp;1, 2017, in compliance, in all material respects, with all Laws
applicable to them, any of their properties or other assets or any of their business or operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2017,
(i)&nbsp;neither the Company nor any of its Subsidiaries has received any written notice or, to the Knowledge of the Company, oral notification from any Governmental Body that alleges (A)&nbsp;any material violation or noncompliance (or reflects
that the Company or any of its Subsidiaries is under investigation or the subject of an inquiry by any such Governmental Body for such alleged noncompliance) with any applicable Law or Permits or (B)&nbsp;any material fine, assessment or cease and
desist order, or the suspension, revocation or limitation or restriction of any material Company Permit, and (ii)&nbsp;neither the Company nor any of its Subsidiaries has entered into any material agreement or settlement with any Governmental Body
with respect to its alleged noncompliance with, or violation of, any applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Since January&nbsp;1, 2017, the Company and each
of its Subsidiaries have timely filed all material regulatory reports, schedules, statements, documents, filings, submissions, forms, registrations and other documents, together with any amendments required to be made with respect thereto, that each
was required to file with any Governmental Body, including state health and regulatory authorities and any applicable federal regulatory authorities, and have timely paid all fees and assessments due and payable in connection therewith. All such
documents were true and correct in all material respects as of the date of submission, and any updates, changes, corrections or modification to such documents required under applicable Laws have been submitted to the Governmental Body. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company and each of its officers and directors are in compliance in all material respects with, and have since January&nbsp;1, 2019
complied in all material respects with, (i)&nbsp;the applicable provisions of the Sarbanes-Oxley Act of 2002 and the related rules and regulations promulgated under such act (&#147;<U>Sarbanes-Oxley</U>&#148;) or the Exchange Act and (ii)&nbsp;the
applicable listing and corporate governance rules and regulations of Nasdaq. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11 <U>Title to Tangible Properties</U><U>; Real Property</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and its Subsidiaries, as applicable, have good and valid title to, or hold pursuant to good, valid and enforceable leases or
other comparable contract rights, all of the tangible personal property and other tangible assets necessary for the conduct of the business of the Company and its Subsidiaries, taken as a whole, as currently conducted, in each case free and clear of
any Liens (other than Permitted Liens), except where the failure to do so has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The real property described in <U>Section</U><U></U><U>&nbsp;3.11(b)</U> of the Company Disclosure Letter (the &#147;<U>Company Leased
Real Property</U>&#148;) is a true and complete list of all the leases, subleases, licenses or similar use or occupancy agreements (including any amendments, extensions and modifications thereto, each, a &#147;<U>Lease</U>&#148;) pursuant to which
the Company or its Subsidiaries leases, subleases or otherwise uses or occupies the Company Leased Real Properties as of the date of this Agreement. Except as would not be material to the Company and its Subsidiaries, taken as a whole, the Company
and its Subsidiaries have valid leasehold interests under each of the Leases, in each case free and clear of any Liens (other than Permitted Liens). Except as disclosed in <U>Section</U><U></U><U>&nbsp;3.11(b)</U> of the Company Disclosure Letter or
as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company or one of its Subsidiaries has performed all material obligations required to be performed by it to date
under each Lease. There are no outstanding options, rights of first offer or rights of first refusal in favor of any other party to purchase or lease the Company Leased Real Property or any portion thereof or interest therein (except as disclosed in
<U>Section</U><U></U><U>&nbsp;3.11(b)</U> of the Company Disclosure Letter). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) With respect to the real property owned by the Company
or any of its Subsidiaries (the &#147;<U>Company Owned Real Property</U>&#148; and, together with the Company Leased Real Property, the &#147;<U>Company Real Property</U>&#148;), either the Company or a Subsidiary of the Company has good and valid
title to such Company Owned Real Property, free and clear of all Liens other than any Permitted Liens. <U>Section</U><U></U><U>&nbsp;3.11(c)</U> of the Company Disclosure Letter sets forth a true, complete and correct list of all Company Owned Real
Property as of the date of this Agreement. Neither the Company nor any of its Subsidiaries is a lessor or grantor under any lease or other similar instrument granting to any other Person any right to the possession, lease or occupancy of any Company
Owned Real Property or portion thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) There are no leases, subleases, licenses, occupancy agreements, consents, assignments,
purchase agreements or other contracts granting to any person (other than the Company or its Subsidiaries) the right to use or occupy the Company Real Property or any portion thereof, and no other Person (other than the Company and its Subsidiaries)
is in possession of the Company Real Property or any portion thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Neither the Company nor any of its Subsidiaries has received
any written notice of any material appropriation, condemnation or like proceeding, or of any material violation of any applicable zoning or land use Law or other Law relating to or affecting any of the Company Real Property. To the Knowledge of the
Company, (i)&nbsp;there are no pending or threatened proceedings to condemn the Company Real Property or to take by power of eminent domain or other governmental power the Company Real Property and (ii)&nbsp;the Company Real Property is in
compliance in all material respects with applicable Laws, permits, zoning, regulations and restrictive covenants applicable to such property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) The Company and its Subsidiaries have timely filed (taking into account any applicable extensions) all material income Tax Returns and
all other material Tax Returns required to be filed by them, (ii)&nbsp;such Tax Returns are true, complete and correct in all material respects, (iii)&nbsp;the Company and its Subsidiaries have paid all material Taxes due and owing (whether or not
shown on such Tax Returns), except for Taxes which are being contested in good faith through appropriate proceedings and for which adequate reserves have been established in accordance with GAAP, (iv)&nbsp;the Company and its Subsidiaries have duly
kept all records that they must keep for Tax purposes or which are needed to substantiate any claim made or position taken in relation to Tax, (v)&nbsp;as of the date of the Company Balance Sheet Date, any material liability of the Company or any of
its Subsidiaries for accrued Taxes not yet due and payable, or which are being contested in good faith through appropriate proceedings, has been provided for in the financial statements of the Company in accordance with GAAP and (vi)&nbsp;any Taxes
incurred after the date of the Company Balance Sheet Date were incurred in the ordinary course of business consistent with past practice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) There are no liens for a material amount of Taxes upon any of the assets of the Company or any of its Subsidiaries other than Permitted
Liens. The Company and its Subsidiaries have withheld and paid all material Taxes required to have been withheld and paid in connection with any amounts paid or owing to any employee, independent contractor, creditor, shareholder or other third
party. Neither the Company nor any of its Subsidiaries has been a party to any &#147;listed transaction&#148; within the meaning of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4</FONT> (or any similar provision of
applicable law). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of the date of this Agreement, neither the Company nor its Subsidiaries have received within the past three years
a written claim from any Governmental Body in a jurisdiction where the Company or any of its Subsidiaries does not currently file a Tax Return that it is or may be subject to taxation by that jurisdiction in respect of Taxes that would be covered by
or the subject of such Tax Return, which claim has not been resolved in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) No U.S., federal, state, local or foreign Tax Actions
are pending or being conducted, or to the Knowledge of the Company as of the date of this Agreement, are being threatened in respect of material Taxes of the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) There is no outstanding request for any extension of time for the Company or any of its Subsidiaries to pay any material Tax or file any
material Tax Return, other than any such request made in the ordinary course of business or regular filing extensions. No deficiencies for a material amount of Taxes have been claimed, proposed, assessed in writing or, to the Knowledge of the
Company as of the date of this Agreement, have been threatened, against the Company or any of its Subsidiaries by any Governmental Body that have not been fully paid, settled or withdrawn. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Neither the Company nor any of its Subsidiaries has material liability for the Taxes of
any Person (other than the Company or its Subsidiaries) under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> law), as a
transferee or successor, by contract or otherwise (other than any commercial agreements entered into in the ordinary course of business that do not relate primarily to Taxes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Within the last two years, none of the Company or any of its Subsidiaries has been a &#147;distributing corporation&#148; or
&#147;controlled corporation&#148; in any transaction intended to qualify under Section&nbsp;355 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Neither the Company nor
any of its Subsidiaries will be required to include any item of income in, or exclude any item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any &#147;closing
agreement&#148; as described in Section&nbsp;7121 of the Code (or any corresponding or similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Tax law) executed on or prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company has made available to Parent and Buyer true and complete copies of all Tax rulings issued by and Tax agreements with any
Governmental Body, including relevant correspondence in respect thereof, that will remain in effect or apply for any period after the Closing Date and, to the Knowledge of the Company, there is no basis for revocation of such Tax rulings and
agreements, and the Company has made available to Parent and Buyer true and complete copies of all examination reports and statements of deficiencies with respect to material amounts of Taxes assessed against or agreed to by the Company or any of
its Subsidiaries, in each case, filed or received since December&nbsp;27, 2015. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Neither the Company nor any of its Subsidiaries is
treated as a &#147;surrogate foreign corporation&#148; as defined in Section&nbsp;7874(a)(2)(B) of the Code or a domestic corporation as a result of the application of Section&nbsp;7874(b) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Notwithstanding any other provision of this Agreement except for <U>Section</U><U></U><U>&nbsp;3.12(j)</U>, nothing in this Agreement will
be construed as providing a representation or warranty with respect to (i)&nbsp;the amount of any net operating losses, Tax credit or capital loss carryovers that are available to the Company or any of its Subsidiaries or have been reported by the
Company or any of its Subsidiaries for any federal, state or other Tax purposes, or (ii)&nbsp;any limitation on use by the Company or any of its Subsidiaries of any net operating losses, Tax credit or capital loss carryovers that might apply either
before or after the Closing Date under Code Section&nbsp;382 or any other applicable limitations under any Tax Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) The Company and
its Subsidiaries are only treated as resident for Tax purposes in the countries of their incorporation under the applicable Law of such countries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) To the Knowledge of the Company, as of the date of this Agreement, neither the Company nor its Subsidiaries has received within the past
three years a written claim from any Governmental Body stating that it has not complied with all terms and conditions of an exemption from or reduction of Tax, that it has claimed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13 <U>Contracts and Commitments</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of the date of this Agreement, other than as set forth in <U>Section</U><U></U><U>&nbsp;3.13(a)</U> of the Company Disclosure Letter,
neither the Company, any of its Subsidiaries nor any of their respective assets or properties is a party to or bound by any: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)
&#147;material contract&#148; (as such term is defined in Item 601(b)(10) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> of the SEC) with respect to the Company or any of its Subsidiaries that was required to be, but has not been, filed
with the SEC with the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;30, 2018, or any Company SEC Documents filed after the date of filing of such Form <FONT
STYLE="white-space:nowrap">10-K</FONT> until one (1)&nbsp;Business Day prior to date of this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Contract (A)&nbsp;relating
to the disposition or acquisition by the Company or any of its Subsidiaries of a material amount of assets (1)&nbsp;after the date of this Agreement, other than the sale of inventory in the ordinary course of business consistent with past practice,
or (2)&nbsp;prior to the date of this Agreement, that contains any ongoing obligations (including sale of inventory, indemnification, <FONT STYLE="white-space:nowrap">&#147;earn-out&#148;</FONT> or other contingent obligations or payments) that are
still in effect that would reasonably be expected to be in excess of $2,500,000 or (B)&nbsp;pursuant to which the Company or any of its Subsidiaries will acquire any ownership interest in any other person or other business enterprise other than the
Company&#146;s Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Contract providing for the employment, engagement, retention or termination of any Person on a
full-time, part-time, material independent contractor, temporary or other basis or otherwise providing compensation or other benefits to any officer, director, employee or material independent contractor, other than Contracts terminable by the
Company for any reason upon less than thirty (30)&nbsp;days&#146; notice without incurring any liability (other than any Company Plan); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) collective bargaining agreement or other Contract with any labor union, labor or trade organization, works council or other employee
representative body (other than any statutorily mandated agreement in <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) Contract establishing any research and development collaboration, joint venture, partnership, alliance, or similar arrangement, or that
imposes any <FONT STYLE="white-space:nowrap">co-promotion</FONT> obligations with respect to any product or product candidate of the Company or any of its Subsidiaries (it being understood that the foregoing excludes any service or product
development Contracts with health care providers entered into in the ordinary course of business consistent with past practice); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi)
Contract described in <FONT STYLE="white-space:nowrap">sub-clause</FONT> (xv)&nbsp;or (xvi) of this Section&nbsp;3.13(a)&nbsp;(A) prohibiting, restricting or limiting, or that purports to prohibit, restrict or limit, the right of the Company or any
of its Subsidiaries to compete or to engage in any line or type of business or to conduct business with any Person or in any geographical area, (B)&nbsp;obligating the Company or any of its Subsidiaries to purchase or otherwise obtain any product or
service exclusively from a single party, to purchase a specified minimum amount of goods or services, sell any product or service exclusively to a single party or conduct any business on an exclusive basis with any third Person or (C)&nbsp;under
which any Person has been granted the right to manufacture, sell, market or distribute any product of the Company or any of its Subsidiaries on an exclusive basis to any Person or group of Persons or in any geographical area; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) Contracts in respect of Indebtedness of $2,500,000 or more, other than
(A)&nbsp;accounts receivables and payables and (B)&nbsp;loans to direct or indirect wholly owned Subsidiaries or other loans between or among the Company and its direct or indirect wholly owned Subsidiaries or between or among the Company&#146;s
Subsidiaries and Affiliates, in each case in the ordinary course of business consistent with past practice; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) Contract (other than
any Company Plan) between the Company, on the one hand, and any Affiliate of the Company (other than a Subsidiary of the Company), on the other hand; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) Contract relating to the voting or registration of any securities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) Contract containing a right of first refusal, right of first negotiation, right of first offer, put, call, redemption, repurchase or
similar right with respect to any equity interests, properties or assets that have a fair market value or purchase price of more than $2,500,000 in favor of a party other than the Company or its Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) Contract under which the Company or any of its Subsidiaries is expected to make annual expenditures or receive annual revenues in excess
of $3,000,000 during the current or a subsequent fiscal year; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) Settlement agreements, or agreements entered into in connection with
settlement agreements, corporate integrity agreements, consent decrees, deferred prosecution agreements, or other similar types of agreements with Governmental Bodies that have existing or contingent performance obligations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) Contracts of the Company or any of its Subsidiaries relating to the settlement of any litigation proceeding that provide for any
continuing material obligations on the part of the Company or any of its Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) Contracts of the Company or any of its
Subsidiaries that prohibit, limit or restrict the payment of dividends or distributions in respect of the share capital of the Company or any of its Subsidiaries or otherwise prohibit, limit or restrict the pledging of share capital of the Company
or any of its Subsidiaries or prohibit, limit or restrict the issuance of guarantees by the Company or any of its Subsidiaries, other than the Company Equity Plans or any Contracts evidencing awards granted under the Company Equity Plans; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv) Contracts with third-party manufacturers or suppliers for the manufacture or supply of materials or products in the supply chain for
Products that involve payments in excess of $2,000,000 during the current fiscal year or that involve payments that are reasonably expected to be in excess of $2,000,000 in a subsequent fiscal year; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvi) an agency, sales, marketing, commission, distribution, international or domestic sales representative or similar Contract involving
payments in excess of $3,000,000 during the current fiscal year or are reasonably expected to in a subsequent fiscal year; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvii)
Contract that creates or would create a Lien (other than a Permitted Lien) on any material asset or property of the Company or any of its Subsidiaries; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xviii) IP Contracts; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xix) Hedging, derivative or similar Contract (including interest rate, currency or commodity swap agreements, cap agreements, collar
agreements and any similar Contract designed to protect a Person against fluctuations in interest rates, currency exchange rates or commodity prices); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xx) Contract which provides for a loan or advance of any amount to any employee of the Company or any temporary agency employee, consultant
or other independent contractor of the Company or any of its Subsidiaries, in each case, in excess of $100,000 individually, other than the ordinary course of business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxi) Contract described in <FONT STYLE="white-space:nowrap">sub-clauses</FONT> (i)&nbsp;through (xx) with any Governmental Body, except for
commercial tenders made outside of the United States in the ordinary course of business; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxii) Contract to enter into any of the
foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each such Contract described in <FONT STYLE="white-space:nowrap">sub-clauses</FONT><U>&nbsp;Section 3.13(a)(i)</U> through
<U>Section</U><U></U><U>&nbsp;3.13(a)(xxii)</U> above of this <U>Section</U><U></U><U>&nbsp;3.13(a)</U> or excluded therefrom due to the exception of being filed as an exhibit to the Company SEC Documents, together with each Lease, is referred to
herein as a &#147;<U>Company Material Contract</U>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as set forth in <U>Section</U><U></U><U>&nbsp;3.13(b)</U> of the
Company Disclosure Letter, true, correct and complete copies of all written Company Material Contracts, together with all material amendments, waivers or other changes thereto have been made available to Parent, and a true, correct and complete
written summary setting forth the terms and conditions of each oral Company Material Contract has been made available to Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
Except as would not be material to the Company and its Subsidiaries, taken as a whole, neither the Company nor any of its Subsidiaries (A)&nbsp;is in violation or breach of or default (with or without notice or lapse of time or both) under the terms
of any Company Material Contract or (B)&nbsp;has waived, failed to enforce or assigned any rights or benefits under any Company Material Contract. Each Company Material Contract is in full force and effect and is a legal, valid and binding agreement
of, and enforceable against, the Company or any of its Subsidiaries, and, to the Knowledge of the Company, each other party thereto. As of the date of this Agreement, no party to any Company Material Contract has given any written notice of
termination or cancellation of any Company Material Contract or that it intends to seek to terminate or cancel any Company Material Contract (whether as a result of the Transactions or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14 <U>Intellectual Property</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;3.14(a)</U> of the Company Disclosure Letter sets forth, as of the date of this Agreement, a list of all
(i)&nbsp;Patents, (ii) Trademarks (excluding internet domain names) and (iii)&nbsp;Copyrights, in each instance, that are owned (or purported to be owned) by the Company or any of its Subsidiaries and that have been registered with a Governmental
Body, or with respect to which the Company or any of its Subsidiaries has filed an application for registration, except </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for any such Patents, Trademarks (excluding internet domain names) or Copyrights that have been abandoned by the Company or any of its Subsidiaries as of the date of this Agreement in the normal
course of business (collectively, &#147;<U>Company Registered Intellectual Property</U>&#148;), indicating for each such item in (i), (ii) and (iii), as applicable and as of the date of this Agreement, the name of the current record holder(s), the
jurisdiction of application/registration, the application/registration number and the filing/issuance date. <U>Section</U><U></U><U>&nbsp;3.14(a)(iv)</U> of the Company Disclosure Letter sets forth, as of the date of this Agreement, a list of all
internet domain names with respect to which the Company or any of its Subsidiaries are the registrant. All Company Registered Intellectual Property and, to the Knowledge of the Company, the Patents and registered or
<FONT STYLE="white-space:nowrap">applied-for</FONT> Trademarks and Copyrights included in the Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP are subsisting. To the Knowledge of the Company, all Company Registered
Intellectual Property and all Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP that is registered is valid and enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company or its applicable Subsidiary is the sole and exclusive beneficial and record owner of all rights, title and interests in the
Owned Intellectual Property (including all Company Registered Intellectual Property), free and clear of all Liens (except for Permitted Liens, licenses granted under the IP Contracts and Liens set forth in
<U>Section</U><U></U><U>&nbsp;3.14(b)(i)</U> of the Company Disclosure Letter). Except as set forth in <U>Section</U><U></U><U>&nbsp;3.14(b)(ii)</U> of the Company Disclosure Letter, since January&nbsp;1, 2017, the Company and its Subsidiaries have
not transferred any Patents to any third Person. The Company and its Subsidiaries own or otherwise possess legally sufficient rights to use all Intellectual Property used in connection with the conduct of the Company&#146;s and any of its
Subsidiary&#146;s businesses as of the Closing; <U>provided</U>, <U>however</U>, that the foregoing will not be interpreted as a representation of <FONT STYLE="white-space:nowrap">non-infringement</FONT> of third-party Intellectual Property, which
is dealt with exclusively in <U>Section</U><U></U><U>&nbsp;3.14(d)</U> below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Section 3.14(c)</U> of the Company Disclosure Letter
sets forth, as of the date of this Agreement, a list of all registered or <FONT STYLE="white-space:nowrap">applied-for</FONT> Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP. To the Knowledge of the Company, the rights,
licenses and interests of the Company or any of its Subsidiaries in and to all Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP are free and clear of all Liens or similar restrictions that materially restrict the use of the
Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP where such Liens or similar restrictions are the result of an action by the Company or any of its Subsidiaries, other than Permitted Liens and restrictions contained in the
applicable agreements with the licensor of such Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To the
Knowledge of the Company, since January&nbsp;1, 2017, the conduct of the Company&#146;s business and its Subsidiaries&#146; businesses has not misappropriated, infringed or otherwise violated the Intellectual Property of any Person, except as would
not reasonably be expected to have a Company Material Adverse Effect. Since January&nbsp;1, 2017, neither the Company nor any of its Subsidiaries has received any written notice from any Person claiming any, misappropriation, infringement or other
violation of the Intellectual Property of any Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Since January&nbsp;1, 2017, (i) to the Knowledge of the Company, no Person has
misappropriated, infringed or otherwise violated any Owned Intellectual Property or any Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP, except as would not reasonably be material to the Company and its Subsidiaries, taken
as a whole and (ii)&nbsp;no written claims are pending or, to the Knowledge of the Company, threatened, against the Company or any of its Subsidiaries </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
challenging the Company&#146;s or any of its Subsidiaries&#146; ownership of, or the validity or enforceability of, any Owned Intellectual Property or, to the Knowledge of the Company, any
Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP. No item of Company Registered Intellectual Property or, to the Knowledge of the Company, Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP has been
held to be invalid or unenforceable in a court decision or other proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as would not reasonably be expected to be
material to the Company and its Subsidiaries, taken as a whole, (i)&nbsp;since January&nbsp;1, 2017, neither the Company nor any of its Subsidiaries has received any written request or demand under any Contract to indemnify, defend, hold harmless or
reimburse any other Person with respect to, or otherwise assumed or agreed to discharge or otherwise take responsibility for, any existing or potential claim of misappropriation, infringement or other violation of Intellectual Property,
(ii)&nbsp;since January&nbsp;1, 2017, neither the Company nor any of its Subsidiaries has submitted or tendered any written request or demand under any Contract for a third Person to indemnify, defend, hold harmless or reimburse the Company or any
of its Subsidiaries with respect to, or otherwise to assume or agree to discharge or otherwise take responsibility for, any existing or potential claim of misappropriation, infringement or other violation of Intellectual Property, and (iii)&nbsp;no
Action regarding any existing or potential claim of misappropriation, infringement or other violation of Intellectual Property is pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries or against any
other Person who is or may be entitled to be indemnified, defended, held harmless or reimbursed by the Company or any of its Subsidiaries with respect to any such Action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) To the Knowledge of the Company, each current and former employee and independent contractor of the Company or any of its Subsidiaries who
was or is involved in the invention, creation, development, design or modification of any Intellectual Property that is material to the Company&#146;s or any of its Subsidiaries&#146; businesses has executed a valid and binding written agreement
expressly assigning to the Company or any of its Subsidiaries, as applicable, all rights, title, and interests in, to and under all such Intellectual Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) To the Knowledge of the Company, each current and former employee of the Company or any of its Subsidiaries, each current and former
independent contractor of the Company or any of its Subsidiaries and any other third parties with access to any confidential information that is material to the businesses of the Company or any of its Subsidiaries is subject to a written
nondisclosure or other confidentiality agreement requiring them to maintain the confidentiality of such information and use such information only for the benefit of the Company or its Subsidiaries, as applicable. The Company and its Subsidiaries
have taken reasonable steps to prevent the unauthorized disclosure or use of its and their material Trade Secrets. To the Knowledge of the Company, there has been no material unauthorized access, disclosure or use of any material Trade Secrets that
are Owned Intellectual Property or Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP, or any material Trade Secrets disclosed to the Company or its Subsidiaries for which the Company or any of its Subsidiaries had or has an
obligation of secrecy, against unauthorized access, disclosure or misuse. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) (i) No funding, facilities, resources or personnel of any Governmental Body or any
university, college or other educational institution were used by any Person to develop or create or reduce to practice, in whole or in part, any Owned Intellectual Property or, to the Company&#146;s Knowledge, any Company Exclusively <FONT
STYLE="white-space:nowrap">In-Licensed</FONT> IP. (ii)&nbsp;Neither the Company nor any of its Subsidiaries is now, or has since January&nbsp;1, 2017 been, a member or promoter of, or a contributor to, any industry standards body or any similar
organization that requires or obligates the Company or any of its Subsidiaries, to grant or offer to any other Person any license or right to any Owned Intellectual Property or Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT>
IP. (iii)&nbsp;None of the Patents included in the Owned Intellectual Property are subject to any declaration that obligates the Company or any of its Subsidiaries to grant a license, covenant not to sue, immunity or other right under any Owned
Intellectual Property on reasonable and <FONT STYLE="white-space:nowrap">non-discriminatory</FONT> (RAND) or fair reasonable and <FONT STYLE="white-space:nowrap">non-discriminatory</FONT> (FRAND) terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) None of the Products (i)&nbsp;contain any Software bug, defect or error that adversely affects the use, functionality, or performance of
such Products or (ii)&nbsp;fails to comply with any applicable Software warranty relating to the use, functionality or performance of such Products, in each case ((i) and (ii)) except as would not reasonably be expected to be material to the Company
and its Subsidiaries, taken as a whole. Since January&nbsp;1, 2017, no written claims have been asserted against the Company, any of its Subsidiaries or, to the Company&#146;s Knowledge, any of its or their customers, suppliers or distributors
related to the Products alleging any material defects, malfunctions or nonconformities, nor have there been any written threats thereof (excluding, in each case, ordinary course support claims), in each case of the foregoing except as would not be
material to the Company and its Subsidiaries, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) With regard to material proprietary Software that is incorporated
into, or otherwise necessary to use, any Products: (i)&nbsp;neither the Company nor any of its Subsidiaries has assigned, delivered, licensed or made available, and does not have any obligation to assign, deliver, license or make available, the
source code for any such Software to any Person, including any escrow agent or similar Person; (ii)&nbsp;since January&nbsp;1, 2017, neither the Company nor any of its Subsidiaries has experienced any defects or disruptions in such Software,
including any error or omission in the processing of any transactions that have not been corrected, except as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole; (iii)&nbsp;to the Knowledge of the
Company, no such Software contains any code that disrupts, disables, harms or otherwise impedes in any manner the operation of, or provides unauthorized access to, a computer system or network or other device on which such code is stored or
installed, or damages or destroys data or files without the user&#146;s consent; and (iv)&nbsp;current copies of the source code for all such Software are recorded on machine readable media and clearly identified and securely stored (together with
the applicable documentation) by the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Except as would not be material to the Company and its
Subsidiaries, taken as a whole, to the Knowledge of the Company, no proprietary Software that is contained in or distributed with any Products is combined with, derived from, distributed with or was developed using any Open Source Code in a manner
that: (i)&nbsp;imposes a requirement or condition that the Company or any of its Subsidiaries grant a license under its Patent rights; (ii)&nbsp;imposes a requirement or condition that any such Software or portion thereof (A)&nbsp;be disclosed or
distributed in source code form, (B)&nbsp;be licensed for the purpose of making modifications or derivative works or (C)&nbsp;be redistributable at no charge; or (iii)&nbsp;otherwise imposes any other material limitation, restriction, or condition
on the right or ability of the Company or any of its Subsidiaries to use or distribute any such Software. To the Knowledge of the Company, the Company and its Subsidiaries are in compliance with all applicable Open Source Licenses in all material
respects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Since January&nbsp;1, 2017, (i) to the Company&#146;s Knowledge, there have been no
material security breaches in the information technology systems used by or on behalf of the Company or any of its Subsidiaries and (ii)&nbsp;except as would not reasonably be expected to have a Company Material Adverse Effect, there have been no
disruptions in any such information technology systems. The Company has used commercially reasonable efforts to evaluate the disaster recovery and backup needs of the Company and its Subsidiaries and has implemented plans and systems that are
reasonably designed to address its assessment risk. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15 <U>Litigation</U>. As of the date of this Agreement, there are no
material Actions pending or, to the Company&#146;s Knowledge, no material Actions threatened in writing against the Company or any of its Subsidiaries or any asset or property of the Company or any of its Subsidiaries, at law or in equity, or before
or by any Governmental Body, and neither the Company nor any of its Subsidiaries nor any asset or property of the Company or any of its Subsidiaries is subject to or in violation of any outstanding material judgment, injunction, rule, order or
decree of any court or Governmental Body. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16 <U>Insurance</U>. <U>Section</U><U></U><U>&nbsp;3.16</U> of the Company
Disclosure Letter sets forth each insurance policy (including policies providing casualty, liability, medical and workers compensation coverage) to which the Company or any of its Subsidiaries is currently a party. Each such insurance policy is in
full force and effect, all premiums due thereon have been paid in full, and the Company and its Subsidiaries are in compliance with the terms and conditions of such insurance policy, and (i)&nbsp;neither the Company nor any of its Subsidiaries is in
breach or default under any such insurance policy or has received written notice that they are in breach or default under any such insurance policy, (ii)&nbsp;no notice of cancellation or termination has been received by the Company or any of its
Subsidiaries with respect to any such insurance policy and (iii)&nbsp;no event has occurred which, with notice or lapse of time, would constitute such breach or default, or permit termination, or modification, under any such insurance policy, except
as would not be material to the Company and its Subsidiaries, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17 <U>Employee Benefit Plans</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;3.17</U> of the Company Disclosure Letter lists all material Company Plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) With respect to each material Company Plan, the Company has made available to Parent and Buyer true and complete copies of the following
(as applicable) prior to the date of this Agreement: (i)&nbsp;the plan document, including all amendments thereto or, with respect to any unwritten plan, a summary of all material terms thereof, (ii)&nbsp;the summary plan description along with
summaries of material modifications thereto, (iii)&nbsp;all related trust instruments or other funding-related documents, (iv)&nbsp;a copy of the most recent financial statements for the plan, (v)&nbsp;a copy of all material correspondence (other
than correspondence in the ordinary course) with any Governmental Body relating to a Company Plan received or sent within the last three years and (vi)&nbsp;the most recent Internal Revenue Service determination or opinion letter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Company Plan that is intended to meet the requirements to be qualified under
Section&nbsp;401(a) of the Code is the subject of a favorable determination letter or is covered by a favorable opinion letter from the Internal Revenue Service, and to the Company&#146;s Knowledge, there are no facts or circumstances that would
reasonably be expected to jeopardize the qualification of such Company Plan. Except as would not reasonably be expected to result in material Liability to the Company, each Company Plan has complied in all material respects in form and in operation
with its terms and with the requirements of the Code, the Employee Retirement Income Security Act of 1974 (&#147;<U>ERISA</U>&#148;), and other applicable Law. With respect to each Company Plan that is an &#147;employee welfare benefit plan&#148; as
defined in Section&nbsp;3(1) of ERISA that is self-insured, the Company has accrued on the Company financial statements for incurred but not reported claims in accordance with acceptable commercial practice and accounting standards. Neither the
Company nor any of its Subsidiaries has a formal plan, written commitment, or proposal, whether legally binding or not, and has not made a commitment to employees, to create any additional Company Plan or modify or change any existing Company Plan
other than changes in the ordinary course of business consistent with past practice and that would not reasonably be expected to result in additional material Liability to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as would not reasonably be expected to result in material Liability to the Company, with respect to each Company Plan, (i)&nbsp;all
required contributions to, and premiums payable in respect of, such Company Plan have been made or, to the extent not required to be made on or before the date of this Agreement, have been properly accrued on the Company&#146;s financial statements
in accordance with GAAP, and (ii)&nbsp;there are no Actions pending or, to the Company&#146;s Knowledge, threatened, other than routine claims for benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) None of the Company, any of its Subsidiaries or any of their respective ERISA Affiliates has at any time during the six (6)&nbsp;years
prior to the date of this Agreement sponsored or contributed to, or had any Liability or obligation in respect of, a plan that is or was at any relevant time (i)&nbsp;subject to Title IV of ERISA or Section&nbsp;412 of the Code, (ii)&nbsp;a
&#147;multiemployer plan&#148; within the meaning of Section&nbsp;3(37) of ERISA, (iii)&nbsp;a &#147;multiple employer plan&#148; as described in Section&nbsp;413(c) of the Code, (iv)&nbsp;a &#147;multiple employer welfare arrangement&#148; within
the meaning of Section&nbsp;3(40) of ERISA or (v)&nbsp;a &#147;voluntary employees&#146; beneficiary association&#148; (as defined in Section&nbsp;501(c)(9) of the Code) or any other funded arrangement for the provision of health, other welfare, or
fringe benefits. Except as set forth in <U>Section</U><U></U><U>&nbsp;3.17(e)</U> of the Company Disclosure Letter, none of the Company Plans obligates the Company or any of its Subsidiaries to provide a current or former officer, director,
independent contractor or employee (or any spouse or dependent thereof) any life insurance or medical or health benefits after his or her termination of employment or service with the Company or any of its Subsidiaries, other than as required under
Part 6 of Subtitle B of Title I of ERISA, Section&nbsp;4980B of the Code or any other Law at the sole expense of the participant and coverage through the end of the month of termination of employment or service. None of the Company or any of its
Subsidiaries has engaged in a <FONT STYLE="white-space:nowrap">non-exempt</FONT> &#147;prohibited transaction&#148; (as such term is defined in Section&nbsp;406 of ERISA and Section&nbsp;4975 of the Code) or breached any fiduciary duties with
respect to any Company Plan that reasonably would be expected to subject the Company or any of its Subsidiaries to any material tax or penalty. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as otherwise contemplated by this Agreement, neither the execution or delivery of
this Agreement, nor the consummation of the Transactions, will, either individually or together with a termination of employment or service, (i)&nbsp;result in any payment (including severance, bonus or other similar payment) becoming due to any
current or former officer, director, independent contractor or employee of the Company or any of its Subsidiaries, (ii)&nbsp;increase or otherwise enhance any benefits or compensation otherwise payable under any Company Plan, (iii)&nbsp;result in
the acceleration of the time of payment or vesting of any payments or benefits under any Company Plan, (iv)&nbsp;require the Company or any of its Subsidiaries to set aside any assets to fund any benefits under any Company Plan, (v)&nbsp;result in
the forgiveness in whole or in part of any outstanding loan made by the Company to any Person or (vi)&nbsp;result in the payment of any &#147;excess parachute payment&#148; within the meaning of Section&nbsp;280G of the Code or in the imposition of
an excise Tax under Section&nbsp;4999 of the Code. Within sixty (60)&nbsp;days following the date of this Agreement, the Company will complete and furnish to Parent an analysis, which will identify individuals who qualify as &#147;disqualified
individuals&#148; under Section&nbsp;280G of the Code and any payment to any such &#147;disqualified individuals&#148; that could constitute a &#147;parachute payment&#148; (as defined in Section&nbsp;280G of the Code) and that may not be deductible
for federal income Tax purposes by virtue of Section&nbsp;280G of the Code. Neither the Company nor any of its Subsidiaries has any obligation to <FONT STYLE="white-space:nowrap">gross-up,</FONT> indemnify or otherwise reimburse any individual with
respect to any Tax, including under Sections 409A or 4999 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) With respect to each
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan, except as would not be expected to result in any material Liability to the Company or any of its Subsidiaries: (i)&nbsp;such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan is in
compliance and has been administered at all times in compliance with the applicable provisions of the Laws of such jurisdiction in which such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan is established and the terms of the applicable <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Plan; (ii)&nbsp;the Company and each of its Subsidiaries have complied with all applicable reporting and notice requirements, and such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan has obtained from
the Governmental Body having jurisdiction with respect to such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan required determinations, if any, that such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan is in material compliance with the
Laws of the relevant jurisdiction if such determinations are required in order to give effect to such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan; (iii)&nbsp;to the Knowledge of the Company, there are no pending investigations by any
Governmental Body involving any <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan; and (iv)&nbsp;other than as provided in this Agreement, the consummation of the contemplated transactions will not by itself create or together with another event
result in any Liability with respect to such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan. Neither the Company nor any of its Affiliates has (i)&nbsp;ever been an employer in relation to, participated in or had any liability (whether
prospective, contingent or otherwise) to or in respect of a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan constituting a defined benefit pension program or scheme or (ii)&nbsp;otherwise entered into any contractual arrangements, or given any
promises or commitments, relating to providing defined benefit pension benefits to employees or officers (or former employees or officers) pursuant to any plan, program, agreement or arrangement that would constitute a
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan. If required under applicable laws to be funded and/or book-reserved, such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan is funded and/or book-reserved, as appropriate, to the extent so
required by applicable Laws. Each <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan that is intended to qualify for <FONT STYLE="white-space:nowrap">tax-preferential</FONT> treatment under applicable Laws so qualifies, except as could not
reasonably be expected to result in a material Liability to the Company. Each <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Plan required to be registered has been so registered </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18 <U>Environmental Compliance and Conditions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except for matters that would not be material to the Company and its Subsidiaries, taken as a whole: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company and its Subsidiaries are, and, except for matters which have been fully resolved, have been, in compliance with all
Environmental Laws; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company and each of the Companies Subsidiaries hold, and are in compliance with, all Permits required under
Environmental Laws to operate their business at the Company Real Property as presently conducted; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Except for matters that are
resolved, neither the Company nor any of its Subsidiaries has received any written claim, notice or complaint, or been subject to any Action from any Governmental Body or third party regarding any actual or alleged violation of Environmental Laws or
any Liabilities or potential Liabilities under Environmental Laws, and, to the Knowledge of the Company, no such Action has been threatened; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) To the Company&#146;s Knowledge, neither the Company nor any of its Subsidiaries has released any Hazardous Substance on, under or about
the Company Real Property or any other real property now or formerly occupied or used by the Company or any of its Subsidiaries in a manner that reasonably would be expected to give rise to Liability for the Company or any of its Subsidiaries under
any Environmental Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company has made available to Parent and Buyer all material and
<FONT STYLE="white-space:nowrap">non-privileged</FONT> reports, studies and audits in the Company possession prepared since January&nbsp;1, 2017 and relating to the environmental condition of the Company Real Property or to the compliance of the
Company or any of its Subsidiaries&#146; compliance with, or liability under, Environmental Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19 <U>Employment and
Labor Matters</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Neither the Company nor any of its Subsidiaries is a party to, bound by or in the process of negotiating any
collective bargaining agreement or other Contract with any labor union, labor or trade organization, works council or other employee representative body, there are no such agreements which pertain to employees of the Company or any of its
Subsidiaries in existence or in negotiation, and no employees of the Company or any of its Subsidiaries are represented by any labor union, labor or trade organization, works council or other employee representative body. Neither the Company nor any
of its Subsidiaries has experienced any picketing, strike, slowdown, work stoppage, lockout or material grievance, claim of unfair labor practices or other labor dispute since January&nbsp;1, 2017. Neither the Company nor any of its Subsidiaries
will incur any notice, consultation or consent obligations with respect to any labor union, labor or trade organization, works council or other employee representative body in connection with the execution of this Agreement or the consummation of
the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i) There are no, and since January&nbsp;1, 2017 there have not been any, Actions or any material disputes pending
or, to the Company&#146;s Knowledge, threatened (A)&nbsp;between the Company or any of its Subsidiaries and any of their respective current or former officers, directors, employees, independent contractors, or applicants to any such positions or
(B)&nbsp;by or before any Governmental Body against or affecting the Company or any of its Subsidiaries concerning employment-related matters, and (ii)&nbsp;there is no current, and since January&nbsp;1, 2017
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
there has not been any, campaign to solicit cards from or otherwise organize employees of the Company or any of its Subsidiaries or to authorize a labor union, labor or trade organization, works
council or other employee representative body to request that the National Labor Relations Board (or any other Governmental Body) certify or otherwise recognize such a body with respect to employees of the Company or any of its Subsidiaries, and
neither the Company nor any of its Subsidiaries has been subject to an application by a labor union, labor or trade organization, works council or other employee representative body to be declared a common or related employer under labor relations
legislation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company and its Subsidiaries are, and since January&nbsp;1, 2017 have been, in compliance in all material respects
with all Laws relating to labor and employment, including all such Laws relating to wages (including minimum wage and overtime wages), hours, withholdings and deductions, human rights, discrimination, harassment (including sexual harassment),
retaliation, pay equity, employment equity, workers&#146; compensation, safety and health, immigration, work authorization, worker classification (including employee-independent contractor classification and the proper classification of employees as
exempt employees and <FONT STYLE="white-space:nowrap">non-exempt</FONT> employees), employee leave of absence and the Worker Adjustment and Retraining Notification Act and any similar foreign, state, provincial or local &#147;mass layoff&#148; or
&#147;plant closing&#148; Law (&#147;<U>WARN</U>&#148;). The Company and its Subsidiaries are not delinquent in material payments to any employees, former employees or individual independent contractors for any services or material amounts required
to be reimbursed or otherwise paid, except for any arrearages occurring in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) There has been no
&#147;mass layoff&#148; or &#147;plant closing&#148; (as defined by WARN) requiring notice to employees or any other obligations under WARN implemented by the Company or any of its Subsidiaries since January&nbsp;1, 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Neither the Company nor any of its Subsidiaries has a single employer, joint employer, alter ego or similar relationship with any other
Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) No Key Employee of the Company or any of its Subsidiaries is employed under a
<FONT STYLE="white-space:nowrap">non-immigrant</FONT> work visa or other work authorization that is limited in duration. The Company and each of its Subsidiaries maintains, and has maintained since January&nbsp;1, 2017, a valid Form <FONT
STYLE="white-space:nowrap">I-9</FONT> for each of its or their U.S. employees. To the Company&#146;s Knowledge, all employees employed by the Company or any of its Subsidiaries are authorized to work in the jurisdiction in which they are working.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) (i) In the last five (5)&nbsp;years, no officer or Key Employee of the Company or any of its Subsidiaries has been the subject of any
sexual harassment or other misconduct allegations or any violations of the Company employee handbook (which was made available to Parent and Buyer prior to the date of this Agreement) during his or her tenure at the Company, and (ii)&nbsp;neither
the Company nor any of its Subsidiaries nor any current or former officer or Key Employee of the Company or any of its Subsidiaries has entered into any settlement agreement or confidentiality agreement relating to allegations of sexual harassment
or misconduct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) To the Company&#146;s Knowledge, no Key Employee of the Company or any of its Subsidiaries is in material violation of
any employment agreement, nondisclosure agreement, common law nondisclosure obligation, <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement, restrictive covenant or other obligation that would reasonably be expected to be injurious to
the Company or its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20 <U>FDA and Regulatory Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and its Subsidiaries hold all material Permits, and have submitted all required applications, notices or submissions to, all
Governmental Bodies, including all authorizations under the Federal Food, Drug and Cosmetic Act of 1938 (the &#147;<U>FDCA</U>&#148;), the Public Health Service Act of 1944 and the regulations of the U.S. Food and Drug Administration (the
&#147;<U>FDA</U>&#148;) promulgated thereunder, necessary for the lawful operation of the businesses of the Company and its Subsidiaries as currently conducted (the &#147;<U>Company Permits</U>&#148;), and as of the date of this Agreement, all such
Company Permits are valid and in full force and effect. There has not occurred any material violation of, default (with or without notice or lapse of time or both) under, or event giving to others any threat of termination, amendment or cancellation
of, with or without notice or lapse of time or both, any Company Permit. The Company and each of its Subsidiaries are in compliance in all material respects with the terms of all Company Permits, and no event has occurred that, to the Knowledge of
the Company, would reasonably be expected to result in the revocation, suspension, cancellation, <FONT STYLE="white-space:nowrap">non-renewal</FONT> or adverse material modification of any material Company Permit. To the Knowledge of the Company,
any third Person that is a manufacturer or contractor for the Company or any of its Subsidiaries is in material compliance with all Permits insofar as they pertain to the manufacture of product components or products for the Company or any of its
Subsidiaries, as applicable. Since January&nbsp;1, 2017, neither the Company nor any of its Subsidiaries has received notice of any pending or threatened claim, suit, proceeding, hearing, enforcement, audit, investigation, arbitration or other
action from any Governmental Body alleging that any operation or activity of the Company or any of its Subsidiaries is in violation of any Law that applies to a Company Permit. The Transactions, in and of themselves, will not cause the revocation or
cancellation of any Company Permit pursuant to the terms of any such Company Permit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2017, all of the
Company&#146;s and its Subsidiaries&#146; Products that are subject to the jurisdiction of the FDA or other Governmental Body are being manufactured, imported, exported, processed, developed, investigated, produced, labeled, stored, tested,
marketed, promoted, advertised, distributed and sold by or on behalf of the Company or any of its Subsidiaries in all material respects in compliance with all applicable requirements under any Permit or Law, including applicable statutes and
implementing regulations administered or enforced by the FDA, and any comparable Laws enforced by any other Governmental Body that has jurisdiction over the operations of the Company or any of its Subsidiaries, including those regarding <FONT
STYLE="white-space:nowrap">non-clinical</FONT> research, clinical research, establishment registration, device listing, <FONT STYLE="white-space:nowrap">pre-market</FONT> notification, good manufacturing practices, labeling, advertising,
record-keeping, device importation and exportation, adverse event reporting and reporting of corrections and removals. To the Knowledge of the Company, except as would not be material to the Company and its Subsidiaries, taken as a whole, any third
Person that is a manufacturer or contractor for the Company or any of its Subsidiaries is in material compliance with all applicable statutes and implementing regulations administered or enforced by the FDA or any other applicable Law insofar as
they pertain to the manufacture of product components or products for the Company or any of its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Since January&nbsp;1, 2017, none of the Company, any of its Subsidiaries or, to the
Knowledge of the Company, any of their respective material contract manufacturers for Products, has received or been subject to any (i)&nbsp;FDA Form 483, (ii) notice of adverse finding, (iii)&nbsp;warning letter, (iv)&nbsp;notice of violation or
&#147;untitled letter,&#148; (v) requests or requirements to make changes to the Company&#146;s or any of its Subsidiaries&#146; Products, manufacturing processes or procedures related to any Product of the Company or any of its Subsidiaries or
(vi)&nbsp;other similar correspondence or notice from the FDA or any other Governmental Body alleging or asserting material noncompliance with any applicable Laws or the Company Permits with respect to any Product of the Company or its Subsidiaries.
Neither the Company nor any of its Subsidiaries is subject to any obligation arising under an administrative or regulatory action, FDA inspection, FDA warning letter, FDA notice of violation letter or other notice, response or commitment made to or
with the FDA or any comparable Governmental Body. Each of the Company and its Subsidiaries has made all notifications, submissions, responses and reports required by FDA or another Governmental Body, including any such obligation arising under any
administrative or regulatory action, FDA inspection, FDA warning letter, FDA notice of violation letter or other notice, response or commitment made to or with the FDA or any comparable Governmental Body and all such notifications, submissions,
responses and reports were true, complete and correct in all material respects as of the date of submission to the FDA or comparable Governmental Body. To the Knowledge of the Company, as of the date hereof, no basis for liability exists with
respect to any such notification, submission or report. Since January&nbsp;1, 2017, no manufacturing site owned by the Company, its Subsidiaries or, to the Knowledge of the Company, any of their respective contract manufacturers for Products, is or
has been subject to a shutdown or import or export prohibition imposed or requested by FDA or another Governmental Body. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Since
January&nbsp;1, 2017, all studies, tests and preclinical and clinical trials sponsored or being conducted by or on behalf of the Company or its Subsidiaries have been and are being conducted in material compliance with all applicable Laws and other
requirements, including the applicable requirements of Good Laboratory Practices or Good Clinical Practices, other FDA Laws, applicable research protocols, corrective action plans and federal and state laws, rules and regulations relating to patient
privacy requirements or restricting the use and disclosure of individually identifiable health information. Since January&nbsp;1, 2017, the Company and its Subsidiaries have not received any notices, correspondence or other communication from any
institutional review board, the FDA or any other Governmental Body, recommending or requiring the termination, suspension or material modification of any ongoing or planned clinical trials conducted by, or on behalf of, the Company or its
Subsidiaries, and neither the FDA nor any other applicable Governmental Body, nor any institutional review board that has or has had jurisdiction over a clinical trial conducted or sponsored on behalf of the Company or its Subsidiaries, has ordered
or commenced, or, to the Knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or to otherwise terminate, materially delay, limit, modify or suspend, any proposed or ongoing clinical trial conducted or
proposed to be conducted by or on behalf of the Company or its Subsidiaries, or, to the Knowledge of the Company, alleged any violation of any FDA Law in connection with any such clinical trial. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Since January&nbsp;1, 2017, the Company and its Subsidiaries have not either voluntarily
or involuntarily, initiated, conducted or issued, or caused to be initiated, conducted or issued, any material recall, market withdrawal, or replacement, field notifications, field corrections, &#147;dear doctor&#148; letter, investigator notice,
safety alert or other notice or action relating to an alleged lack of safety or efficacy or material regulatory compliance of any product or product candidate. The Company and its Subsidiaries are not aware of any facts which are reasonably likely
to cause (i)&nbsp;the material recall, market withdrawal or replacement of any product sold or intended to be sold by the Company or its Subsidiaries, (ii)&nbsp;a change in the marketing classification or a material change in the labeling of any
such products or (iii)&nbsp;termination or suspension of the marketing or such products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Neither the Company nor any of its
Subsidiaries or any of its or their respective officers, directors, managing employees (as such terms are defined in 42 C.F.R. &#167; 1001.2), nor to the Knowledge of the Company, any agent (as such term is defined in 42 C.F.R. &#167; 1001.2) of the
Company or its Subsidiaries, is a party to, or bound by, any order, any individual integrity agreement, corporate integrity agreement, monitoring agreement, consent decree, deferred prosecution agreement, settlement order or similar agreements with
or imposed by any Governmental Body. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Neither the Company, any of its Subsidiaries nor any of their respective directors, officers or
employees, nor, to the Knowledge of the Company, any of its agents or distributors or any other Person acting on behalf of the Company or any of its Subsidiaries has, at any time since January&nbsp;1, 2017, directly or indirectly, in any material
respect, (i)&nbsp;violated or been in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977 (the &#147;<U>FCPA</U>&#148;), (ii) violated or is in violation of any applicable Law enacted in any jurisdiction in connection with
or arising under the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions (the &#147;<U>OECD Convention</U>&#148;), (iii)&nbsp;violated or been in violation of any provision of the UK Bribery Act
2010 (the &#147;<U>UK Bribery Act</U>&#148;), (iv) violated or been in violation of any anti-bribery or anti-corruption Law in any foreign jurisdiction (collectively, with the FCPA, Laws enacted in connection with the OECD Convention, the UK Bribery
Act, and any related order or plan issued by any Governmental Body, the &#147;<U>Anti-Corruption Laws</U>&#148;), (v) made, offered to make, promised to make, or authorized the payment or giving of, directly or indirectly, any bribe, rebate, payoff,
influence payment, kickback or other unlawful payment or gift of money or anything of value prohibited under any applicable Law addressing matters comparable to those addressed by the FCPA, the UK Bribery Act or the OECD Convention implementing
legislation concerning such payments or gifts in any jurisdiction (any such payment, a &#147;<U>Prohibited Payment</U>&#148;), or (vi)&nbsp;violated or been in violation of any other Laws regarding use of funds for political activity or commercial
bribery. Since January&nbsp;1, 2017, neither the Company, nor any of its Subsidiaries, nor, any of their respective directors, officers or employees, nor, to the Knowledge of the Company, any of its agents or distributors or any other Person acting
on behalf of the Company or any of its Subsidiaries (i)&nbsp;is or has been the subject of an unresolved claim or allegation relating to (A)&nbsp;any potential violation of the Anti-Corruption Laws or (B)&nbsp;any potentially unlawful Prohibited
Payment, contribution, gift, bribe, rebate, payoff, influence payment, kickback or other payment or the provision of anything of value, directly or indirectly, to an official, to any political party or official thereof or to any candidate for
political office, or (ii)&nbsp;has received any notice or other communication from, or made a voluntary disclosure to, any Governmental Body regarding any actual, alleged or potential violation of, or failure to comply with, any Anti-Corruption Law.
Since January&nbsp;1, 2017, the Company and its Subsidiaries has had and maintains a system or systems of internal controls reasonably designed to (i)&nbsp;ensure compliance with the Anti-Corruption Laws and (ii)&nbsp;prevent and detect violations
of the Anti-Corruption Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Since January&nbsp;1, 2017, the Company and its Subsidiaries have complied in all
materials respects with all Privacy Obligations. The Company and its Subsidiaries have in place, and have complied in all material respects with each of their respective, written and published policies and procedures concerning the privacy, security
and Processing of Personal Information. As of the date of this Agreement, no claims or notices alleging or referencing the investigation of any breach or the improper use, disclosure or access to any Personal Information in its possession, custody
or control have been asserted or, to the Knowledge of the Company, threatened against the Company or its Subsidiaries by any Person alleging a violation of any Privacy Obligations. Neither the Company nor any of its Subsidiaries is a &#147;Business
Associate&#148; as defined under HIPAA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Neither the Company nor any of its Subsidiaries, and no director, officer employee, or agent
of any of the Company or its Subsidiaries is a Sanctioned Person. Each of the Company and its Subsidiaries and each director, officer, employee and, to the Knowledge of the Company, agent thereof is in compliance with, and, since January&nbsp;1,
2017, has not violated, any Sanctions. The Company and its Subsidiaries have in place adequate controls and systems reasonably designed to ensure compliance with applicable Sanctions in each of the jurisdictions in which the Company or any of its
Subsidiaries do or in the past have done business. Neither the Company nor any of its Subsidiaries has pending or, to the Knowledge of the Company, any threatened legal action, investigation, or claim against it with respect to Sanctions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) None of the Company, its Subsidiaries, or any of their respective officers, directors, managing employees, or authorized agents, or to the
Knowledge of the Company, other employees or contractors: (i)&nbsp;has been charged with or convicted of any criminal offense relating to the delivery of an item or service under any Federal Health Care Program, (ii)&nbsp;has been debarred, excluded
or suspended from participation in any Federal Health Care Program, (iii)&nbsp;has had a civil monetary penalty assessed against it, him or her under 42 U.S.C. <FONT STYLE="white-space:nowrap">&#167;1320a-7a,</FONT> (iv)&nbsp;is currently listed on
the list of parties excluded from federal procurement programs and <FONT STYLE="white-space:nowrap">non-procurement</FONT> programs as maintained in the Government Services Administration&#146;s System for Award Management or other federal agencies,
(v)&nbsp;to the Knowledge of the Company, is the target or subject of any current or potential investigation relating to any Federal Health Care Program-related offense or (vi)&nbsp;has engaged in any activity that is in material violation of, or is
cause for civil penalties or mandatory or permissive exclusion under, federal or state Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Each of the Company and its Subsidiaries
has an operational healthcare compliance program that: (i)&nbsp;governs all employees and authorized agents, (ii)&nbsp;is consistent with the current U.S. Federal Sentencing Guidelines standards for effective compliance programs, (iii)&nbsp;reflects
the AdvaMed Code of Ethics on Interactions with Healthcare Professionals and (iv)&nbsp;addresses compliance with federal and state Laws regulating, or requiring the disclosure to a state agency of, interactions between medical device manufacturers
or related entities and healthcare providers or other individuals and entities associated with the healthcare industry. The Company and its Subsidiaries further operate in material compliance with such healthcare compliance program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Each of the Company and its Subsidiaries (i)&nbsp;has in place current agreements for
its marketed product to participate in Federal Health Care Programs and (ii)&nbsp;is in material compliance with all such agreements including, provisions in such agreements pertaining to the timely and current submission of accurate prices to
federal and state agencies. Neither the Company nor its Subsidiaries is, in any material respect, resubmitting or planning to resubmit to the government any data reported under the Medicaid Rebate Statute, Medicare <U>Part</U><U></U><U>&nbsp;B</U>
Drug Pricing requirements, 340B Program requirements, Veterans Health Care Act of 1992, or the Medicare <U>Part</U><U></U><U>&nbsp;D</U> Coverage Gap Discount Program, or refunding any monies owed due to a resubmission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Except as has not been, and would not reasonably be expected to be, individually, or in the aggregate, material to the Company and its
Subsidiaries, taken as a whole, (i)&nbsp;all agreements or other arrangements between the Company or any of its Subsidiaries on the one hand and any physician on the other hand for services are in writing, describe bona fide services required by the
Company or its Subsidiaries, as the case may be, provide for compensation that is no more than fair market value for such services determined as of the effective date of the agreement, and are in material compliance with the Federal Anti-Kickback
Statute (42 U.S.C.&#167; <FONT STYLE="white-space:nowrap">1320a-7b(b))</FONT> (&#147;<U>AKS</U>&#148;), (ii) all payments made and things of value provided by the Company or any of its Subsidiaries to any healthcare professional for services
rendered by such health care professional have been made at fair market value determined as of the effective date of any such agreement and are in material compliance with AKS and (iii)&nbsp;all such agreements, arrangements, payments and things of
value are in compliance in all material respects with all applicable Laws, including all Federal Health Care Program Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) To the
extent the Company and any of its Subsidiaries provide to customers or other reimbursement coding or billing advice regarding products offered for sale by the Company or any of its Subsidiaries and procedures related thereto, such advice is
(i)&nbsp;true, complete and correct, (ii)&nbsp;in compliance with Medicare and other Federal Health Care Program Laws, (iii)&nbsp;conforms to the applicable American Medical Association&#146;s Current Procedural Terminology (CPT), the International
Classification of Disease, Tenth Revision, Clinical Modification <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(ICD-10-CM)</FONT></FONT> and other applicable coding systems, (iv)&nbsp;includes a disclaimer advising customers to
contact individual payers to confirm coding and billing guidelines and (v)&nbsp;has been independently verified as supporting accurate claims for reimbursement by federal, state and commercial payors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) The Company and its Subsidiaries has timely, accurately and completely reported all payments and transfers of value made to physicians and
teaching hospitals, as required by the Physician Payment Sunshine Act (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7h)</FONT> and the Company is in full compliance with all analogous state laws requiring the reporting of financial
interactions with health care providers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21 <U>Brokerage</U>. Other than Guggenheim Securities, LLC, no Person is entitled
to any brokerage commissions, finders&#146; fees or similar compensation in connection with this Agreement or the Transactions based on any arrangement or agreement made by or on behalf of the Company or any of its Affiliates. A true, correct and
complete copy of the engagement letter between the Company and Guggenheim Securities, LLC has been made available to Parent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22 <U>Disclosure</U>. None of the information supplied or to be supplied by
or on behalf of the Company specifically for inclusion or incorporation by reference in the Offer Documents will, at the time such documents are filed with the SEC, at the time they are mailed to the holders of Shares, or at the time any amendment
or supplement thereto is filed with the SEC, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances
under which they are made, not misleading or necessary in order to correct any statement of a material fact in any earlier communication with respect to such Offer Documents that has become false or misleading. The <U>Schedule</U><U></U><U><FONT
STYLE="white-space:nowrap">&nbsp;14D-9</FONT></U> and EGM Materials (including any amendments or supplements thereto, the &#147;<U>Company Disclosure Documents</U>&#148;) will not, when filed with the SEC or mailed to the holders of Shares, as
applicable, or at the time any amendment or supplement thereto is filed with the SEC, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they are made, not misleading or necessary in order to correct any statement of a material fact in any earlier communication with respect to such Company Disclosure Documents<U> </U>that has
become false or misleading. Notwithstanding the foregoing, no representation or warranty is made by the Company with respect to information supplied by or on behalf of Parent, Buyer, or any Affiliate of Parent or Buyer specifically for inclusion in
the Offer Documents or the Company Disclosure Documents. The Company Disclosure Documents will, when filed with the SEC or mailed to the holders of Shares, as applicable, and at the time any amendment or supplement thereto is filed with the SEC,
comply as to form in all material respects with the provisions of the Exchange Act and the rules and regulations of the SEC thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23 <U>Anti-Takeover Measures</U>. No anti-takeover measure (such as any measure which would qualify as a
&#147;<I>beschermingsmaatregel</I>&#148; under the Laws of The Netherlands) that may be invoked or implemented by the Company (or any of its Affiliates) or by a third party pursuant to a right granted to such third party by the Company (or any of
its Affiliates) (each, an &#147;<U>Anti-Takeover Measure</U>&#148;) has been implemented by the Company (or such Affiliate) in relation to the Offer or the other Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24 <U>Opinion</U>. The Company Board has received the opinion of Guggenheim Securities, LLC to the effect that, as of the date
of such opinion and based upon and subject to the assumptions made, matters considered and limits on the review undertaken set forth therein, the Offer Consideration to be paid to the Company&#146;s shareholders (excluding Parent, Buyer, or any of
their Affiliates) pursuant to this Agreement (other than in the case of the Compulsory Acquisition or any other Post-Offer Reorganization resulting in payments other than the Offer Consideration) is fair, from a financial point of view, to such
shareholders. Such opinion has not been withdrawn, revoked or modified. Promptly after the date of this Agreement, a true, correct and complete copy of such opinion will be made available to Parent for informational purposes only. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25 <U>No Other Representations and Warranties</U>. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN <U>ARTICLE
</U><U>III</U> OF THIS AGREEMENT (AS MODIFIED BY THE COMPANY DISCLOSURE LETTER), NEITHER THE COMPANY NOR ANY PERSON ON BEHALF OF THE COMPANY MAKES ANY EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY, AND THE COMPANY
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
HEREBY DISCLAIMS ANY SUCH REPRESENTATION OR WARRANTY. IN CONNECTION WITH PARENT&#146;S INVESTIGATION OF THE COMPANY, PARENT HAS RECEIVED FROM OR ON BEHALF OF THE COMPANY CERTAIN PROJECTIONS. THE
COMPANY MAKES NO REPRESENTATIONS OR WARRANTIES WHATSOEVER WITH RESPECT TO ESTIMATES, PROJECTIONS AND OTHER FORECASTS AND PLANS (INCLUDING THE REASONABLENESS OF THE ASSUMPTIONS UNDERLYING ESTIMATES, PROJECTIONS AND FORECASTS). THE COMPANY
ACKNOWLEDGES THAT, EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN <U>ARTICLE IV</U> OF THIS AGREEMENT, NONE OF PARENT OR BUYER OR ANY OF THEIR RESPECTIVE AFFILIATES OR REPRESENTATIVES OR ANY OTHER PERSON MAKES (AND THE COMPANY IS NOT
RELYING ON) ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, TO THE COMPANY IN CONNECTION WITH THE TRANSACTIONS. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>OF PARENT AND BUYER </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Parent and Buyer, jointly and severally, hereby represent and warrant to the Company as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Organization and Corporate Power</U>. Each of Parent and Buyer is duly organized and validly existing under the Laws of the
jurisdiction in which it was organized, with all necessary corporate power and authority to enter into this Agreement and perform its obligations hereunder. Each of Parent and Buyer has all requisite corporate power and authority and all
authorizations, licenses and Permits necessary to own, lease and operate its properties and to carry on its business as it is now being conducted, except where the failure to hold such authorizations, licenses and Permits would not reasonably be
expected to have a Buyer Material Adverse Effect. Parent owns beneficially and of record all of the outstanding capital stock of Buyer free and clear of all Liens. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Authorization; Valid and Binding Agreement</U>. The execution and delivery of this Agreement and performance of
Parent&#146;s and Buyer&#146;s obligations under this Agreement by each of Parent and Buyer, and the consummation by Parent and Buyer of the Signing Transactions, including the Offer, the Compulsory Acquisition, the Asset Sale, the Second Step
Distribution, the Liquidation and the Mergers are within the corporate powers of Parent and Buyer and have been duly and validly authorized by all necessary corporate action on the part of Parent and Buyer. This Agreement has been duly executed and
delivered by Parent and Buyer and, assuming due authorization, execution and delivery by the Company, this Agreement constitutes a legal, valid and binding obligation of each of them, enforceable against each of them in accordance with its terms,
subject to the Enforceability Exceptions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>No Breach</U>. The execution, delivery and performance of this Agreement of
this Agreement by Parent and Buyer and the consummation of the Transactions do not and will not (a)&nbsp;conflict with or violate the respective certificates of incorporation or bylaws (or similar governing documents) of Buyer and Parent,
(b)&nbsp;assuming all Consents registrations, declarations, filings and notices described in <U>Section</U><U></U><U>&nbsp;4.4</U> have been obtained or made, and except as set forth </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in <U>Section</U><U></U><U>&nbsp;3.5(b) </U>of the Company Disclosure Letter, conflict with or violate any Law, order, judgment or decree to which Parent, Buyer, either of their Subsidiaries or
any of their properties or assets is subject, except any conflicts, breaches, defaults, violations, terminations, cancellations or accelerations that would not reasonably be expected to have a Buyer Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>Consents</U>. Except for (a)&nbsp;the applicable requirements of the HSR Act and any other Antitrust Laws of other
jurisdictions, (b)&nbsp;applicable requirements of the Exchange Act and the Securities Act, (c)&nbsp;any filings required by, or compliance with the rules and regulations of, the Nasdaq or the New York Stock Exchange, (d)&nbsp;the filing of
applications, registrations, declarations, listings, reports, submissions, amendments, modifications, consents, approvals, clearances, authorizations, notices and other documents, as required by the FDA, the U.S. Drug Enforcement Administration and
any other federal, state, local or foreign Governmental Body that is concerned with or regulates the marketing, sale, use, handling and control, safety, efficacy, reliability or manufacturing of medical devices or is concerned with or regulates
public health care programs, (e)&nbsp;any filings with the relevant authorities of other states in which Parent or any of its Subsidiaries is qualified to do business or state securities or &#147;blue sky&#148; laws of various states and
(f)&nbsp;any notices, reports or other filings to be made by Parent or Merger Sub in connection with the Mergers, Parent and Buyer are not required to submit any material notice, report or other filing with any Governmental Body in connection with
the execution, delivery or performance by them of this Agreement or the consummation of the Transactions. Other than as stated in the immediately preceding sentence in clauses (a) &#150; (e), no Consent of, registration, declaration or filing with
or notice to any Governmental Body or any other party or Person is required to be obtained or made by or with respect to Parent or Buyer in connection with the execution, delivery and performance by them of this Agreement or the consummation of the
Transactions, except for those Consents, registrations, declarations, filings or notices the failure of which to be obtained or made would not reasonably be expected to have Buyer Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5 <U>Litigation</U>. As of the date of this Agreement, there are no proceedings pending or, to the Knowledge of Parent or
Buyer, overtly threatened against Parent or any of its Subsidiaries that seeks to enjoin the Offer, Asset Sale, Compulsory Acquisition, Liquidation, Second Step Distribution, the Mergers or the other Transactions, other than any such proceedings
that have not had and would not reasonably be expected to have a Buyer Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6 <U>Offer Documents;
Schedule</U><U></U><U><FONT STYLE="white-space:nowrap">&nbsp;14D-9</FONT></U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) None of the Offer Documents, will, at the time such
documents are filed with the SEC, at the time they are mailed to the holders of Shares and at the time any amendment or supplement thereto is filed with the SEC, contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they are made, not misleading or necessary in order to correct any statement of a material fact in any earlier
communication with respect to such Offer Documents that has become false or misleading. Notwithstanding the foregoing, no representation is made by Parent or Buyer with respect to information supplied by or on behalf of the Company or any Affiliate
of the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
specifically for inclusion in the Offer Documents. The Offer Documents will, at the time such documents are filed with the SEC, at the time the Offer Documents are mailed to the holders of
Shares, and at the time any amendment or supplement thereto is filed with the SEC, comply as to form in all material respects with the applicable provisions of the Exchange Act and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The information with respect to Parent, Buyer and any of their Affiliates that Parent or Buyer supplies to the Company for use in any
Company Disclosure Document will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading or necessary in order to make the statements made therein, in the light of the circumstances under which they are made, not misleading or necessary in order to correct any statement of a material fact in any earlier
communication with respect to such Offer Documents that has become false or misleading at the time of the filing of such Company Disclosure Document or any supplement or amendment thereto and at the time of any distribution or dissemination thereof.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7 <U>Brokerage</U>. Except for any such Person whose commissions, fees or compensation will be paid by Parent or Buyer
(and for which none of the Company nor any of its Subsidiaries shall be liable), no Person is entitled to any brokerage commissions, finders&#146; fees or similar compensation in connection with this Agreement or the Transactions based on any
arrangement or agreement made by or on behalf of Parent or Buyer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8 <U>Operations of Buyer</U>. Buyer has been formed
solely for the purpose of engaging in the Transactions and has engaged in no business activities and will have incurred no liabilities or obligations except as contemplated by this Agreement or incident to its formation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9 <U>Ownership of Shares</U>. Neither Parent nor Buyer, nor any of their respective Subsidiaries, beneficially owns any Shares
or other securities of the Company or any options, warrants or other rights to acquire any economic interest in, the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10 <U>Funds</U>. At the Closing, Parent and Buyer will have available to them all funds necessary to enable Buyer to consummate
the Offer and the other Transactions pursuant to the terms of this Agreement and to satisfy all of Buyer&#146;s obligations under this Agreement, including to pay the aggregate Offer Consideration and to pay all amounts required to consummate the
Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11 <U>Investigation by Parent and Buyer; Disclaimer of Reliance</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of Parent and Buyer has relied solely upon its own investigation and analysis and the representations and warranties of the Company
in <U>Article III</U> of this Agreement, and each of Parent and Buyer acknowledges that, except for the representations and warranties of the Company expressly set forth in <U>Article III</U> of this Agreement, none of the Company, its Subsidiaries
or any of their Representatives makes any representation or warranty, either express or implied, as to the accuracy or completeness of any of the information provided or made available to Parent or Buyer or any of their Representatives. Without
limiting the generality of the foregoing, none of the Company, its Subsidiaries or any of their Representatives or any other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Person has made a representation or warranty to Parent or Buyer with respect to any materials, documents or information relating to the Company or its Subsidiaries made available to each of
Parent or Buyer or their Representatives in any &#147;data room,&#148; confidential memorandum, other offering materials or otherwise, except as expressly and specifically covered by a representation or warranty set forth in <U>Article III</U> of
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In connection with Parent&#146;s and Buyer&#146;s investigation of the Company, each of Parent and Buyer has received
from the Company and its Representatives certain projections and other forecasts and certain business plan information of the Company and its Subsidiaries. Each of Parent and Buyer acknowledges that there are uncertainties inherent in attempting to
make such projections and other forecasts and plans and accordingly is not relying on them, that each of Parent and Buyer is familiar with such uncertainties, that each of Parent and Buyer is taking full responsibility for making its own evaluation
of the adequacy and accuracy of all projections and other forecasts and plans so furnished to it, and that each of Parent, Buyer, and their Representatives will have no claim against any Person with respect thereto. Accordingly, each of Parent and
Buyer acknowledges that, without limiting the generality of this <U>Section</U><U></U><U>&nbsp;4.11(b)</U>, neither the Company nor any Person acting on behalf of the Company has made any representation or warranty with respect to such projections
and other forecasts and plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12 <U>Other Agreements</U>. Parent and Buyer have disclosed to the Company all contracts,
agreements, or understandings (and, with respect to those that are written, Parent and Buyer has furnished to the Company correct and complete copies thereof) between or among Parent, Buyer or any Affiliate of Parent, on the one hand, and any member
of the Company Board or officers or employees of the Company or its Subsidiaries, on the other hand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.13 <U>No Other
Representations and Warranties</U>. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN <U>ARTICLE </U><U>IV</U> OF THIS AGREEMENT (AS MODIFIED BY THE PARENT DISCLOSURE LETTER), NONE OF PARENT OR BUYER OR ANY OTHER PERSON ON BEHALF OF PARENT
OR BUYER MAKES NO EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY, AND EACH OF PARENT AND BUYER HEREBY DISCLAIM ANY SUCH REPRESENTATION OR WARRANTY. EACH OF PARENT AND BUYER ACKNOWLEDGES THAT, EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN
<U>ARTICLE III</U> OF THIS AGREEMENT, NONE OF THE COMPANY OR ANY OF ITS AFFILIATES OR REPRESENTATIVES OR ANY OTHER PERSON MAKES (AND PARENT AND BUYER ARE NOT RELYING ON) ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, TO PARENT OR BUYER IN
CONNECTION WITH THE TRANSACTIONS. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COVENANTS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Covenants of </U><U>the Company</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except (i)&nbsp;as set forth in <U>Section</U><U></U><U>&nbsp;5.1(a)</U> of the Company Disclosure Letter, (ii)&nbsp;as required by
applicable Law, (iii)&nbsp;as expressly required by this Agreement or (iv)&nbsp;with the prior written consent of Parent (which consent will not be unreasonably delayed, withheld or conditioned), from the date of this Agreement until the earlier of
the Closing or the date this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement is validly terminated in accordance with <U>Article</U><U></U><U>&nbsp;VI</U> (the &#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period</U>&#148;), the Company shall, and
shall cause its Subsidiaries to, carry on their respective businesses in the ordinary course of business consistent with past practice and use reasonable best efforts to preserve intact their respective current business organizations, keep available
the services of their respective current officers, employees and consultants and preserve their respective relationships with customers, suppliers, partners, licensors, licensees, distributors and others having business dealings with it. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without limiting the generality of <U>Section</U><U></U><U>&nbsp;5.1(a)</U>, during the
<FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period and except as set forth in <U>Section</U><U></U><U>&nbsp;5.1(b</U>) of the Company Disclosure Letter, as required by applicable Law or as expressly required by this Agreement, the Company
shall not and shall not permit any of its Subsidiaries, without the prior written consent of Parent (which, in the case of <U>Section</U><U></U><U>&nbsp;5.1(b)(iii)</U>, <U>Section</U><U></U><U>&nbsp;5.1(b)(v)</U>,
<U>Section</U><U></U><U>&nbsp;5.1(b)(vi)</U>, <U>Section</U><U></U><U>&nbsp;5.1(b)(x)</U>, <U>Section</U><U></U><U>&nbsp;5.1(b)(xiii)</U>, <U>Section</U><U></U><U>&nbsp;5.1(b)(xiv)</U>, <U>Section</U><U></U><U>&nbsp;5.1(b)(xvii)</U>, and
<U>Section</U><U></U><U>&nbsp;5.1(b)(xxiv)</U> (solely to the extent relating to the foregoing actions described in this parenthetical) consent will not be unreasonably delayed, withheld or conditioned), to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) (A) declare, set aside or pay any dividends on or make other distributions (whether in cash, stock or property) in respect of any of its
share capital, equity interests or other ownership or voting interests or (B)&nbsp;directly or indirectly redeem, repurchase or otherwise acquire any shares of its share capital, equity interests or other ownership or voting interests or any Company
Stock Options, Company RSUs, Company PSUs, or Company ESPP Purchase Rights with respect thereto except, in each case, (1)&nbsp;for the declaration and payment of cash dividends or distributions by a direct or indirect wholly owned Subsidiary of the
Company solely to its parent in the ordinary course of business consistent with past practice, (2)&nbsp;Shares for the purpose of fulfilling its obligations under the Company ESPP, to the extent consistent with past practice and as contemplated by
this Agreement, (3)&nbsp;for any dispositions of Shares to the Company as a result of a net share settlement of any Company Stock Option or to satisfy withholding Tax obligations in respect of any Company Stock Option, Company RSU, or Company PSU,
in each case in accordance with the applicable Company Equity Plan or (4)&nbsp;any forfeitures or repurchases of Shares issued pursuant to or granted as awards under the Company Equity Plans, in each case, in accordance with the applicable Company
Equity Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) issue, transfer, sell, pledge, dispose of or otherwise encumber, or authorize the issuance, transfer, sale, pledge,
disposition or other encumbrance of, (A)&nbsp;any shares of its share capital, equity interests or other ownership or voting interests in the Company or any of its Subsidiaries, (B)&nbsp;any securities convertible into or exchangeable or exercisable
for any such shares, equity interests or ownership or voting interests, (C)&nbsp;any phantom equity or similar contractual rights or (D)&nbsp;any rights, warrants or options to acquire or with respect to any such share capital, equity interests or
other ownership or voting interests or convertible or exchangeable securities or take any action to cause to be exercisable any otherwise unexercisable option under any existing share option plan except, in each case: for issuances of the Shares in
respect of (x)&nbsp;any exercise of Company Stock Options outstanding on the date of this Agreement, in accordance with their terms on the date of this Agreement, (y)&nbsp;any vesting or delivery of Shares under Company RSUs outstanding on the date
of this Agreement, in accordance with their terms as of the date of this Agreement or (z)&nbsp;the exercise of any Company ESPP Purchase Rights under the terms of the Company ESPP; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) except as required by the terms of a Company Plan or pursuant to a collective
bargaining agreement or similar Contract as in effect as of the date of this Agreement, (A)&nbsp;increase the wages, salary or other compensation or benefits with respect to any of the Company&#146;s or any of its Subsidiaries&#146; officers,
directors, independent contractors or employees, except for increases in compensation in the ordinary course of business consistent with past practice, (B)&nbsp;establish, adopt, enter into, amend in any material respect or terminate any Company
Plan or any other plan, agreement, program or arrangement that would be a Company Plan if in existence on the date of this Agreement, except in the ordinary course or business consistent with past practice and as would not result in material
Liability the Company, (C)&nbsp;accelerate or take any action to accelerate any payment or benefit, or accelerate the funding of any payment or benefit, payable or to become payable to any current or former director, officer, employee or consultant
of the Company or any Subsidiary or (D)&nbsp;communicate with the employees of the Company or any of its Subsidiaries regarding the compensation, benefits or other treatment they will receive following the Closing, unless such communication is
(1)&nbsp;in the case of written communications, approved by Parent in advance of such communication, (2)&nbsp;required by applicable Law or (3)&nbsp;in the case of communications not in writing, consistent with how such compensation, benefits or
other treatment is contemplated in this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) (A) adopt, enter into or amend any collective bargaining agreement or other
Contract with any labor union, labor or trade organization or other employee representative body applicable to the Company or its Subsidiaries, or (B)&nbsp;recognize or certify any labor union, labor or trade organization, works council or group of
employees of the Company or its Subsidiaries as the bargaining representative for any employees of the Company or its Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)
waive the restrictive covenant obligations of any current or former director, officer or employee of the Company or any of its Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) (A) hire or engage, or make a written offer to hire or engage, any (1)&nbsp;officer or employee (other than sales representatives),
whose annual base salary or fee arrangement would exceed $175,000, other than in the ordinary course of business consistent with past practices to replace an employee who has resigned or had his or her employment or engagement terminated or
(2)&nbsp;sales representatives other than in the ordinary course of business consistent with past practices, or (B)&nbsp;terminate the employment or service of any officer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) amend, or propose to amend, or permit the adoption of any amendment of any the Company Organizational Document (including by merger,
consolidation or otherwise) or the comparable charter or organization documents of any of its Subsidiaries or adopt a shareholders&#146; rights plan, or enter into any agreement with respect to the voting of its share capital; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) effect a recapitalization, reclassification of shares, stock split, reverse stock split or similar transaction or authorize the
issuance of any other securities in respect of, in lieu of, or in substitution for shares of its share capital, equity interests or other ownership or voting interests; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) merge or consolidate with any Person or adopt or effect a plan of complete or partial
liquidation, dissolution, consolidation, restructuring, including an internal reorganization or transfer of equity of a subsidiary, or recapitalization; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) subject to clause&nbsp;(xi), make capital expenditures (other than amounts spent on instruments in the ordinary course of business
consistent with past practices) in any year in an aggregate amount in excess of 115% of the aggregate amount indicated in the capital expenditure budget of the Company for such year set forth in <U>Section</U><U></U><U>&nbsp;5.1(b)(x)</U> of the
Company Disclosure Letter; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) acquire or agree to acquire, by merging or consolidating with, by purchasing an equity interest in or a
material portion of the assets of any business or any corporation, partnership, association or other business organization or division thereof, or otherwise acquire or agree to acquire any material assets of any other Person, except for the purchase
of inventory and supplies from suppliers or vendors in the ordinary course of business or in individual transactions involving less than $1,500,000 in assets; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) (A) incur, create, assume or otherwise become liable or responsible for, whether directly, indirectly, contingently or otherwise, any
Indebtedness, renew or extend any existing credit or loan arrangements, enter into any &#147;keep well&#148; or other agreement to maintain any financial condition of another Person or enter into any agreement or arrangement having the economic
effect of any of the foregoing, except for loans between or among the Company and any of its Subsidiaries incurred in the ordinary course of business consistent with past practice; (B)&nbsp;make any loans or advances to any other Person other than
loans between or among the Company and any of its Subsidiaries made in the ordinary course of business consistent with past practice, (C)&nbsp;make any capital contributions to, or investments in, any other Person, (D)&nbsp;repurchase, prepay or
refinance any Indebtedness, except for short-term Indebtedness incurred in the ordinary course of business consistent with past practice, (E)&nbsp;cancel any material Indebtedness (individually or in the aggregate), (F) enter into any capital lease
with aggregate annual payments of an amount greater than $1,000,000 and (G)&nbsp;incur any Indebtedness not otherwise covered by clauses (xii)(A) &#150; (F) in the ordinary course of business consistent with past practice of any amount greater than
$1,000,000 per incurrence or $5,000,000 in the aggregate; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) sell, contribute, distribute, transfer, license, assign, mortgage,
encumber, or incur or permit to exist any Lien on (other than Permitted Liens) or otherwise abandon, withdraw or dispose of (A)&nbsp;any assets (other than Owned Intellectual Property) with a net book value in excess of $100,000 in the aggregate or
(B)&nbsp;any Owned Intellectual Property or Company Exclusively <FONT STYLE="white-space:nowrap">In-Licensed</FONT> IP, except, in the case of clause (A), in the ordinary course of business consistent with past practices among the Company and any of
its Subsidiaries or, in the case of clause (B), with respect to (i)&nbsp;Incidental Licenses and <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses granted in the ordinary course of business consistent with past practices pursuant to the
Company&#146;s or its Subsidiaries&#146; standard customer contracts (copies of the forms of which have been provided to Parent) or (ii)&nbsp;abandonments or withdrawals of immaterial Owned Intellectual Property in the ordinary course of business
consistent with past practices; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) commence, pay, discharge, settle, compromise or satisfy any Action, except, in the
case of Actions unrelated to this Agreement or the Transactions, settlements that result solely in payment of monetary consideration (without the admission of wrongdoing) not greater than $500,000 in any individual Action or $5,000,000 in the
aggregate; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv) change its fiscal year, revalue any of its material assets (except for the revaluation of inventory on an annual basis
in the ordinary course of business) or change any of its financial, actuarial, reserving or Tax accounting methods or practices in any material respect, except as required by GAAP or Law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvi) (A) make, change or revoke any material Tax election with respect to the Company or any of its Subsidiaries, (B)&nbsp;file any material
amended Tax Return or claim for refund of material Taxes with respect to the Company or any of its Subsidiaries, (C)&nbsp;enter into any &#147;closing agreement&#148; as described in Section&nbsp;7121 of the Code (or any corresponding or similar
provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> law), Tax allocation agreement, Tax sharing agreement, Tax indemnity agreement relating to or affecting any material Tax liability or refund of material Taxes with respect
to the Company or any of its Subsidiaries, (D)&nbsp;extend or waive the application of any statute of limitations regarding the assessment or collection of any material Tax with respect to the Company or any of its Subsidiaries or (E)&nbsp;settle or
compromise any material Tax liability or refund of material Taxes with respect to the Company or any of its Subsidiaries or surrender any right to claim a material Tax refund; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvii) enter into, waive, release or assign any material rights or claims under, or renew, affirmatively determine not to renew, amend or
modify in any material respect, exercise any options or rights of first offer or refusal under or terminate, any Company Material Contract or any Contract that would have been a Company Material Contract if entered into prior to the date of this
Agreement, except, in the case of any Contract of the type described in <U>Section</U><U></U><U>&nbsp;3.13(a)(xi)</U>, <U>Section</U><U></U><U>&nbsp;3.13(a)(xv)</U> or <U>Section</U><U></U><U>&nbsp;3.13(a)(xvi)</U>, in the ordinary course of
business consistent with past practices; <U>provided</U>, <U>however</U>, that the foregoing exception shall not apply to the extent such entry into, waiver, release or assignment of, renewal or affirmative determination not to renew, amendment,
exercise or termination of such Contract requires or provides for consent, acceleration, termination or any other material right for the benefit of a third party or consequence to the Company that is triggered in whole or in part by any of the
Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xviii) abandon, withdraw, terminate, suspend, abrogate, amend or modify in any material respect any Company Permits in a
manner that would materially impair the operation of the business of the Company and its Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xix) enter into a research or
collaboration arrangement (it being understood that the foregoing excludes any service or product development agreements with health care providers entered into in the ordinary course of business consistent with past practice) under which
contemplated payments by or to the Company are in excess of $2,500,000 in the aggregate in any twelve (12)&nbsp;month period; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xx) grant
any options or rights or enter into any agreement, which requires payments to or from the Company or any of its Subsidiaries in excess of $2,500,000, to (A)&nbsp;sell, assign, transfer, lease, license or otherwise dispose of any Company Real
Property or any portion thereof or interest therein, or (B)&nbsp;purchase or otherwise acquire any real property or any interest therein; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxi) unless the Company determined in good faith, after consultation with its outside
legal counsel, that a meeting is required by applicable Law, convene any general or special meeting of the shareholders of the Company other than the EGM, any Subsequent EGM, pursuant to <U>Section</U><U></U><U>&nbsp;2.6(a)</U> and the holding of
the 2020 annual general meeting of shareholders of the Company on or prior to June&nbsp;30, 2020; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxii) forgive any loans or advances
to any officers, employees or directors of the Company or its Subsidiaries, or any of their respective Affiliates, or change its existing borrowing or lending arrangements for or on behalf of any of such Persons; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxiii) fail to use commercially reasonable efforts to (a)&nbsp;maintain in effect the existing material insurance policies covering the
Company and its Subsidiaries and their respective properties, assets and businesses or (b)&nbsp;preserve the rights of the Company and its Subsidiaries to pursue current and/or future claims under the current and prior versions of such material
insurance policies; <U>provided</U> nothing herein shall require the Company or its Subsidiaries to institute a lawsuit against any present or former insurance carrier; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxiv) authorize, agree or commit to take any of the actions described in
<FONT STYLE="white-space:nowrap">sub-clauses</FONT><U>&nbsp;(i)</U>&nbsp;through <U>(xxiii)</U>&nbsp;of this <U>Section</U><U></U><U>&nbsp;5.1(b</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Access to Information; Confidentiality</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) From and after the date of this Agreement until the earlier of the Closing and the termination of this Agreement in accordance with its
terms, the Company shall, upon reasonable advance notice, to (i)&nbsp;give Parent and Buyer and their respective Representatives reasonable access during normal business hours to the employees, advisors and facilities and to the books, contracts and
records of the Company and its Subsidiaries, (ii)&nbsp;permit Parent and Buyer to make such <FONT STYLE="white-space:nowrap">non-invasive</FONT> inspections as they may reasonably request and (iii)&nbsp;furnish Parent and Buyer with such financial
and operating data and other information with respect to the business, properties, and personnel of the Company and its Subsidiaries as Parent or Buyer may from time to time reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Information obtained by Parent or Buyer pursuant to <U>Section</U><U></U><U>&nbsp;5.2(a)</U> will constitute &#147;Information&#148; under
the confidentiality agreement dated as of September&nbsp;22, 2019, by and between the Company and Parent (the &#147;<U>Confidentiality Agreement</U>&#148;) and will be subject to the provisions of the Confidentiality Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Nothing in <U>Section</U><U></U><U>&nbsp;5.2(a)</U> requires the Company to permit any inspection, or to disclose any information, that in
the reasonable judgment of the Company would (i)&nbsp;violate any of its or its Affiliates&#146; respective obligations with respect to confidentiality, (ii)&nbsp;result in a violation of applicable Law or (iii)&nbsp;result in loss of legal
protection, including the attorney-client privilege and work product doctrine; <U>provided</U>, <U>however</U>, that the Company shall use its reasonable best efforts to permit such inspection or disclose the applicable information to Parent in a
way that would not violate obligations with respect to confidentiality, result in a violation of applicable Law or result in loss of legal protection. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <U>Acquisition Proposals</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall not, shall cause its Subsidiaries not to, and shall instruct (and use it reasonable best efforts to cause) its
Representatives not to: (i)&nbsp;directly or indirectly initiate, solicit, or knowingly encourage or knowingly facilitate (including by way of providing information) any inquiries, proposals or offers, or the making of any submission or announcement
of any inquiry, proposal or offer that constitutes or would reasonably be expected to lead to an Acquisition Proposal or any inquiry, proposal or offer that, in each case, constitutes or would reasonably be expected to lead to an Acquisition
Proposal, (ii)&nbsp;directly or indirectly engage in, enter into, or participate in any discussions or negotiations with any Person (or its Representatives) making an Acquisition Proposal or inquiry, proposal or offer that, in each case, constitutes
or would reasonably be expected to lead to an Acquisition Proposal, or (iii)&nbsp;provide any information or afford access to the properties of the Company or its Subsidiaries to, or take any other action to knowingly assist or knowingly encourage
or knowingly facilitate any effort by any Person (other than Parent, Buyer or any Representatives of Parent or Buyer) in a manner that would reasonably be expected to lead to an Acquisition Proposal or in connection with or in response to any
inquiry, offer or proposal that constitutes or would reasonably be expected to lead to an Acquisition Proposal. The Company shall, and shall cause its Subsidiaries to, and shall instruct (and use it reasonable best efforts to cause) its
Representatives to, (x)&nbsp;immediately cease any activities, solicitation, discussions or negotiations with any Person (or its Representatives) (other than Parent, Buyer or any Representatives of Parent or Buyer) with respect to any inquiry,
proposal or offer that constitutes or would reasonably be expected to lead to an Acquisition Proposal, (y)&nbsp;to the extent the Company has the right to do so, shall, within one (1)&nbsp;Business Day of the date of this Agreement, request the
return or destruction of all confidential information provided by or on behalf of the Company or its Subsidiaries to any such Person (or its Representatives) and (z)&nbsp;terminate, within one (1)&nbsp;Business Day of the date of this Agreement,
access to any such Person (or its Representatives) any physical or electronic data rooms relating to a possible Acquisition Proposal. Subject to the other provisions of this <U>Section</U><U></U><U>&nbsp;5.3</U>, the Company and its Representatives
may in any event inform a Person that has made an&nbsp;Acquisition Proposal&nbsp;about the provisions of this<U>&nbsp;Section 5.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding <U>Section</U><U></U><U>&nbsp;5.3(a)</U> or any other provision of this Agreement, if at any time following the date of
this Agreement and prior to the Acceptance Time, (i)&nbsp;the Company has received a written Acquisition Proposal that did not result from a material breach of this <U>Section</U><U></U><U>&nbsp;5.3</U> and (ii)&nbsp;the Company Board determines, in
good faith, after consultation with its outside counsel and financial advisor, that such Acquisition Proposal constitutes or is reasonably likely to lead to or result in a Superior Proposal, then the Company may (A)&nbsp;furnish information with
respect to the Company and its Subsidiaries to the Person making such Acquisition Proposal and its Representatives and (B)&nbsp;participate in discussions or negotiations with such Person and its Representatives regarding such Acquisition Proposal;
<U>provided</U> that (x)&nbsp;the Company shall not, and shall instruct (and use it reasonable best efforts to cause) its Representatives not to, disclose any <FONT STYLE="white-space:nowrap">non-public</FONT> information to such Person (or its
Representatives) unless the Company has, or first enters into, a confidentiality agreement with such Person with confidentiality provisions that, taken as a whole, are not less restrictive to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other Person than those contained in the Confidentiality Agreement and (y)&nbsp;the Company shall, substantially concurrently, and in any event within one (1)&nbsp;Business Day, provide or make
available to Parent any information concerning the Company or its Subsidiaries provided or made available to such other Person (or any of its Representatives) that was not previously provided or made available to Parent and Buyer. The Company shall
not, and shall cause its Representatives not to, release any Person from, or waive, amend or modify any provision of, or grant permission under or fail to enforce, any standstill provision in any agreement to which the Company is a party;
<U>provided</U> that, if the Company Board determines in good faith, after consultation with its outside counsel that the failure to take such action would be inconsistent with its fiduciary duties under applicable Law, the Company may waive any
such standstill provision to the extent necessary to permit the applicable Person (if such Person has not been solicited in material breach of this <U>Section</U><U></U><U>&nbsp;5.3</U>) to make, on a confidential basis to the Company Board, an
Acquisition Proposal, conditioned upon such Person agreeing that the Company shall not be prohibited from providing any information to Parent (including regarding any such Acquisition Proposal) in accordance with, and otherwise complying with, this
<U>Section</U><U></U><U>&nbsp;5.3</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall promptly (and in any event within one (1)&nbsp;Business Day after receipt
thereof) notify Parent of (i)&nbsp;the receipt by the Company of an Acquisition Proposal or inquiry, proposal or offer that constitutes or would reasonably be expected to lead to an Acquisition Proposal or any requests for information, or any
discussions or negotiations sought to be initiated or continued related to the foregoing and (ii)&nbsp;the terms and conditions of any Acquisition Proposal (including a copy of such Acquisition Proposal) and any such inquiry, proposal, offer,
request or contact. The Company shall keep Parent reasonably informed, on a prompt basis (and, in any case, within one (1)&nbsp;Business Day of any significant development, discussions or negotiations) as to the status of such Acquisition Proposal
or such inquiry, proposal, offer, request or contact, including by promptly (and in no event later than one (1)&nbsp;Business Day)&nbsp;(A) disclosing to Parent the identity of the Person making such Acquisition Proposal or such inquiry, proposal,
offer, request or contact and (B)&nbsp;providing to Parent complete, unredacted copies of any correspondence, proposals, indications of interest, and/or draft and final agreements (including schedules, exhibits and any other written materials
related thereto (including any financing commitments received)) (and comments thereon) exchanged between the Company or its Subsidiaries or any of its or its Subsidiaries Representatives, on the one hand, and the Person (or any of its
Representatives) making such Acquisition Proposal or such inquiry, proposal, offer, request or contact, on the other hand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as
expressly provided in Section&nbsp;5.3(e), the Company Board and each committee thereof shall not (i)&nbsp;approve or adopt, or permit the Company or any of its Subsidiaries to (and neither the Company nor any of its Subsidiaries will) enter into or
execute, any binding or <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent, memorandum of understanding, agreement in principle, acquisition agreement, option agreement, merger agreement, joint venture agreement, partnership
agreement or other agreement relating to or that would reasonably be expected to lead to (other than a confidentiality agreement referred to in <U>Section</U><U></U><U>&nbsp;5.3(b)</U>) an Acquisition Proposal (an &#147;<U>Alternative Acquisition
Agreement</U>&#148;) or publicly propose to take such action or (ii)&nbsp;make a Change of Board Recommendation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding <U>Section</U><U></U><U>&nbsp;5.3(d)</U> or any other provision of this
Agreement, prior to the Acceptance Time: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the Company may make a Change of Board Recommendation and terminate this Agreement to enter
into a definitive Alternative Acquisition Agreement pursuant to <U>Section</U><U></U><U>&nbsp;6.3(c)</U> with respect to a Superior Proposal (so long as prior to or concurrently with, and as a condition to the effectiveness of, such termination, the
Company pays to Parent the termination fee payable pursuant to <U>Section</U><U></U><U>&nbsp;6.5(b)</U>) if: (A)&nbsp;the Company receives a written Acquisition Proposal that did not result from a material breach of this
<U>Section</U><U></U><U>&nbsp;5.3</U>, and the Company Board determines in good faith, after consultation with its outside counsel and financial advisor, constitutes a Superior Proposal; (B)&nbsp;the Company Board determines in good faith, after
consultation with its outside counsel, that the failure to take any such action would be inconsistent with its fiduciary duties under applicable Law; (C)&nbsp;the Company has notified Parent in writing that it intends to terminate this Agreement to
enter into such Alternative Acquisition Agreement and provided Parent a copy of the proposed definitive agreement (and related agreements); (D) the Company shall have negotiated, and shall have instructed (and shall have used it reasonable best
efforts to cause) its Representatives to negotiate, in good faith, with Parent and its Representatives during the Notice Period, to the extent Parent requests to negotiate, to enable Parent to revise the terms of this Agreement in such a manner that
would cause such Superior Proposal to no longer constitute a Superior Proposal; and (E)&nbsp;no earlier than the end of the Notice Period, the Company Board determines in good faith (after consultation with its outside counsel and financial
advisor), after taking into consideration the terms of any proposed amendment or modification to this Agreement that Parent has committed in writing to make during the Notice Period, that (x)&nbsp;the Acquisition Proposal that is subject of the
Determination Notice continues to constitute a Superior Proposal and (y)&nbsp;that the failure to take any such action would be inconsistent with its fiduciary duties under applicable Law; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) other than in connection with or relating to an Acquisition Proposal, the Company Board may make a Change of Board Recommendation in
response to an Intervening Event if (A)&nbsp;the Company Board determines in good faith, after consultation with its outside counsel, that the failure to take any such action would be inconsistent with its fiduciary duties under applicable Law;
(B)&nbsp;the Company has notified Parent in writing that it intends to effect a Change of Board Recommendation (which notice shall reasonably specify the facts and circumstances providing the basis of the Intervening Event and for the Company
Board&#146;s determination to effect the Change of Board Recommendation); (C) the Company shall have negotiated, and shall have instructed (and shall have used it reasonable best efforts to cause) its Representatives to negotiate, in good faith,
with Parent and its Representatives during the Notice Period, to the extent Parent requests to negotiate, to enable Parent to revise the terms of this Agreement in such a manner that would eliminate the need for taking such action; and (D)&nbsp;no
earlier than the end of the Notice Period, the Company Board determines in good faith (after consultation with its outside counsel), after considering the terms of any proposed amendment or modification to this Agreement that Parent has committed in
writing to make during the Notice Period, that the failure to effect a Change of Board Recommendation in response to such Intervening Event would be inconsistent with its fiduciary duties under applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The provisions of this <U>Section</U><U></U><U>&nbsp;5.3(e)</U> apply to any change to the financial terms or any other material terms of any applicable
Superior Proposal with respect to clause (i)&nbsp;and require a revised Determination Notice and a new Notice Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Nothing contained in this Agreement prohibits the Company Board or a committee thereof
from (i)&nbsp;taking and disclosing to the holders of Shares a position contemplated by Rule <FONT STYLE="white-space:nowrap">14e-2(a)</FONT> and Rule <FONT STYLE="white-space:nowrap">14d-9</FONT> promulgated under the Exchange Act or
(ii)&nbsp;making any disclosure if the Company Board determines, in good faith, after consultation with its outside counsel, that the failure to make such statement would be inconsistent with its fiduciary duties under applicable Law;
<U>provided</U> that (A)&nbsp;in no event shall this <U>Section</U><U></U><U>&nbsp;5.3(f)</U> permit the Company Board or a committee thereof to make a Change of Board Recommendation except as otherwise expressly permitted pursuant to
<U>Section</U><U></U><U>&nbsp;5.3(e)</U>, (B) in no event shall this <U>Section</U><U></U><U>&nbsp;5.3(f)</U> affect, modify or supplement the definition of Change of Board Recommendation (or to the consequences thereof in accordance with this
Agreement) and (C)&nbsp;any such disclosure (other than issuance by the Company of a &#147;stop, look and listen&#148; or similar communication of the type contemplated by Rule <FONT STYLE="white-space:nowrap">14d-9(f)</FONT> under the Exchange Act)
that does not expressly reaffirm the Company Board Recommendation shall be deemed to be a Change of Board Recommendation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4 <U>Employment and Employee Benefits Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent shall, and shall cause the Company and each of its other Subsidiaries to, maintain for each individual employed by the Company or
any of its Subsidiaries at the Closing (each, a &#147;<U>Current Employee</U>&#148;) for the period commencing at the Closing and ending on the earlier of (x)&nbsp;the date that is twelve (12)&nbsp;months following the Closing and (y)&nbsp;the date
on which the employment of a Current Employee terminates (i)&nbsp;each of base compensation and a target annual cash incentive compensation or bonus opportunity (but subject to applicable adjustments to performance goals following the Closing) at
least as favorable as that provided to the Current Employee as of immediately prior to the Closing, (ii)&nbsp;benefits that are at least as favorable in the aggregate to the benefits (excluding for such purposes any equity or equity-related awards,
and any defined benefit pension benefits) maintained for and provided to the Current Employee as of immediately prior to the Closing and (iii)&nbsp;severance benefits that are at least as favorable as the severance benefits (excluding for such
purposes any equity or equity-related severance benefit terms) provided by the Company to the Current Employee as of immediately prior to the Closing; <U>provided</U>, that in no event shall the compensation to be paid or benefits to be provided to
a Current Employee pursuant to clauses (i) &#150; (iii) be less than the amount required to be paid or benefits provided to such Current Employee under any severance, employment or similar agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Prior to the Acceptance Time, the Company may pay to each Current Employee who is employed by the Company or one of its Subsidiaries at
the time of such payments the following cash bonuses (i)&nbsp;at the time such bonuses are typically paid, up to an amount due to such Current Employee under the Company&#146;s annual bonus program assuming the achievement of applicable performance
metrics at the higher of &#147;target&#148; or actual performance in 2019, (ii) up to an amount due to such Current Employee under the Company&#146;s annual bonus program assuming if the Acceptance Time occurs in 2020, the achievement of applicable
performance metrics at &#147;target&#148; in 2020 with such amount being <FONT STYLE="white-space:nowrap">pro-rated</FONT> for the portion of the year prior to the Acceptance Time and (iii)&nbsp;up to an amount due to such Current Employee under the
Company&#146;s annual bonus program assuming if the Acceptance Time occurs in 2021, (A) the achievement of applicable performance metrics at the higher of &#147;target&#148; or actual performance in 2020, and (B)&nbsp;the achievement of applicable
performance metrics at &#147;target&#148; in 2021 with such amount being <FONT STYLE="white-space:nowrap">pro-rated</FONT> for the portion of the year prior to the Acceptance Time; <U>provided</U> that in no event shall any cash bonus paid to a
Current Employee for in the year in which the Acceptance Time occurs be less than the amount required to be paid to such Current Employee under any severance agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent shall, and shall cause the Company and each of its other Subsidiaries to, cause
service rendered by Current Employees to the Company and its Subsidiaries, prior to the Closing to be taken into account for all purposes of eligibility, vesting, level of benefits (including vacation and severance, but excluding, for the avoidance
of doubt, for purposes of benefit accrual under any defined benefit pension plan) and as required by law under all employee benefit plans of Parent, the Company and its other Subsidiaries (each, a &#147;<U>Buyer Plan</U>&#148;), to the same extent
as such service was taken into account under the corresponding Company Plans immediately prior to the Closing; <U>provided</U>, that, the foregoing will not apply to the extent that its application would result in a duplication of benefits with
respect to the same period of service. Without limiting the generality of the foregoing, Parent shall not, and shall cause the Company to not, subject Current Employees to any eligibility requirements, waiting periods,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">actively-at-work</FONT></FONT> requirements or <FONT STYLE="white-space:nowrap">pre-existing</FONT> condition limitations under any Buyer Plan for any condition for which they would
have been entitled to coverage under the corresponding Company Plan in which they participated prior to the Closing. If Parent chooses to have the Current Employees commence participation in an applicable Buyer Plan other than on the first day of a
plan year, Parent will use commercially reasonable efforts to, or to cause the Company and its Subsidiaries to provide, credit under such employee benefit plans for any eligible expenses incurred by such Current Employees and their covered
dependents under a Company Plan during the portion of the year prior to the Closing for purposes of satisfying all <FONT STYLE="white-space:nowrap">co-payments,</FONT> <FONT STYLE="white-space:nowrap">co-insurance,</FONT> deductibles, maximum <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> requirements, and other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses or similar requirement under any
such plans applicable to such Current Employees and their covered dependents in respect of the plan year in which the Closing occurs; <U>provided</U>, <U>however</U>, that Parent&#146;s obligations under this sentence shall be subject to its receipt
of, using reasonable best efforts to obtain, all necessary information, from either the Company or the Current Employee, related to such amounts paid by such Current Employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If directed in writing by Parent at least fifteen (15)&nbsp;Business Days prior to the Acceptance Time, the Company shall terminate,
effective as of at least one (1)&nbsp;day prior to the Closing Date, any and all Company Plans intended to include a Code Section&nbsp;401(k) arrangement (each, a &#147;<U>Company 401(k) Plan</U>&#148;). If so directed, no later than five
(5)&nbsp;Business Days prior to the Closing Date, the Company shall provide Parent with evidence that the Company has taken action to terminate each Company 401(k) Plan (effective as of no later than one (1)&nbsp;day prior to the Closing Date)
pursuant to resolutions of the Company Board. The form and substance of such resolutions shall be subject to review and approval of Parent (which shall not be unreasonably withheld, conditioned or delayed). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Without limiting the generality of <U>Section</U><U></U><U>&nbsp;7.5</U>, no provision of this Agreement (i)&nbsp;prohibits Parent or the
Company from amending or terminating any individual Company Plan or any other employee benefit plan in accordance with its terms and applicable Law, (ii)&nbsp;requires Parent or the Company to keep any Person employed for any period of time, or
(iii)&nbsp;constitutes the establishment or adoption of, or amendment to, any Company Plan or employee benefit plan. No Current Employee or any other individual employed by the Company or its Subsidiaries has any third-party beneficiary or other
rights with respect to this <U>Section</U><U></U><U>&nbsp;5.4</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5 <U>Directors</U><U>&#146;</U><U> and Officers</U><U>&#146;</U><U>
Indemnification and Insurance</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent and Buyer agree that all rights to indemnification and exculpation from liabilities,
including advancement of expenses, for acts or omissions occurring at or prior to the Closing now existing in favor of the present (as of the Closing) or former directors or officers of the Company (each, together with such Person&#146;s heirs,
executors, or administrators, an &#147;<U>Indemnified Party</U>&#148;) as provided in the Company Organizational Documents shall survive the Closing and shall continue in full force and effect. For a period of six (6)&nbsp;years from the Closing,
the Company shall, and Parent shall cause the Company to, maintain in effect the exculpation, indemnification and advancement of expenses equivalent to the provisions of the Company Organizational Documents as in effect immediately prior to the
Closing solely with respect to acts or omissions occurring prior to the Closing and shall not amend, repeal or otherwise modify any such provisions in any manner that would adversely affect the rights thereunder of any present (as of the Closing) or
former director or officer of the Company; <U>provided</U>, <U>however</U>, that all rights to indemnification in respect of any action pending or asserted or any claim made for indemnification within such period shall continue until the disposition
of such action or resolution of such claim. From and after the Closing, Parent shall guarantee and stand surety for, and shall cause the Company to honor, in accordance with their respective terms, each of the covenants contained in this
<U>Section</U><U></U><U>&nbsp;5.5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without limiting any additional rights that any Person may have under any agreement or
applicable Law, Parent and Buyer shall, jointly and severally, from and after the Closing, indemnify and hold harmless the Company, its Subsidiaries and each Indemnified Party against any liability for or on account of Tax in connection with a
Post-Offer Reorganization, including all obligations to pay a judgment, settlement, or penalty and reasonable expenses incurred in connection with any Action in relation thereto; <U>provided</U> that, any such indemnity of an Indemnified Party shall
be limited to Taxes incurred by such Indemnified Party in his or her capacity as a director or officer of the Company and not as a holder of any of the Shares or other equity of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company may purchase prior to the Closing, and if the Company does not purchase prior to the Closing, Parent shall use reasonable best
efforts to cause the Company to purchase at or after the Closing, a tail policy under the current directors&#146; and officers&#146; liability insurance policies maintained at such time by the Company in respect of acts or omissions occurring at or
prior to the Closing, which tail policy (i)&nbsp;will be effective for a period from the Closing through and including the date six (6)&nbsp;years after the Closing with respect to claims arising from facts or events that existed or occurred prior
to or at the Closing and (ii)&nbsp;will contain coverage that is at least as protective to such directors and officers as the coverage provided by such existing policies; <U>provided</U>, that, the premium for such tail policy may not be (and Parent
shall not be required to cause the Company to expend) in excess of three hundred percent (300%) of the last annual premium paid prior to the Closing. Parent shall cause any such policy to be maintained in full force and effect for their full term,
and cause all obligations thereunder to be honored by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Without limiting any of the rights or obligations under this
<U>Section</U><U></U><U>&nbsp;5.5</U>, for a period of six (6)&nbsp;years after the Closing Parent shall cause the Company to keep in full force and effect, and comply with the terms and conditions of, (solely with respect to acts or omissions
occurring prior to the Closing) any agreement in effect as of the date of this Agreement between or among the Company or any of its Subsidiaries and any Indemnified Party providing for the indemnification of such Indemnified Party that has been made
available to Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) This <U>Section</U><U></U><U>&nbsp;5.5</U> will survive the consummation of the Transactions and is intended to
benefit, and after the Closing is enforceable by, any Person or entity referred to in this <U>Section</U><U></U><U>&nbsp;5.5</U>. The indemnification and advancement provided for in this <U>Section</U><U></U><U>&nbsp;5.5</U> is not exclusive of any
other rights to which the Indemnified Party is entitled whether pursuant to Law, Contract, or otherwise. If Parent, Buyer, the Company or any of their respective successors or assigns (other than pursuant to the Transactions) (i)&nbsp;consolidates
with or merges into any other Person and is not the continuing or surviving corporation or entity resulting from such consolidation or merger or (ii)&nbsp;transfers all or a majority of its properties and assets to any Person, then, and in each such
case, Parent or Buyer, as applicable, shall make proper provisions such that such successors or assigns assume the applicable obligations set forth in this <U>Section</U><U></U><U>&nbsp;5.5</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6 <U>Further Action; Efforts</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions of this Agreement, prior to the Closing, each party shall use reasonable best efforts to take, or
cause to be taken, all actions and to do, or cause to be done, all things necessary, proper, or advisable under applicable Laws to consummate the Offer by or before the Outside Date. Notwithstanding anything in this Agreement to the contrary, the
parties hereto agree to, (i)&nbsp;in cooperation and consultation with each other, make an appropriate filing of a Notification and Report Form pursuant to the HSR Act and all other filings required pursuant to applicable foreign Antitrust Laws with
respect to the Transactions as promptly as reasonably practicable and in any event prior to the expiration of any applicable legal deadline (provided that the filing of a Notification and Report Form pursuant to the HSR Act must be made within ten
(10)&nbsp;Business Days after the date of the Agreement, unless otherwise agreed to by the Company and Parent in writing) and (ii)&nbsp;to supply as promptly as reasonably practicable any additional information and documentary material that may be
requested (including pursuant to a second or similar request) pursuant to the HSR Act or any other Antitrust Law. Parent shall, with the reasonable cooperation of the Company, be responsible for making any filing or notification, or draft filing as
may be the case, required or advisable under foreign Antitrust Laws as promptly as reasonably practicable after the date of this Agreement, unless otherwise agreed to by the Company and Parent in writing. The parties shall also consult and cooperate
with one another, and consider in good faith the views of one another, in connection with, and provide to the other parties in advance, any analyses, appearances, presentations, memoranda, briefs, arguments, opinions and proposals made or submitted
by, or on behalf of, such party in connection with proceedings under or relating to any Antitrust Laws; <U>provided</U>, <U>however</U>, that Parent shall have the right to devise, control and direct the strategy and timing for, and making of all
material decisions relating to (and shall take the lead in all meetings and communications with any Governmental Body relating to), obtaining any Consent of a Governmental Body contemplated by this <U>Section</U><U></U><U>&nbsp;5.6</U>, including
resolving any Action related to any such Consent; <U>provided</U>, further, however, in devising, controlling and directing the strategy and timing for, and making of all material decisions relating to obtaining any Consent of a Governmental Body
contemplated by this <U>Section</U><U></U><U>&nbsp;5.6</U> Parent must at all times use its reasonable best efforts to consummate the Offer by or before the Outside Date. Without </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
limiting the foregoing, the parties hereto agree (A)&nbsp;to furnish to the other such information and assistance as the other may reasonably request in connection with obtaining any Consent or
any Action under or relating to Antitrust Laws or otherwise relating to or to facilitate a Remedy, (B)&nbsp;to give each other reasonable advance notice of all meetings with any Governmental Body relating to any Antitrust Laws or otherwise relating
to or to facilitate a Remedy, (C)&nbsp;to give each other an opportunity to participate in each of such meetings, (D)&nbsp;to the extent practicable, to give each other reasonable advance notice of all substantive oral communications with any
Governmental Body relating to any Antitrust Laws, (E)&nbsp;if any Governmental Body initiates a substantive oral communication regarding any Antitrust Laws, to promptly notify the other party of the substance of such communication, (F)&nbsp;to
provide each other with a reasonable advance opportunity to review and comment upon all substantive written communications (including any analyses, presentations, memoranda, briefs, arguments, opinions and proposals) with a Governmental Body
regarding any Antitrust Laws and (G)&nbsp;to provide each other with copies of all substantive written communications to or from any Governmental Body relating to any Antitrust Laws. Any such disclosures or provision of copies by one party to the
other may be made on an outside counsel basis, if appropriate. Parent shall pay all filing fees in connection with any filings that may be required by this <U>Section</U><U></U><U>&nbsp;5.6(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In furtherance of, and without limiting the efforts referenced in <U>Section</U><U></U><U>&nbsp;5.6(a)</U>, Parent shall, and shall cause
each of its Subsidiaries to, take any and all actions necessary to obtain any consents, clearances or approvals required under or in connection with the HSR Act, the Sherman Act, as amended, the Clayton Act, as amended, the Federal Trade Commission
Act, as amended, the EU Merger Regulation and any other federal, state or foreign law, regulation, or decree designed to prohibit, restrict, or regulate actions for the purpose or effect of monopolization or restraint of trade or significant
impediment of effective competition (collectively &#147;<U>Antitrust Laws</U>&#148;) to enable all waiting periods under applicable Antitrust Laws to expire, and to avoid or eliminate impediments under applicable Antitrust Laws asserted by any
Governmental Body, in each case, to cause the Offer to be consummated prior to the Outside Date, including if necessary to obtain clearance by any Governmental Body before the Outside Date, offering, negotiating, committing to, and effecting, by
consent decree, hold separate order, or otherwise, the sale, divestiture, license or other disposition of any and all of the capital stock, assets, equity holdings, rights, products or businesses of Parent and its Subsidiaries (including the Company
and its Subsidiaries), and any other restrictions on the activities of Parent and its Subsidiaries (including the Company and its Subsidiaries) (the foregoing and any other action contemplated by this <U>Section</U><U></U><U>&nbsp;5.6(b)</U>, a
&#147;<U>Remedy</U>&#148;). To assist Parent in complying with its obligations set forth in this <U>Section</U><U></U><U>&nbsp;5.6</U>, the Company shall (and shall cause its Subsidiaries to) enter into one or more agreements requested by Parent to
be entered into by any of them prior to the Closing with respect to a Remedy. Without Parent&#146;s prior written consent, the Company shall not (and shall not permit any of its Subsidiaries to) take or cause to be taken, do or cause to be done,
offer, negotiate, commit to or effect any Remedy. For the avoidance of doubt, no party hereto (or their respective Subsidiaries) shall be required pursuant to this <U>Section</U><U></U><U>&nbsp;5.6</U> to offer, negotiate, commit to or effect any
Remedy that is not conditioned upon the Closing. Notwithstanding anything in this Agreement to the contrary, (i)&nbsp;Parent&#146;s obligation to (and to cause its Subsidiaries (including for this purpose, the Company and its Subsidiaries) to)
offer, negotiate, commit to or effect any Remedy or Remedies shall be limited to (a)&nbsp;total ankle replacement products and services and (b)&nbsp;other products and services that represented, individually or in the aggregate, less than
$25,000,000 of annual revenue generated during the 2018 fiscal year, and (ii)&nbsp;Parent shall not be required to (or to cause its Subsidiaries (including for this purpose, the Company and its Subsidiaries) to) offer, negotiate, commit to or effect
any Remedy or Remedies other than those required pursuant to clause (i). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Without limiting the obligations in clauses (a)&nbsp;and (b) of this
<U>Section</U><U></U><U>&nbsp;5.6</U>, including Parent&#146;s right to devise, direct and control the strategy relating to such actions or proceedings, in the event that any administrative or judicial action or proceeding is instituted (or
threatened to be instituted) by a Governmental Body challenging any Transaction, each of Parent, Buyer and the Company shall cooperate in all respects with each other and shall use its reasonable best efforts to contest and resist any such action or
proceeding and to have vacated, lifted, reversed or overturned any decree, judgment, injunction, decision or other order, whether temporary, preliminary or permanent, that is in effect and that prohibits, prevents or restricts consummation of the
Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Prior to the Acceptance Time, each party shall use commercially reasonable efforts to obtain any consents, approvals or
waivers of third parties with respect to any Contracts to which it (or any Subsidiary of the Company) is a party as may be necessary for the consummation of the Transactions or required by the terms of any Contract as a result of the execution,
performance or consummation of the Transactions; <U>provided</U>, that, notwithstanding anything to the contrary in this Agreement, except in order to effect a Remedy in accordance with the terms of this Agreement, in no event will Parent, Buyer or
the Company be required to pay or make or commit to pay or make (and without the prior written consent of Parent, none of the Company or any of its Subsidiaries shall pay or make or commit to pay or make), prior to the Closing, any fee, penalty or
other consideration or any other accommodation to any third party to obtain any consent, approval or waiver required with respect to any such Contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Each of the parties agrees that, between the date of this Agreement and the earlier of the Closing and the termination of this Agreement
in accordance with <U>Article VI</U>, it will not, and will ensure that none of their respective Subsidiaries will, consummate, or enter into any agreement providing for, any investment, acquisition or other business combination that would
reasonably be expected to materially delay or prevent the consummation of the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7 <U>Public Announcements</U>.
The Company shall not, and shall cause its Subsidiaries to not, and Parent shall not, and shall cause each of its Subsidiaries to not, issue any press release, announcement or other public statement concerning the Agreement or the Transactions
without the prior consent of the other (which consent may not be unreasonably withheld, conditioned, or delayed), except any release or announcement required by applicable Law or any rule or regulation of Nasdaq, the New York Stock Exchange or any
other stock exchange to which the relevant party is subject, in which case the party required to make the release or announcement shall use commercially reasonable efforts to allow each other party reasonable time to comment on such release or
announcement in advance of such issuance; it being understood that the final form and content of any such release or announcement, to the extent so required, shall be at the final discretion of the disclosing party. The restrictions of this
<U>Section</U><U></U><U>&nbsp;5.7</U> do not apply to communications by the Company or Parent in connection with a Change of Board Recommendation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8 <U>Approval of Compensation Actions</U>. Prior to the Acceptance Time, the
Compensation Committee of the Company Board shall take all such actions as may be required to approve, as an employment compensation, severance, or other employee benefit arrangement in accordance with Rule
<FONT STYLE="white-space:nowrap">14d-10(d)(2)</FONT> under the Exchange Act and the instructions thereto, any and all Compensation Actions taken after January&nbsp;1 of the current fiscal year and prior to the Acceptance Time that have not already
been so approved. For the purposes of this Agreement, &#147;<U>Compensation Action</U>&#148; means any (a)&nbsp;granting by the Company or its Subsidiaries to any present or former director or officer of any increase in compensation or benefits or
of the right to receive any severance or termination compensation or benefit; (b)&nbsp;entry by the Company or its Subsidiaries into any employment, consulting, indemnification, termination, change of control,
<FONT STYLE="white-space:nowrap">non-competition,</FONT> or severance agreement with any present or former director or officer, or any approval, amendment, or modification of any such agreement; or (c)&nbsp;approval of, amendment to, or adoption of
any Company Plan. For the avoidance of doubt, nothing contained in this <U>Section</U><U></U><U>&nbsp;5.8</U> shall permit the Company to take any action that would be prohibited under any other provision of this Agreement, including
<U>Section</U><U></U><U>&nbsp;5.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9 <U>Treatment of Certain Indebtedness</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall provide written notice of the anticipated effective date of the Closing to holders of the Convertible Notes, the
Trustee, and the paying agent and conversion agent identified in the Indentures within three (3)&nbsp;Business Days after the date of this Agreement and in accordance with Section&nbsp;14.01(b)(iii) of each of the Indentures. Prior to the Closing,
the Company shall not make any change to the terms of the Indentures relating to the Convertible Notes without the prior written consent of Parent. In addition, the Company and its Subsidiaries shall take all actions as may be required in accordance
with, and subject to, the terms of the Indentures including, without limitation, delivery, issuance or entry into, as applicable, of any notices, certificates, press releases, supplemental indentures, legal opinions, officers&#146; certificates or
other documents or instruments required to comply with the Indentures. The Company shall provide Parent and its counsel reasonable opportunity to review and comment on any notices, certificates, press releases, supplemental indentures, legal
opinions, officers&#146; certificates, and written or verbal responses to any inquiries from holders of the Convertible Notes or other documents or instruments deliverable pursuant to or in connection with the Indentures prior to the dispatch or
making thereof, and the Company shall promptly respond to any questions from, and shall reflect any reasonable comments made by, Parent or its counsel with respect thereto prior to the dispatch or making thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At the Closing, the Company shall take all necessary action to perform and comply with all obligations of the Company pursuant to the
Indentures within the time periods required by the terms of the Indentures; <U>provided</U> that any opinions of counsel required by the Indentures, or as may be required by the Trustee pursuant to the Indentures, shall be delivered by the Company
and its counsel to the extent required to be delivered in connection with the transactions contemplated by this Agreement. Promptly following the Closing (and in any event no later than five Business Days following the Closing), the Company shall
issue one or more press releases (and make such press releases available on the Company&#146;s website) announcing the date of the Closing, providing notice of the occurrence of a Make-Whole Fundamental Change (as defined in the Indentures) and
detailing any adjustment to the Conversion Rate (as defined in the 2020 Indenture and the 2021 Indenture) or Exchange Rate (as defined in the 2023 Indenture), as applicable, and other relevant information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall take all commercially reasonable actions requested by Parent in
connection with making elections under, amending, obtaining waivers, and/or unwinding or otherwise settling the Hedging Documentation. The Company shall use its commercially reasonable efforts to cooperate with Parent at Parent&#146;s request in
connection with, and at Parent&#146;s request shall use its commercially reasonable efforts to initiate or continue, and shall permit Parent to directly initiate or continue, any discussions, negotiations or agreements with the 2020 Dealers, 2021
Dealers or 2023 Dealers, any of their respective Affiliates or any other Person, with respect to any determination, adjustment, cancellation, termination, exercise, settlement or computation in connection with the Hedging Documentation, including,
without limitation, with respect to any amounts that may be receivable or payable by the Company pursuant to the Hedging Documentation; provided that, in no event will this <U>Section</U><U></U><U>&nbsp;5.9(c)</U> require the Company to comply with
any instruction or request from the Parent to cancel or terminate any transaction under the Hedging Documentation prior to the Closing. The Company (i)&nbsp;shall not, without Parent&#146;s prior written consent (which shall not be unreasonably
withheld, conditioned or delayed)&nbsp;(A) make any amendments, modifications or other changes to the terms of, or agree to any adjustment under or amounts due upon termination, cancellation or settlement of the Hedging Documentation,
(B)&nbsp;exercise any right it may have to terminate, or affirmatively cause the early settlement, exercise or cancellation of any of the Hedging Documentation (other than, in the case of settlement or exercise, in connection with any conversion or
exchange under the Convertible Notes), (C)&nbsp;except as contemplated herein, enter into any discussions, negotiations or agreements with respect to any of the foregoing in this <U>Section</U><U></U><U>&nbsp;5.9(c)</U> or (D)&nbsp;make any payments
or deliveries with respect to the Hedging Documentation, and (ii)&nbsp;shall keep Parent fully informed of all such discussions and negotiations and shall give Parent the option to participate (or have its counsel participate) in any such
discussions and negotiations. The Company shall take all actions as may be required in accordance with, and subject to, the terms of the Hedging Documentation, including delivery of any notices or other documents or instruments required to give
effect to the foregoing or in connection with the consummation of the Transactions. The Company shall provide Parent and its counsel reasonable opportunity to review and comment on any notices or other documents or instruments in connection with the
Hedging Documentation prior to the dispatch or making thereof, and the Company shall promptly respond to any questions from, and shall reflect any reasonable comments made by, Parent or its counsel with respect thereto prior to the dispatch or
making thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event that Parent desires to consummate a repurchase offer or similar transaction with respect to any or all
of the Convertible Notes (any such transaction, a &#147;<U>Repurchase Transaction</U>&#148;), each of the Company and Parent shall use their respective reasonable best efforts to, and to cause their respective Subsidiaries to, cooperate with one
another in good faith to permit such Repurchase Transaction to be effected on such terms, conditions and timing as requested by Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Following the occurrence of any event that would require an adjustment to the Conversion Rate (as defined in the 2020 Indenture or the
2021 Indenture) or the Exchange Rate (as defined in the 2023 Indenture), as applicable, under any of the Indentures at or prior to the Closing, the Company shall promptly provide Parent written notice accurately setting out (i)
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the updated Conversion Rate or Exchange Rate, as applicable, for each of the Indentures and (ii)&nbsp;the Cash Make-Whole Premiums (as defined in the Indentures) number of Additional Shares (as
defined in the Indentures), if any, reflecting the amount by which such Conversion Rate or Exchange Rate, as applicable, will be increased upon the occurrence of a Make-Whole Fundamental Change (as defined in the Indentures), in each case, as
adjusted to reflect all events that have occurred through the date on which such update is provided that would result in an adjustment pursuant to the terms of the Indentures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) In connection with each of the Mergers, the Company shall take all necessary action to perform and comply with all obligations of the
Company and its Subsidiaries pursuant to each of the Indentures at such times as are required by the terms of the Indentures, including, without limitation, delivering or issuing (or causing to be delivered by counsel to the Company in the case of
legal opinions), as applicable, any notices, certificates, press releases, legal opinions, officers&#146; certificates or other documents or instruments required to comply with each of the Indentures and executing and delivering any supplemental
indentures to each of the Indentures as may be required in connection with each of the Mergers (each a &#147;<U>Supplemental Indenture</U>&#148; and, collectively, the &#147;<U>Supplemental Indentures</U>&#148;). The Supplemental Indentures with
respect to the Third-Step Merger shall provide, inter alia, that, at and after the Final Effective Time (as defined in the Merger Agreement), (i) the right to convert the Convertible Notes (as defined under the Purchase Agreement) will be changed
into a right to convert each $1,000 principal amount of Convertible Notes into cash in an amount equal to (A)&nbsp;the Conversion Rate (as defined in the 2020 Indenture and the 2021 Indenture) or Exchange Rate (as defined in the 2023 Indenture) in
effect on the Conversion Date (as defined in each of the Indentures) (as increased, if at all, pursuant to Section&nbsp;14.03 of each of the Indentures), multiplied by (B)&nbsp;the Merger Consideration (as defined in the Merger Agreement) in
accordance with Section&nbsp;14.07 of each of the Indentures and (ii)&nbsp;that the Surviving Company (as defined in the Merger Agreement) shall expressly assume the obligation of the Company and WMGI, as applicable, under the Indentures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company shall promptly provide to Parent any notices, communications or other correspondence received from the 2020 Dealers, the 2021
Dealers or the 2023 Dealers in connection with the Hedging Documentation or the transactions thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Notwithstanding anything to
the contrary in this Agreement, the Company agrees that, at Parent&#146;s request, prior to the Acceptance Time, the Company shall either (1)&nbsp;deliver to Parent a fully executed and effective waiver under the Credit Agreement, in form and
substance reasonably satisfactory to Parent, waiving any Default (as defined in the Credit Agreement) or Event of Default (as defined in the Credit Agreement) in connection with the consummation of the Transactions or (2)&nbsp;repay all amounts owed
under the Credit Agreement, terminate the Credit Agreement and provide evidence, in form and substance reasonably satisfactory to Parent, of such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Notwithstanding anything to the contrary in this Agreement, the Company and WMGI shall be permitted to take any and all actions expressly
required under the terms of the Indentures and the Convertible Notes, and no such action shall give rights to any rights of Parent or Buyer under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <U>Post-Closing Reorganizations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Promptly after the date hereof, the Company shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) form a Luxembourg <I>soci</I><I>&eacute;</I><I>t</I><I>&eacute;</I><I> anonyme</I> that is a direct, wholly owned subsidiary of the
Company (&#147;<U>Wave Luxembourg</U>&#148;) with articles of association substantially in the form set forth in Exhibit C attached hereto; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) cause Wave Luxembourg to form a Bermuda exempted company that is a direct, wholly owned subsidiary of Wave Luxembourg (&#147;<U>Wave
Bermuda</U>&#148;) with a memorandum of association substantially in the form set forth in Exhibit D attached hereto and <FONT STYLE="white-space:nowrap">bye-laws</FONT> substantially in the form set forth in Exhibit E attached hereto; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) (A) execute and deliver, and cause Wave Luxembourg and Wave Bermuda to execute and deliver, the Merger Agreement (together with all
amendments reasonably agreed by Parent and the Company and all documents and instruments contemplated thereby in the form reasonably satisfactory to Parent and the Company, the &#147;<U>Merger Documentation</U>&#148;) and (B)&nbsp;comply with, and
cause Wave Luxembourg and Wave Bermuda to comply with, the terms and conditions of the Merger Documentation; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) cause Wave
Luxembourg and Wave Bermuda not to engage in any business activities, own property or incur any liabilities or obligations except as contemplated by this Agreement or incident to their formation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Promptly after the date hereof, Parent shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) form a Bermuda exempted company that is a direct or indirect wholly owned subsidiary of Buyer (&#147;<U>Merger Sub</U>&#148;) with a
memorandum of association substantially in the form set forth in Exhibit F attached hereto and <FONT STYLE="white-space:nowrap">bye-laws</FONT> substantially in the form set forth in Exhibit G attached hereto; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) (A) execute and deliver, and cause Merger Sub, to execute and deliver, the Merger Documentation and (B)&nbsp;comply with, and cause
Merger Sub to comply with, the terms and conditions of the Merger Documentation; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) cause Merger Sub not to engage in any
business activities, own property or incur any liabilities or obligations except as contemplated by this Agreement or incident to its formation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Promptly after the date hereof, the Company shall take the actions set forth on <U>Section</U><U></U><U>&nbsp;5.10(c)</U> of the Company
Disclosure Letter in connection with the Demerger, the Mergers and the Asset Sale and Liquidation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Prior to the Closing, the Company
shall (and shall cause its Subsidiaries to) use its reasonable best efforts to take such additional steps and do all such things as are reasonably requested by Parent or Buyer to procure that, to the extent any such actions, transactions or matters
are validly elected (subject to the Company&#146;s prior written consent, if required pursuant to <U>Section</U><U></U><U>&nbsp;2.7(a)</U>) to be effectuated by Parent or Buyer pursuant to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Section</U><U></U><U>&nbsp;2.7(a)</U>, including the Asset Sale, Liquidation, Second Step Distribution, the Demerger and the Mergers are able to occur at the time elected by Buyer or Parent
after the Closing. Notwithstanding anything in this Agreement to the contrary, and provided that the Company and its Subsidiaries comply with their obligations in this <U>Section</U><U></U><U>&nbsp;5.10(d)</U>, any actions taken by the Company or
its Subsidiaries in furtherance of this <U>Section</U><U></U><U>&nbsp;5.10(d)</U> shall not affect the representations, warranties, covenants or agreements of the parties hereto or the conditions to the obligations of the parties hereto hereunder
and notwithstanding anything to the contrary in this <U>Section</U><U></U><U>&nbsp;5.10(d)</U>, the parties agree that the taking of any such actions will not be taken into account for purposes of determining whether any Offer Condition or condition
to the Transactions has been satisfied or whether any right of termination arises under <U>Article VI</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <U>Conduct
of Buyer</U>. Parent shall cause Buyer to comply with all of its obligations under this Agreement in accordance with the terms and subject to the conditions set forth in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <U>No Control of the Company</U><U>&#146;</U><U>s Business</U>. Nothing contained in this Agreement gives Parent or Buyer,
directly or indirectly, the right to control or direct the Company&#146;s or any of its Subsidiaries&#146; operations prior to the Closing. Prior to the Closing, the Company shall exercise, consistent with the terms and conditions of this Agreement,
complete control and supervision over its and its Subsidiaries&#146; respective operations subject to <U>Section</U><U></U><U>&nbsp;5.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <U>Operations of Buyer</U>. Prior to the Closing, Buyer shall not engage in any other business activities and shall not
incur any liabilities or obligations other than in connection with the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <U>Shareholder Litigation</U>. The
Company shall notify Parent as soon as possible of actions, suits, or claims instituted against the Company or any of its directors or officers relating to or in connection with this Agreement or the Transactions (&#147;<U>Shareholder
Litigation</U>&#148;). The Company shall consult with Parent regarding the defense of any such Shareholder Litigation, and Parent shall have a right to participate in such defense. The Company agrees that it shall not compromise or settle or offer
to compromise or settle any such litigation without the prior written consent of Parent (which consent shall not be unreasonably withheld, delayed or conditioned). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <U>Delisting</U>. Prior to the Closing, the Company shall, at Buyer&#146;s request, cooperate with Parent and Buyer and use
reasonable best efforts to take, or cause to be taken, all actions, and do or cause to be done all things, reasonably necessary, proper or advisable on its part under applicable Laws and rules and policies of the Nasdaq to cause the delisting of the
Company and the Shares from the Nasdaq as promptly as practicable after the Closing and the deregistration of the Shares under the Exchange Act as promptly as practicable after such delisting. If the Company is required to file any quarterly or
annual report by a filing deadline that is imposed by the Exchange Act which falls on a date within the ten (10)&nbsp;days following the date that the Company is expected to be delisted from the Nasdaq, the Company will use its reasonable best
efforts to deliver to Parent at or prior to the Closing a substantial final draft of any such annual or quarterly report reasonably likely to be required to be filed during such period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16 <U>Social and Economic Council Merger Regulation</U>. Promptly after the
date of this Agreement, Buyer shall, also acting on behalf of the Company, notify the Social and Economic Council and the relevant Dutch trade unions, if any, of the Offer in accordance with the provisions of the Social and Economic Council Merger
Regulation for the protection of employees (<I><FONT STYLE="white-space:nowrap">SER-Besluit</FONT> Fusiegedragsregels</I> 2015), if and to the extent applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17 <U>Anti-Takeover Measures</U>. The Company and the Company Board (and any applicable committees thereof) shall take all
actions necessary so that no Anti-Takeover Measure is or becomes applicable to any of the Transactions. If any Anti-Takeover Measure becomes applicable to any of the Transactions, the Company and the Company Board (and any applicable committees
thereof) shall grant such approvals and take such actions as are necessary so that any such Transactions may be consummated as promptly as practicable on the terms contemplated by this Agreement and otherwise act to eliminate such Anti-Takeover
Measures in respect of such Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18 <U>Notification of Certain Matters</U>. The Company shall give prompt notice
to Parent of: (a)&nbsp;the occurrence or <FONT STYLE="white-space:nowrap">non-occurrence</FONT> of any event whose occurrence or <FONT STYLE="white-space:nowrap">non-occurrence,</FONT> as the case may be, would reasonably be expected to prevent or
materially delay the consummation of the Offer or the other Transactions and (b)&nbsp;any notice or other communication from any third Person alleging that the consent of such third Person, which would reasonably be expected to be material to the
Company and its Subsidiaries, taken as a whole, is or may be required in connection with the Offer or the other Transactions. Notwithstanding anything in this Agreement to the contrary, no such notification shall affect the representations,
warranties, covenants or agreements of the parties hereto or the conditions to the obligations of the parties hereto hereunder and notwithstanding anything to the contrary in this <U>Section</U><U></U><U>&nbsp;5.18</U>, the parties agree that the
failure to provide any notice contemplated by this <U>Section</U><U></U><U>&nbsp;5.18</U> will not be taken into account for purposes of determining whether any Offer Condition or condition to the Transactions has been satisfied or whether any right
of termination arises under <U>Article VI</U>, unless the underlying event would independently result in the failure of any Offer Condition or condition to the Transactions to be satisfied or give rise to any right of termination under <U>Article
VI</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19 <U>Parent</U><U>&#146;</U><U>s Financing Activities</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Without limiting the generality of <U>Section</U><U></U><U>&nbsp;5.6</U>, prior to the Closing, the Company shall, and shall cause its
Subsidiaries to, and shall use its reasonable best efforts to cause its and their respective Representatives to, on a timely basis, provide reasonable cooperation requested in writing by Parent that is customary in connection with the arrangement,
marketing, syndication and consummation of any public or private debt financing or any public or private equity offering, including any offering of derivative securities or other securities exchangeable for, or convertible into, equity securities
(and the satisfaction of the conditions precedent to funding thereof) for transactions that are similar to the transactions contemplated by this Agreement. Such cooperation shall, at the reasonable request of Parent or any of its Subsidiaries or
Representatives, include the following to the extent necessary in order to arrange, market, syndicate and consummate such financing: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) furnishing, or causing to be furnished, to Parent or its Subsidiaries or their
Representatives, (A)&nbsp;audited consolidated balance sheets and related audited consolidated statements of income, stockholders&#146; equity and cash flows of the Company for each fiscal year ended after the date hereof and more than sixty
(60)&nbsp;days prior to the Closing Date and (B)&nbsp;unaudited consolidated balance sheets and related unaudited consolidated statements of income and cash flows of the Company for each fiscal quarter ended after the date hereof and more than forty
(40)&nbsp;days prior to the Closing Date, and in the case of clauses (A)&nbsp;and (B), prepared in accordance with GAAP and reviewed (in accordance with applicable accounting standards) by the Company&#146;s accountants and meeting the requirements
of Rule <FONT STYLE="white-space:nowrap">3-05</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Securities Act (with such review (x)&nbsp;including a review of the financial statements for the corresponding period in the
previous fiscal year and (y)&nbsp;being conducted in accordance with applicable accounting standards); <U>provided</U>, that no financial statements need be furnished by the Company until the Company has filed such financial statements on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> or Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> as applicable, with the SEC; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) providing
reasonable assistance to Parent for the preparation of pro forma financial information required to consummate any such financing or to comply with applicable Law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) requesting that the Company&#146;s and its Subsidiaries&#146; independent accountants participate in customary accounting due diligence
sessions upon reasonable advance notice and requesting that such accountants provide customary comfort letters (including &#147;negative assurance&#148; comfort) as are customarily requested in an underwritten offering of securities and consents
customary for Parent&#146;s use of the financial statements of the Company and its Subsidiaries in any marketing or offering materials to be used in connection with such financing, provided that none of the foregoing interfere with any ordinary
course audit or review of the Company&#146;s or its Subsidiaries&#146; financial statements or internal control over financial reporting; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) providing reasonable assistance to Parent and its Subsidiaries in their preparation of customary rating agency presentations, road show
materials, customary bank or <FONT STYLE="white-space:nowrap">co-investor</FONT> information memoranda, prospectuses, bank syndication materials, credit agreements, offering memoranda, private placement memoranda, definitive financing documents (as
well as customary certificates) and similar or related documents customarily prepared in connection with financings of the type described in this <U>Section</U><U></U><U>&nbsp;5.19</U>, and which may incorporate by reference periodic and current
reports filed by the Company with the SEC; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) reasonably cooperating with customary marketing efforts and due diligence efforts of
Parent and its Subsidiaries for all or any portion of such financing; <U>provided</U>, that no officer, director or employee of the Company shall be required to participate in any &#147;roadshow&#148; or similar
<FONT STYLE="white-space:nowrap">in-person</FONT> or telephonic presentation regarding the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) using reasonable best efforts
to deliver to Parent, no later than five (5)&nbsp;Business Days prior to the Closing Date (to the extent requested by Parent no later than ten (10)&nbsp;Business Days prior to the Closing Date), any materials and documentation about the Company and
its Subsidiaries required by any Financing Party under applicable &#147;know your customer&#148; and anti-money laundering rules, applicable Laws and regulations (including the USA PATRIOT Act and the Beneficial Ownership Regulation); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) informing Parent promptly in writing if the chief financial officer of the Company
shall have knowledge of any facts as a result of which a restatement of any of the Company&#146;s or its Subsidiaries&#146; financial statements is necessary; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) reasonably cooperating with Parent and the Financing Parties in connection with providing customary authorization letters in
connection with any debt financing to the Financing Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Agreement to the contrary, (1)&nbsp;neither the Company nor
any of its Affiliates shall be required to (A)&nbsp;pay any commitment or other similar fee in connection with any such financing to be obtained by Parent or any of Parent&#146;s Affiliates in connection with the transactions contemplated by this
Agreement, (B)&nbsp;take any action that would conflict with or violate the Company Organizational Documents or any of its Subsidiaries&#146; organizational documents or any applicable Law or (C)&nbsp;take any action to the extent such action would
interfere in any material respect with the business or operations of the Company or its Subsidiaries, (2)&nbsp;the effectiveness of any documentation executed by the Company with respect thereto, and the attachment of any Lien to any assets of the
Company or any of its Subsidiaries, shall be subject to the consummation of the Closing, (3)&nbsp;the Company (and any of its Subsidiaries) and any director or officer of the Company (or any of its Subsidiaries) shall not be required to execute any
agreement, certificate, document or instrument or adopt any resolutions with respect to any such financing that would be effective prior to the Closing (other than certifications of financial statements and customary authorization letters
contemplated by <U>Section</U><U></U><U>&nbsp;5.19(a)(viii)</U>) and no such directors that shall not be continuing directors shall be required to take any such action, whether effective prior to or after Closing and (4) (A) Parent shall, upon
written request by the Company, reimburse the Company or any of its Subsidiaries for all reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs or expenses actually incurred by
each such Person in complying with their respective covenants pursuant to this <U>Section</U><U></U><U>&nbsp;5.19</U> and (B)&nbsp;Parent shall indemnify and hold harmless the Company, its Subsidiaries and their respective Representatives from and
against any and all liabilities, losses, damages, claims and related reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs or expenses actually suffered or incurred by any of
them of any type in connection with any actual or prospective claim, litigation, investigation or proceeding relating to the arrangement of such financing, other than to the extent any such liabilities, losses, damages, claims or related costs and
expenses are the result of the gross negligence, bad faith or willful misconduct of the Company or its controlled Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All <FONT
STYLE="white-space:nowrap">non-public</FONT> or other confidential information regarding the Company or its Affiliates obtained by Parent, its Affiliates or their respective Representatives, in each case pursuant to this
<U>Section</U><U></U><U>&nbsp;5.19</U>, shall be kept confidential in accordance with the Confidentiality Agreement; <U>provided</U>, that such information may be shared (i)&nbsp;on a confidential basis with prospective Financing Parties during
syndication and marketing of any such financing in connection herewith and with participants in such financing (and, in each case, with their respective counsel and auditors), in each case that enter into confidentiality arrangements customary for
financing transactions of the same type as such financing (including &#147;click-through&#148; confidentiality arrangements), (ii) on a confidential basis with rating agencies and (iii) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by inclusion in a prospectus, confidential offering memorandum or similar offering document used in any financing in connection herewith in order to prevent such document from containing any
misstatement or omission of a material fact necessary to make the statements therein not misleading; <U>provided</U> that in the case of this clause (iii), the Company and its counsel are given a reasonable opportunity to review and comment on the
relevant disclosures and Parent and its Subsidiaries shall incorporate any comments reasonably made by the Company and its counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
The Company hereby consents to the reasonable use of the Company&#146;s and its Affiliates&#146; trademarks, service marks and logos in connection with any such financing; <U>provided</U>, that such trademarks, service marks and logos are used in a
manner that is not intended to or reasonably likely to harm or disparage the Company or its Affiliates or the reputation or goodwill of the Company or its Affiliates, and on such other customary terms and conditions as shall be mutually agreed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent acknowledges and agrees that the obtaining of any such financing is not a condition to the Closing. Notwithstanding anything to the
contrary in this <U>Section</U><U></U><U>&nbsp;5.19</U>, the parties agree that any action taken or omitted to be taken with respect to the matters contemplated by this <U>Section</U><U></U><U>&nbsp;5.19</U> will not be taken into account for
purposes of determining whether any Offer Condition or condition to the Transactions has been satisfied or whether any right of termination arises under <U>Article VI</U> and will not give rise to any Liabilities or obligations of the Company or its
Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20 <U>Ownership of Shares</U>. Prior to the Acceptance Time, Parent and its Subsidiaries shall not, and
shall cause each of its Subsidiaries to not, own (directly or indirectly, beneficially or of record) any Shares, and none of Parent, Buyer, or their respective Affiliates shall hold any rights to acquire any Shares except pursuant to this Agreement.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TERMINATION, AMENDMENT AND WAIVER </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Termination by Mutual Agreement</U>. This Agreement may be terminated, and the Transactions may be abandoned, at any time
prior to the Acceptance Time, by mutual written consent of Parent and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <U>Termination by Either Parent or
the Company</U>. This Agreement may be terminated, and the Transactions may be abandoned, at any time prior to the Acceptance Time, by Parent or the Company if: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) any court or other Governmental Body of competent jurisdiction has issued a final judgment, injunction order, decree or ruling or taken any
other final action permanently restraining, enjoining, or otherwise prohibiting the Offer, Asset Sale, Compulsory Acquisition, Liquidation, Second Step Distribution, the Mergers or any other Transaction, and such judgment, injunction, order, decree,
ruling or other action has become final and <FONT STYLE="white-space:nowrap">non-appealable;</FONT> <U>provided</U>, <U>however</U>, that the right to terminate this Agreement under this <U>Section</U><U></U><U>&nbsp;6.2(a)</U> shall not be
available to any party if the failure of such party to perform or comply with any of its obligations under this Agreement in any material respect has been the principal cause of or principally resulted in the issuance of such judgment, injunction,
order, decree or ruling or the taking of such other action; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Acceptance Time has not occurred on or prior to the date that is twelve
(12)&nbsp;months after the date of this Agreement (the &#147;<U>Outside Date</U>&#148;); <U>provided</U>, <U>however</U>, that if as of such date, the Offer Condition set forth in <U>paragraph 1(b)</U> of <U>Annex I</U> to this Agreement
(Regulatory) is not satisfied but all of the other Offer Conditions shall have been satisfied or waived (other than the Minimum Tender Condition and the delivery of the certificate referenced in <U>paragraph 2(c)</U> of <U>Annex I</U> to this
Agreement, which certificate only need to be capable of being delivered) and the Offer Condition set forth in <U>paragraph 1(b) </U>of <U>Annex I</U> to this Agreement remains capable of being satisfied, then the Outside Date will be automatically
extended until the date that is fifteen (15)&nbsp;months after the date of this Agreement (and such date will then be the Outside Date); <U>provided</U>, <U>however</U>, that the right to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;6.2(b)</U> shall not be available to any party if the failure of such party to perform or comply with any of its obligations under this Agreement in any material respect has been the principal cause of or principally
resulted in the failure of the Acceptance Time to have occurred on or before the Outside Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the Offer (as it may have been
extended and <FONT STYLE="white-space:nowrap">re-extended</FONT> in accordance with the terms of this Agreement) expires as a result of the <FONT STYLE="white-space:nowrap">non-satisfaction</FONT> of any Offer Condition or is terminated pursuant to
its terms and this Agreement without Buyer having accepted for purchase any Shares validly tendered (and not withdrawn) pursuant to the Offer; <U>provided</U>, <U>however</U>, that the right to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;6.2(c)</U> shall not be available to any party if the failure of such party to perform or comply with any of its obligations under this Agreement in any material respect has been the principal cause of or principally
resulted in the <FONT STYLE="white-space:nowrap">non-satisfaction</FONT> of any Offer Condition or the termination of the Offer pursuant to its terms without Buyer having accepted for purchase any Shares validly tendered (and not withdrawn) pursuant
to the Offer; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) the EGM has been held and been concluded and (i)&nbsp;the Governance Resolutions have not been adopted,
(ii)&nbsp;the Asset Sale Resolutions have not been adopted, (iii)&nbsp;the Merger Resolutions have not been adopted or (iv)&nbsp;the Demerger Resolutions have not been adopted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3 <U>Termination by the Company</U>. This Agreement may be terminated, and the Transactions may be abandoned, at any time prior
to the Acceptance Time, by the Company: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) if (i)&nbsp;Buyer fails to commence the Offer in violation of
<U>Section</U><U></U><U>&nbsp;2.1</U> hereof or (ii)&nbsp;Buyer, in violation of the terms of this Agreement, fails to accept for purchase Shares validly tendered (and not withdrawn) pursuant to the Offer; <U>provided</U>, <U>however</U>, that the
right to terminate this Agreement pursuant to clause (i)&nbsp;of this <U>Section</U><U></U><U>&nbsp;6.3(a)</U> shall not be available if the Company shall have breached its obligations under this Agreement in any manner that shall have been the
principal cause of or principally resulted in the failure of the Offer to so commence; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) if there has been a breach of any covenant or agreement made by Parent or Buyer in this
Agreement, or any representation or warranty of Parent or Buyer is inaccurate or becomes inaccurate after the date of this Agreement, and such breach or inaccuracy gives rise to a Buyer Material Adverse Effect, and such breach or inaccuracy is not
capable of being cured within thirty (30)&nbsp;days following receipt by Parent or Buyer of written notice from the Company of such breach or inaccuracy or, if such breach or inaccuracy is capable of being cured within such period, it has not been
cured within such period (provided that the Company may not terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;6.3(b)</U> if the Company is then in material breach of any of its representations, warranties, covenants or
agreements hereunder); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) in order for the Company to enter into a definitive Alternative Acquisition Agreement with respect to a
Superior Proposal to the extent permitted by, and subject to the applicable terms and conditions of, <U>Section</U><U></U><U>&nbsp;5.3(e)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4 <U>Termination by Parent</U>. This Agreement may be terminated, and the Transactions may be abandoned, at any time prior to
the Acceptance Time, by Parent if: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) there has been a breach of any covenant or agreement made by the Company in this Agreement, or any
representation or warranty of the Company is inaccurate or becomes inaccurate after the date of this Agreement, and such breach or inaccuracy gives rise to a failure of the condition set forth in <U>paragraph 2(b)</U> of <U>Annex I</U> to this
Agreement, and such breach or inaccuracy is not capable of being cured within thirty (30)&nbsp;days following receipt by the Company of written notice from Parent or Buyer of such breach or inaccuracy or, if such breach or inaccuracy is capable of
being cured within such period, it has not been cured within such period (provided that Parent may not terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;6.4(a)</U> if Parent or Buyer is then in material breach of any of its
representations, warranties, covenants or agreements hereunder); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i) the Company Board or any committee thereof effects a Change
of Board Recommendation or (ii)&nbsp;the Company Board or any committee thereof or the Company breaches in any material respect <U>Section</U><U></U><U>&nbsp;5.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5 <U>Effect of Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In the event of termination of this Agreement pursuant to this <U>Article VI</U>, this Agreement (other than the last sentence of
<U>Section</U><U></U><U>&nbsp;2.2(a)</U>, <U>Section</U><U></U><U>&nbsp;5.2(b)</U>, this <U>Section</U><U></U><U>&nbsp;6.5</U> and <U>Article VII</U>, each of which will survive any termination hereof) will become void and of no effect with no
liability on the part of any party (or of any of its Representatives) and all rights and obligations of any party shall cease; <U>provided</U>, <U>however</U>, no such termination will relieve any Person of any liability for damages resulting from a
material breach of this Agreement that is a consequence of an act or omission intentionally undertaken by the breaching party with the knowledge that such act or omission would, or would reasonably be expected to, result in a material breach of this
Agreement (an &#147;<U>Intentional Breach</U>&#148;) or fraud. Parent shall cause the Offer to be terminated immediately after any termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)
this Agreement is terminated by the Company pursuant to <U>Section</U><U></U><U>&nbsp;6.3(c)</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) this Agreement is terminated by
Parent pursuant to <U>Section</U><U></U><U>&nbsp;6.4(b)</U>; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) (A) this Agreement is terminated by (x)&nbsp;Parent pursuant to
<U>Section</U><U></U><U>&nbsp;6.4(a)</U> on the basis of a breach of a covenant or agreement, (y)&nbsp;either party pursuant to <U>Section</U><U></U><U>&nbsp;6.2(d)</U> or (z)&nbsp;either Parent or the Company pursuant to
<U>Section</U><U></U><U>&nbsp;6.2(b)</U> or <U>Section</U><U></U><U>&nbsp;6.2(c)</U> (and in the case of a termination by either Parent or the Company pursuant to <U>Section</U><U></U><U>&nbsp;6.2(c)</U>, at the time of the expiration or termination
of the Offer, all Offer Conditions (other than the Minimum Tender Condition and the delivery of the certificate referenced in Paragraph 2(c) of <U>Annex I</U> to this Agreement, which certificate only need to be capable of being delivered) were
satisfied or waived), (B) in any such termination under clause (A), prior to such termination, an Acquisition Proposal made after the date of this Agreement has been publicly disclosed and not publicly withdrawn or is otherwise known to the Company
Board and not withdrawn (publicly, if publicly disclosed) and (C)&nbsp;within twelve (12)&nbsp;months after any such termination, the Company or any of its Subsidiaries enters into an Alternative Acquisition Agreement with respect to any Acquisition
Proposal (regardless of when or whether such transaction is consummated) or any Acquisition Proposal is consummated (<U>provided</U>, that for purposes of clause (C)&nbsp;of this <U>Section</U><U></U><U>&nbsp;6.5(b)(iii)</U>, references to
&#147;fifteen percent (15%) or more &#148; in the definition of Acquisition Proposal will be substituted for &#147;more than fifty percent (50%)&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Then, in any such case, the Company shall pay Parent a termination fee of $150,000,000, by wire transfer of immediately available funds to the account or
accounts designated by Parent. Any payment required to be made (1)&nbsp;pursuant to <U>clause</U><U></U><U>&nbsp;(i)</U> of this <U>Section</U><U></U><U>&nbsp;6.5(b)</U> will be paid concurrently with such termination, (2)&nbsp;pursuant to
<U>clause</U><U></U><U>&nbsp;(ii)</U> of this <U>Section</U><U></U><U>&nbsp;6.5(b)</U> will be paid no later than two (2)&nbsp;Business Days after such termination and (3)&nbsp;pursuant to <U>clause</U><U></U><U>&nbsp;(iii)</U> of this
<U>Section</U><U></U><U>&nbsp;6.5(b)</U> will be payable to Parent upon the earlier of the consummation of, or entry into an Alternative Acquisition Agreement with respect to, the transaction referenced therein. The Company will not be required to
pay the termination fee pursuant to this <U>Section</U><U></U><U>&nbsp;6.5(b)</U> more than once. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company acknowledges that the
agreements contained in <U>Section</U><U></U><U>&nbsp;6.5(b)</U> are an integral part of the Transactions, and that, without these agreements, Parent and Buyer would not have entered into this Agreement. Accordingly, if the Company fails to promptly
pay the amount due pursuant to <U>Section</U><U></U><U>&nbsp;6.5(b)</U> and, in order to obtain such payment, Parent or Buyer commences a suit that results in a judgment against the Company for the amount set forth in
<U>Section</U><U></U><U>&nbsp;6.5(b)</U>, the Company shall pay to Parent or Buyer their costs and expenses in connection with such suit (including reasonable attorneys&#146; fees), together interest on such amount at the prime rate as published in
the Wall Street Journal in effect on the date such payment was required to be made through the date of payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6
<U>Expenses</U>. Except as otherwise specifically provided herein, each party shall bear its own expenses in connection with this Agreement and the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7 <U>Amendment and Waiver</U>. This Agreement may not be amended except by an instrument in writing signed by the parties
hereto. The Company, on the one hand, and Parent and Buyer, on the other hand, may (a)&nbsp;extend the time for the performance of any of the obligations or other acts of the other, (b)&nbsp;waive any inaccuracies in the representations and
warranties of the other contained herein or in any document delivered pursuant hereto and (c)&nbsp;subject to the requirements of applicable Law, waive compliance by the other with any of the agreements or conditions contained herein, except that
the Minimum Tender Condition may only </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be waived by Parent or Buyer with the prior written consent of the Company. Any such extension or waiver will be valid only if set forth in an instrument in writing signed by the party or parties
to be bound thereby. The failure of any party to assert any rights or remedies will not constitute a waiver of such rights or remedies. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>GENERAL
PROVISIONS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1 <U><FONT STYLE="white-space:nowrap">Non-Survival</FONT> of Representations, Warranties, Covenants and
Agreements</U>. None of the representations, warranties, covenants and agreements in this Agreement or in any instrument delivered pursuant to this Agreement, including any rights arising out of any breach of such representations, warranties,
covenants and agreements, will survive the Closing, except for (a)&nbsp;those covenants and agreements contained herein that by their terms apply or are to be performed in whole or in part after the Closing and (b)&nbsp;this
<U>Article</U><U></U><U>&nbsp;VII</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2 <U>Notices</U>. All notices, requests, claims, demands and other communications
hereunder must be in writing and must be given (and will be deemed to have been duly given): (a)&nbsp;when delivered, if delivered in Person, (b)&nbsp;when sent, if sent by email, (c)&nbsp;three (3)&nbsp;Business Days after sending, if sent by
registered or certified mail (postage prepaid, return receipt requested) and (d)&nbsp;one (1) Business Day after sending, if sent by overnight courier, in each case, to the respective parties at the following addresses (or at such other address for
a party as have been specified by like notice): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to Parent or Buyer: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Stryker Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">2825
Airview Boulevard </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Kalamazoo, MI 49002 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Robert S. Fletcher </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with an additional copy
(which will not constitute notice) to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">155 North Wacker Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Chicago, IL 60606 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention:
Richard C. Witzel, Jr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: richard.witzel@skadden.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Houthoff Co&ouml;peratief
U.A. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Gustav Mahlerplein 50 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">1082 MA Amsterdam </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The
Netherlands </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Alexander Kaarls </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: a.kaarls@houthoff.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the Company: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Wright Medical Group N.V. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">1023
Cherry Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Memphis, TN 28117 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Lance Berry, Executive Vice President and Chief Financial and Operations Officer, and James Lightman, Senior Vice President and
General Counsel </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">Email:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">lance.berry@wright.com </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">james.lightman@wright.com </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with an additional copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Ropes&nbsp;&amp; Gray LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Prudential Tower </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">800 Boylston
Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Boston, MA 02199 </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">Attention:&nbsp;&nbsp;&nbsp;Zachary</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">R. Blume </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Paul M. Kinsella </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">Email:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">zachary.blume@ropesgray.com </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">paul.kinsella@ropesgray.com </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Stibbe N.V. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Beethovenplein 10 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">1070 AP
Amsterdam </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">The Netherlands </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">Attention:&nbsp;&nbsp;&nbsp;Duco</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">de Boer </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">Email:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">duco.deboer@stibbe.com </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3 <U>Severability</U>. If any term or other provision of this Agreement is held by a court of competent jurisdiction to be
invalid, illegal, or incapable of being enforced by any rule of law or public policy, the remaining provisions of this Agreement (i)&nbsp;shall remain in full force and effect and (ii)&nbsp;will be enforced so as to conform to the original intent of
the parties as closely as possible in an acceptable manner so that the Transactions are fulfilled to the fullest extent possible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4 <U>Assignment</U>. This Agreement may not be assigned by operation of law or otherwise without the prior written consent of
each of the other parties; <U>provided</U>, that Buyer may assign any or all of its rights, interests and obligations hereunder to one or more direct or indirect wholly owned Subsidiaries of Parent without the Company&#146;s consent;
<U>provided</U>, <U>further</U>, that such assignment will not materially impede or delay the consummation of the Transactions or otherwise materially impact the rights of the Company or the shareholders of the Company under this Agreement. Subject
to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective permitted successors and assigns. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.5 <U>Entire Agreement; Third-Party Beneficiaries</U>. This Agreement
(including the Company Disclosure Letter and the exhibits, annexes, and instruments referred to herein) constitutes the entire agreement and supersedes all prior agreements and understandings, both written and oral, among the parties with respect to
the subject matter hereof; <U>provided</U>, <U>however</U>, that the Confidentiality Agreement will survive the execution or termination of this Agreement and remains in full force and effect. Except for (a)&nbsp;after the Closing, the rights of the
holders of Shares to receive the Offer Consideration, and the holders of Company Equity Awards to receive the consideration described in <U>Section</U><U></U><U>&nbsp;2.3</U>, (b) the right of the Company, on behalf of the holders of Shares and the
holders of Company Equity Awards, to pursue specific performance as set forth in <U>Section</U><U></U><U>&nbsp;7.12</U> or, if specific performance is not sought or granted as a remedy, damages (which damages the parties agree may be based upon a
decrease in share value or lost premium) in the event of Parent&#146;s or Buyer&#146;s Intentional Breach of this Agreement, which right is hereby acknowledged and agreed by Parent and Buyer, (c)&nbsp;the provisions of
<U>Section</U><U></U><U>&nbsp;2.4(a)(v)</U> and <U>Section</U><U></U><U>&nbsp;2.5(e)</U> (which are intended to be for the benefit of, and shall be enforceable by the directors in office at the time of holding the EGM or Subsequent EGM, as
applicable, and any Independent Director as referred to in <U>Section</U><U></U><U>&nbsp;2.5</U> and all members of the Company Board resigning at the Acceptance Time), and (d)&nbsp;as provided in <U>Section</U><U></U><U>&nbsp;5.5</U> (which is
intended for the benefit of the Indemnified Parties, all of whom will be third-party beneficiaries of these provisions) this Agreement is not intended to confer upon any Person other than the parties hereto any rights or remedies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.6 <U>Governing Law</U>. This Agreement and any Action arising out of or relating to this Agreement or the Transactions, will be
governed by, and construed in accordance with, the Laws of the State of Delaware, regardless of the Laws that might otherwise govern under applicable principles of conflicts of laws thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.7 <U>Headings</U>. The descriptive headings contained in this Agreement are included for convenience of reference only and will
not affect in any way the meaning or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.8 <U>Counterparts</U>. This Agreement may be
executed and delivered (including by facsimile or email transmission) in two (2)&nbsp;or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed will be deemed to be an original but all of which
taken together will constitute one and the same agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.9 <U>Performance Guaranty</U>. Parent hereby guarantees the
performance and discharge by, and compliance with, all of the obligations, covenants, terms, conditions and undertakings of Buyer under this Agreement in accordance with the terms, and subject to the conditions, hereof, including any such
obligations, covenants, terms, conditions and undertakings that are required to be performed discharged or complied with following the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10 <U>Jurisdiction; Waiver of Jury Trial</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the parties hereto hereby (i)&nbsp;expressly and irrevocably submits to the exclusive personal jurisdiction of the Court of
Chancery of the State of Delaware or&nbsp;if such Court of Chancery lacks subject matter jurisdiction, the United States District Court for the District of Delaware, in the event any dispute arises out of this Agreement, the Offer, or the other
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Transactions, (ii)&nbsp;agrees that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court and (iii)&nbsp;agrees that it shall
not bring any action relating to this Agreement, the Offer, or the other Transactions in any court other than the Court of Chancery of the State of Delaware or if such Court of Chancery lacks subject matter jurisdiction, the United States District
Court for the District of Delaware; <U>provided</U>, that, each of the parties has the right to bring any action or proceeding for enforcement of a judgment entered by such court in any other court or jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND
DIFFICULT ISSUES, AND THEREFORE SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LITIGATION ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS AGREEMENT. EACH PARTY CERTIFIES AND
ACKNOWLEDGES THAT (I)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II)&nbsp;EACH PARTY UNDERSTANDS AND
HAS CONSIDERED THE IMPLICATION OF THIS WAIVER, (III)&nbsp;EACH PARTY MAKES THIS WAIVER VOLUNTARILY AND (IV)&nbsp;EACH OTHER PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS
SECTION. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.11 <U>Service of Process</U>. Each party irrevocably consents to the service of process in any action or
proceeding arising out of or relating to this Agreement or the Transactions outside the territorial jurisdiction of the courts referred to in <U>Section</U><U></U><U>&nbsp;7.10(a)</U> by mailing copies thereof by registered United States mail,
postage prepaid, return receipt requested, to its address as specified in or pursuant to <U>Section</U><U></U><U>&nbsp;7.2</U>. However, the foregoing will not limit the right of a party to effect service of process on the other party by any other
legally available method. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.12 <U>Specific Performance</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The parties hereto acknowledge and agree that, in the event of any breach of this Agreement, irreparable harm would occur that monetary
damages could not make whole. It is accordingly agreed that (i)&nbsp;each party hereto will be entitled, in addition to any other remedy to which it may be entitled at law or in equity, to compel specific performance to prevent or restrain breaches
or threatened breaches of this Agreement in any action without the posting of a bond or undertaking and (ii)&nbsp;the parties hereto will, and hereby do, waive, in any action for specific performance, the defense of adequacy of a remedy at law and
any other objections to specific performance of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the parties&#146; rights to specific performance
pursuant to <U>Section</U><U></U><U>&nbsp;7.12(a)</U>, each party may pursue any other remedy available to it at law or in equity, including monetary damages; <U>provided</U>, that, it is understood and agreed that claims for monetary damages
following termination of this Agreement will be limited to those arising from or relating to any Intentional Breach of this Agreement or fraud prior to such termination. Notwithstanding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
anything in this Agreement to the contrary, prior to the termination of this Agreement in accordance with its terms, no party hereto is permitted to make any claim or commence any Action seeking
monetary damages against any other party hereto in connection with or arising out of this Agreement or the Transactions; <U>provided</U>, that, the foregoing is without prejudice to the right of any party to seek such monetary damages following such
termination in accordance with, and subject to the limitations set forth in, this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.13 <U>Interpretation</U>.
When reference is made in this Agreement to a Section, such reference will be to a Section of this Agreement unless otherwise indicated. Whenever the words &#147;include,&#148; &#147;includes,&#148; or &#147;including&#148; are used in this
Agreement, they will be deemed to be followed by the words &#147;without limitation.&#148; The words &#147;hereof,&#148; &#147;herein,&#148; &#147;hereby,&#148; &#147;hereto,&#148; and &#147;hereunder&#148; and words of similar import when used in
this Agreement will refer to this Agreement as a whole and not to any particular provision of this Agreement. The word &#147;or&#148; will not be exclusive. Whenever used in this Agreement, any noun or pronoun will be deemed to include the plural as
well as the singular and to cover all genders. The terms &#147;Dollars&#148; and &#147;$&#148; shall refer to the lawful currency of the United States and references to &#147;&#128;&#148; or &#147;Euros&#148; shall refer to the lawful currency of
the European Union. Any references herein to a Law means such Law as amended from time to time and includes any successor Law thereto and any regulations promulgated thereunder. References to a Person are also to its permitted successors and
assigns. Except with respect to <U>Section</U><U></U><U>&nbsp;5.3</U>, the words &#147;made available to Parent&#148; and words of similar import refer to information posted to the electronic data room for &#147;Project Atlantic&#148; hosted by
Intralinks at least one (1)&nbsp;calendar day prior to the date hereof. This Agreement will be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting or causing any instrument to be
drafted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of Page Left Blank Intentionally] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of Parent, Buyer and the Company has caused this Agreement to be
executed as of the date first written above by their respective officers thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">STRYKER CORPORATION</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Kevin A. Lobo</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Kevin A. Lobo</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chairman and Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signature Page to Purchase Agreement </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of Parent, Buyer and the Company has caused this Agreement to be
executed as of the date first written above by their respective officers thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">STRYKER B.V.</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Spencer S. Stiles</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Spencer S. Stiles</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Managing Director</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Stuart A. J. Silk</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Stuart A. J. Silk</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Managing Director</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signature Page to Purchase Agreement </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of Parent, Buyer and the Company has caused this Agreement to be
executed as of the date first written above by their respective officers thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">WRIGHT MEDICAL GROUP N.V.</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Robert J. Palmisano</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Robert J. Palmisano</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer and Executive Director</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signature Page to Purchase Agreement </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>Annex I </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OFFER CONDITIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capitalized terms used in this <U>Annex</U><U></U><U>&nbsp;I</U> and not otherwise defined herein have the meanings assigned to them in the
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Buyer is not required to accept for payment or, subject to any applicable rules and regulations of the SEC, including Rule <FONT
STYLE="white-space:nowrap">14e-l(c)</FONT> under the Exchange Act (relating to Buyer&#146;s obligation to pay for or return tendered Shares promptly after the termination or withdrawal of the Offer), to pay for any Shares validly tendered and not
properly withdrawn in connection with the Offer, unless, immediately prior to the then applicable Expiration Time: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) there have been
validly tendered in accordance with the terms of the Offer, and not properly withdrawn, a number of Shares (excluding Shares tendered pursuant to guaranteed delivery procedures that have not yet been delivered in settlement or satisfaction of such
guarantee prior to the Expiration Time) that, together with the Shares then owned by Parent or its wholly owned Subsidiaries, represents at least ninety-five percent (95%) of the Company&#146;s issued and outstanding capital (<I>geplaatst en
uitstaand kapitaal</I>) immediately prior to the Expiration Time (the &#147;<U>Minimum Tender Condition</U>&#148;); <U>provided</U>, that Buyer may, in its sole discretion, amend at any time and from time to time any reference to &#147;ninety-five
percent (95%)&#148; in the foregoing definition of Minimum Tender Condition to a percentage not less than &#147;eighty percent (80%)&#148;; <U>provided</U>, <U>further</U>, that if, prior to the Expiration Time, the Asset Sale Resolutions, the
Merger Resolutions and the Demerger Resolutions have been adopted at the EGM (or any Subsequent EGM), the reference to &#147;ninety-five percent (95%)&#148; in the foregoing definition of Minimum Tender Condition shall be deemed to be a reference to
&#147;eighty percent (80%)&#148;; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any applicable waiting period (and any extension thereof) under the HSR Act and the Antitrust
Laws listed on <U>Annex III</U> of the Agreement has expired or been terminated, and any relevant approvals, consents or waivers pursuant to the Antitrust Laws listed on <U>Annex III</U> of the Agreement have been obtained and, in each case, shall
not impose a condition or require a Remedy that Parent is not required to accept or agree to after giving effect to <U>Section</U><U></U><U>&nbsp;5.6</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Additionally, Buyer is not required to accept for payment or, subject to any applicable rules and regulations of the SEC, including Rule <FONT
STYLE="white-space:nowrap">14e-l(c)</FONT> under the Exchange Act (relating to Buyer&#146;s obligation to pay for or return tendered Shares promptly after the termination or withdrawal of the Offer), to pay for any Shares validly tendered and not
properly withdrawn in connection with the Offer if, immediately prior to the then applicable Expiration Time, any of the following conditions exist: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) there has been any Law or judgment, injunction, order, decree or ruling (whether temporary, preliminary or permanent), entered, enacted,
promulgated, enforced or issued by any court or other Governmental Body of competent jurisdiction that is then in effect that prohibits, renders illegal or enjoins, the consummation of the Offer, the Asset Sale, the Compulsory Acquisition, the
Liquidation, the Second Step Distribution, the Mergers or the other Transactions or that imposes a condition or requires a Remedy that Parent is not required to accept or agree to after giving effect to <U>Section</U><U></U><U>&nbsp;5.6</U> of the
Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i)&nbsp;the Company has breached or failed to comply in any material respect with any
of its agreements or covenants to be performed or complied with by it under the Agreement on or before the Acceptance Time, (ii)&nbsp;the representations and warranties of the Company contained in the Agreement (other than the representations and
warranties set forth in <U>Section</U><U></U><U>&nbsp;3.2</U> (Authorization; Valid and Binding Agreement), <U>Section</U><U></U><U>&nbsp;3.3(a)</U>, the first sentences of <U>Section</U><U></U><U>&nbsp;3.3(b)</U> and
<U>Section</U><U></U><U>&nbsp;3.3(c)</U>, <U>Sections 3.3(d)</U>-(f) and <U>Section</U><U></U><U>&nbsp;3.3(h)</U> (to the extent it relates to the Company, its share capital or other interests therein) (Capitalization),
<U>Section</U><U></U><U>&nbsp;3.5(a)(i)</U> (No Breach), the first sentence of <U>Section</U><U></U><U>&nbsp;3.9</U> (Absence of Certain Developments), <U>Section</U><U></U><U>&nbsp;3.21</U> (Brokerage), <U>Section</U><U></U><U>&nbsp;3.23
</U>(Anti-Takeover Measures) and <U>Section</U><U></U><U>&nbsp;3.24</U> (Opinion)) and that (x)&nbsp;are not made as of a specific date are not true and correct as of the Expiration Time, as though made on and as of the Expiration Time and
(y)&nbsp;are made as of a specific date are not true as of such date, in each case, except, in the case of (x)&nbsp;or (y), where the failure of such representations and warranties to be true and correct (without giving effect to any limitation as
to &#147;materiality&#148; or &#147;Company Material Adverse Effect&#148;) has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (iii)&nbsp;the representations and warranties
set forth in <U>Section</U><U></U><U>&nbsp;3.2</U> (Authorization; Valid and Binding Agreement), <U>Section</U><U></U><U>&nbsp;3.3(a)</U>, the first sentence of <U>Section</U><U></U><U>&nbsp;3.3(c)</U>, <U>Sections 3.3(d)</U>-(f) and
<U>Section</U><U></U><U>&nbsp;3.3(h)</U> (to the extent it relates to the Company, its share capital or other interests therein) (Capitalization), <U>Section</U><U></U><U>&nbsp;3.5(a)(i)</U> (No Breach), the first sentence of
<U>Section</U><U></U><U>&nbsp;3.9</U> (Absence of Certain Developments) and <U>Section</U><U></U><U>&nbsp;3.23</U> (Anti-Takeover Measures) are not true and correct in all respects, except in the case of <U>Section</U><U></U><U>&nbsp;3.3(a)</U>, the
first sentence of <U>Section</U><U></U><U>&nbsp;3.3(c)</U>, <U>Sections 3.3(d)</U>-(f) and <U>Section</U><U></U><U>&nbsp;3.3(h)</U> (to the extent it relates to the Company, its share capital or other interests therein) (Capitalization) for <I>de
minimis</I> inaccuracies, as of the Expiration Time as though made on and as of such date and time (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty
is not so true and correct or (iv)&nbsp;the representations and warranties set forth in the first sentence of <U>Section</U><U></U><U>&nbsp;3.3(b)</U> (Capitalization), <U>Section</U><U></U><U>&nbsp;3.21</U> (Brokerage) and
<U>Section</U><U></U><U>&nbsp;3.24</U> (Opinion) are not true and correct in all material respects as of the Expiration Time as though made on and as of such date and time (except to the extent that any such representation and warranty expressly
speaks as of an earlier date, in which case such representation and warranty is not so true and correct as of such earlier date); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the
Company has not delivered to Parent a certificate dated as of the Expiration Time signed on behalf of the Company by a senior executive officer of the Company to the effect that the conditions set forth in <U>Paragraphs</U><U></U><U>&nbsp;2(b)</U>
and <U>2(d)</U> have been satisfied as of the Expiration Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) since the date of the Agreement, there has occurred any change,
effect, event, inaccuracy, occurrence or other matter that has had, or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the resignations of the existing members of the Company Board as contemplated by <U>Section</U><U></U><U>&nbsp;2.5(a)</U> of the Agreement
have not been obtained; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) the Governance Resolutions have not been adopted at the EGM or a Subsequent EGM; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) the Agreement has been terminated pursuant to its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The conditions set forth in this <U>Annex I</U> are for the benefit of Parent and Buyer and (except for the Minimum Tender Condition and the
condition set forth in paragraph 2(g)) may be waived (where permitted by applicable Law) by Parent or Buyer in whole or in part at any time or from time to time prior to the Expiration Time, in each case, subject to the terms and conditions of the
Agreement and the applicable rules and regulations of the SEC. The foregoing conditions shall be in addition to, and not a limitation of, the rights and obligations of Buyer to extend, terminate, amend and/or modify the Offer in accordance with the
terms and conditions of the Agreement and the applicable rules and regulations of the SEC. The failure by Parent or Buyer at any time to exercise any of the foregoing rights shall not be deemed a waiver of any such right and each such right shall be
deemed an ongoing right that may be asserted at any time and from time to time. In addition, each of the foregoing conditions is independent of any of the other foregoing conditions; the exclusion of any event from a particular condition does not
mean that such event may not be included in another condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
